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Abstract
Geobacillus thermoglucosidasius has been identified as an organism capable of producing bio-
ethanol from lignocellulosic biomass based on its ability to ferment both hexose and pentose
sugars. Engineering of the wild-type strain DL33 (wt) has produced a single knock out strain
DL44 (∆ldh) and a double knock out strain DL66 (∆ldh∆pfl↑pdh), both of which have increased
capacity for bioethanol production. The nutritional requirements of the strains under anaerobic
conditions are yet to be fully understood.
In this study, a systems approach to understanding the metabolism of the wild-type and engi-
neered strains has been taken in order to further understand the changes in metabolism resulting
from the mutations introduced. For the first time 13C-metabolic flux analysis has been applied to
the comparative study of the wild-type and engineered strains using global isotopomer balancing.
This has revealed flux through the anaplerotic reactions has reversed from being in the direction
of pyruvate / phosphoenolpyruvate in the wild-type, to being in the direction of oxaloacetate /
malate in the engineered strains. Alterations in TCA cycle flux between the strains were also
seen. Furthermore alanine was found to be produced as a fermentation product in each strain.
Analysis of the genome sequence has revealed an unusual oxidative branch of the pentose
phosphate pathway, missing 6-phosphogluconolactonase but with genes encoding the rest of
the pathway still present, suggesting that flux through this pathway may still proceed, dependent
on the themolability of glucono-1,5-lactone-6-phosphate.
It has been found that RNA extracted from G. thermoglucosidasius is prone to rapid degrada-
tion which may affect the outcome of analysis of the transcriptome by RNA-seq. Nonetheless,
it has been possible to apply RNA-seq to the wild-type organism grown aerobically and use this
to identify transcripts for the major pathways of central carbon metabolism and the most highly
expressed transcripts of the culture.
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1Introduction
1.1 Systems biology
1.1.1 What is systems biology?
Systems biology is the study of biological organisms at a whole system level and thus seeks to
develop a more complete understanding of an organism and cellular processes rather than focus-
ing on individual proteins and genes, which has previously been the dominant focus in molecular
biology [1–3]. Kitano [2] describes four key properties of biological systems which need to be
elucidated for a systems-wide understanding of a cell - structure of the system, dynamics of the
system, mechanism for control of the system and having the ability to rationally design desired
properties within the system. The field has been divided into "top-down" approaches, that is the
understanding of networks based on correlations in ’omics’ studies, or "bottom-up" approaches,
which by contrast seek to understand a whole system using molecular methods [3]. The top
down approach is the most common, which has become possible through functional genomics
studies, and it is this division of systems biology which will be dealt with here.
Advancements in this area of systems biology are being driven by developments in both molecu-
lar biology and computer science [2]; computational tools are of great importance within systems
biology due to the large volume and complexity of data such studies generate. Techniques for
systems wide analysis span the various levels of cellular hierarchy - genomic, transcriptomic,
proteomic, metabolomic and fluxomic [4, 5]. In micro-organisms this approach enables a greater
understanding of microbial metabolism to be developed, which is fuelling more effective engi-
neering of organisms for required purposes. This is described in more detail below.
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1.1.2 Application of systems biology in metabolic engineering of micro-
organisms
Metabolic engineering increasingly seeks to produce biofuels and chemicals in model and non-
model micro-organisms, in order to make use of the diverse metabolic pathways they offer. To
make novel compounds or products from complex substrates such as lignocellulosic biomass
an increased understanding of control of metabolism is required to help drive this development.
There are three approaches that have been applied to the engineering of microbial metabolism
- random mutagenesis, metabolic engineering and pathway modification based on the overall
cellular system, so called ’systems metabolic engineering’ [5].
Traditionally, random mutagenesis and selection has been used in the metabolic engineering
of micro-organisms to create mutants exhibiting a desired phenotype and has provided strains
capable of producing useful compounds such as amino acids, proteins with increased activity
or stability and fermentation products [5–10]. However there are problems associated with this
method of strain development. Random mutagenesis produces many mutations which may not
be related to the intended phenotypic outcome; this can result in increased nutritional require-
ments of the strains due to loss of biosynthetic pathways [7]. Additionally strains may also exhibit
slower growth rates, lower tolerance to stress and increased byproduct formation, which reduce
final product yields [5–7]. Ultimately strains produced by this method may exhibit several pheno-
typic disadvantages and may become resistant to further development [7].
Due to the limitations of random mutagenesis, attempts have been made to direct engineering
through logical targeting of steps in the pathway of interest. This has been done by building
on endogenous pathways and reactions within the organism through insertion of heterologous
genes or altering genomic regulatory elements [5, 11]. This approach to metabolic engineering
has been applied to numerous organisms and has proven effective in producing many strains that
exhibit a desired phenotype not present in the wild type organism. It has been applied extensively
in the targeting of fermentation pathways to produce ethanol and longer chain alcohols, both in
thermophiles and mesophiles [12–15]. The limitations of this technique, however, lie in the focus
on local pathways rather than being system wide. This has therefore led to the development of
systems metabolic engineering [5].
Systems metabolic engineering was proposed by Park et al. [5] as metabolic engineering aided
by new systems biology tools that enable engineering to be carried out in the context of the entire
cellular system (Fig. 1.1). Once a base strain has been produced by the metabolic engineering
of known regulatory steps, a systems metabolic engineering approach is applied in order to seek
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further targets for strain development [6]. The movement towards optimising cells at the systems
level has been aided by a reduction in the cost of genome and transcript analysis and sequencing
together with improvements in metabolomic and fluxomic methods.
Figure 1.1: Overview of common systems biology approaches used to guide the rational
metabolic engineering of micro-organisms.
This approach has been used in the development of E. coli strains expressing high yields of
L-valine [5] and L-threonine [16]. In both studies, production of the respective amino acid was
increased by first targeting the metabolic and regulatory elements based on literature information
and then using transcriptomic and in silico constraint-based flux analysis. In the case of L-valine
synthesis, the authors were able to achieve titres in excess of those produced using the indus-
trial strains created by random mutagenesis [6]. Further examples of how systems metabolic
engineering has recently been implemented are summarised in Table 1.1. The contribution of
systems biology tools to the engineering of micro-organisms is discussed at each level of the
biological hierarchy below.
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Table 1.1: Studies applying systems metabolic engineering to the de-
velopment of micro-organisms and their outcomes
Systems biology
tool(s)
Organism Findings Reference
Flux balance analy-
sis (FBA)
Saccharomyces
cerevisiae
Creation of an engineered strain
capable of muconic acid produc-
tion 24 times higher than seen in
the wild type organism
[17]
13C -Metabolic flux
analysis (13C-MFA)
Corynebacterium
glutamicum
L-lysine yield more than dou-
bled from 114 mmol mol-1 af-
ter metabolic engineering to 258
mmol mol-1 after making further
mutations based on systems wide
analysis of the cell
[7]
FBA E. coli Produced strain capable of 1,4-
butanediol titres of 18 g-1, sys-
tems wide analysis of the cell re-
sulted in 3 fold increase in end
product titre relative to starting en-
gineered strain.
[18]
FBA E. coli Engineering resulted in 4-fold
higher malonyl-CoA production
relative to wild type, strain also
able to produce 474 mg L-1 of the
plant secondary metabolite narin-
genin
[19]
FBA Pseudomonas
putida
Produced FBA model and vali-
dated with experimental analyses
including 13C-MFA to determine
targets for increased polyhydrox-
yalkanoate production
[20]
Continued on next page
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Systems biology
tool(s)
Organism Findings Reference
Transcriptomic anal-
ysis - microarrays
and metabolomics
P. putida Comparison of wild type and ri-
boflavin producing strains for tran-
scriptomic, metabolomic and ge-
netic differences revealed rational
targets for engineering resulting in
a 25 % increase in riboflavin pro-
duction.
[21]
Metabolomics S. cerevisiae Metabolomic analysis revealed
transketolase or transaldolase as
target to engineer greater toler-
ance to acetic and formic acid in a
xylose fermenting strain. The sub-
sequent engineered strain exhib-
ited increased ethanol production.
[22]
Transcriptomics -
microarrays
Penicillium
chrysogenum
Comparative transcriptomics of
the wild type and a penicillin pro-
ducing strain of P. chrysogenum
showed that penicillin production
is associated with increased ex-
pressing for metabolic precursors
and transporters providing poten-
tial for developing rationally engi-
neered penicillin producers.
[23]
Proteomics - iTRAQ Synechocystis
sp. PCC 6803
Authors found 135 and 293 up-
regulated proteins at 24 and 48
h after treatment with ethanol,
showing potential targets for en-
gineering ethanol tolerance in the
cyanobacterium.
[24]
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1.1.3 Genomic analysis
Since 2001, the cost of DNA sequencing has reduced dramatically, from over $ 5,000 USD per
megabase (Mb) to $ 0.45 USD per Mb by early 2014 [25]. This has made full genomic sequenc-
ing far more available than previously.
Genomic sequencing alone is sometimes considered not to meet the criteria that define a sys-
tems biology tool, as it does not provide any information about systems-wide interactions or
dynamics [3] but rather provides an inventory of all genetic components of the organism. The
use of comparative genomics to identify targets for metabolic engineering however, has led other
authors to categorise this technique as a systems biology tool [4, 5]. Studies have elucidated
targets for metabolic engineering using comparative genomics either alone or in combination
with other methods. For example, comparative genome analysis of a strain of Corynebacterium
glutamicum engineered for L-lysine production with its parental strain revealed mutations re-
sponsible for increased L-lysine production; when these mutations were reintroduced into the
wild-type strain, L-lysine production exceeded that of the high-producing strain derived by mu-
tagenesis and additionally exhibited better growth [26]. Comparative genomics therefore can
provide a means to improve production strains that have previously been created using classical
mutagenesis methods [26]. Conversely, Lee et al. [27] found comparative genomics alone to be
insufficient for engineering increased succinic acid yield but in combination with in silico knock
out analysis they were able to increase production seven-fold.
In addition to the use of high throughput genome sequencing for comparative genomics, DNA
sequencing technology has enabled the development of other systems biology techniques, par-
ticularly transcriptomic and fluxomic studies, where it is necessary for the mapping of transcript
reads and the construction of metabolic models respectively.
1.1.4 Transcriptomic analyses
Transcriptomic analysis has become an important technique in systems biology. Understand-
ing cellular expression levels can provide substantial information about the cellular response to
changes in its environment or those that arise as a result of genetic engineering. Several tech-
niques have been developed investigating the transcriptome, including Southern blotting [28],
quantitative reverse transcription polymerase chain reaction (qRT-PCR), serial analysis of gene
expression (SAGE) [29], cap analysis of gene expression (CAGE) [30] and expressed sequence
tag (EST) [31]. However, for large scale transcriptomic analysis of cells, two methods in particular
have become paramount - microarray analysis and RNA-seq. Microarrays are the more estab-
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lished technique, whilst RNA-seq has become possible with the revolution in next generation
sequencing technologies; both enable the large scale quantification of relative gene expression
levels. The two techniques and their application in systems metabolic engineering are described
below.
1.1.4.1 Microarray analysis
Microarray analysis has become a long standing means of investigating the transcriptome. Ini-
tially, hybridisation experiments like Southern blotting were conducted by affixing DNA to nitro-
cellulose filter paper and hybridising radiolabelled DNA or RNA molecules to the affixed probes
[28, 32, 33]. In 1995, Schena developed the technique of fixing DNA probes to a microarray
and measuring expression by fluorescently labelling the sample cDNA and hybridising it to the
probes. This was used to measure gene expression in Arabidopsis [34].
Using this technique, genes of interest are selected, DNA probes for these genes are synthe-
sized, mounted on a chip and denatured. Isolated cellular mRNA is converted to cDNA and
a fluorescent probe attached. The DNA on the chip is hybridised with the fluorescent cDNA,
giving regions of fluorescence on the chip, the intensity of which corresponds to expression of
nucleotide sequence [34]. Since its development, the technique has been applied in numerous
studies and has provided a key role in determining gene expression data and targets for rational
metabolic engineering.
Degenkolbe et al. used microarrays for the comparative analysis of rice species that were tol-
erant and sensitive to drought [35]. The authors identified genes related to senescence were
upregulated in a drought sensitive species in response to water limitation, whilst a drought tol-
erant species exhibited down regulation of photosynthesis related genes, offering potential for
engineering greater drought tolerance in rice. In another study Shi et al. [21] were able to in-
crease riboflavin production in B. subtilis using comparative analysis of the wild type organism
with a high producing strain that had been developed through classical mutagenesis and selec-
tion. The comparison identified a bottleneck in riboflavin production, which when addressed in
the classically developed strain by overexpression of genes involved in the production of precur-
sors for riboflavin, increased total riboflavin production in this strain by 25 %.
Certain limitations exist with microarrays and this has led to the development of RNA-seq tech-
nologies. A notable problem is that all genes of interest must be specified beforehand, which
means that truly large scale studies become difficult [36, 37]. Because quantification of gene ex-
pression using microarrays involves quantification of fluorescence (or sometimes radioactivity),
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they can lack sensitivity and therefore may not be able to detect low levels of expression. How-
ever very high levels of expression can result in signal saturation meaning there is also an upper
limit for detectable expression [36–39]. Finally, false positives for gene expression can occur due
to cross hybridisation of cDNA to the probes, affecting the accuracy of expression quantification
[36, 39].
1.1.4.2 RNA-seq
The improvement of DNA sequencing technologies has led to development of whole transcrip-
tome profiling, commonly called RNA-seq [39, 40]. RNA-seq differs from other forms of RNA
quantification, as unlike methods such as qRT-PCR, Northern blotting and microarrays which
rely on hybridisation of specified DNA primers or probes binding to cDNA, RNA-seq involves
the direct sequencing of cDNA and subsequent alignment of the sequenced cDNA against the
genome nucleotide sequence [37].
The first whole transcriptome sequencing by RNA-seq was carried out on S. cerevisiae. This
provided a large amount of information on expression and structure of the yeast transcriptome,
such as the identification of overlapping genes, upstream open reading frames and alternative
initiation codons [41]. Briefly, the technique consists of extraction of total RNA from the cells, the
RNA is treated with DNAse and converted to cDNA by reverse transcription. As RNA-seq was
first developed in yeast, the poly(A) tail present on all mRNAs was used for reverse transcription
priming so only the mRNA fraction was converted to cDNA [41, 42]. This should be the case
for all eukaryotes. However due to the lack of poly(A) tails on prokaryotic mRNA, RNA-seq in
prokaryotes uses alternative priming methods for reverse transcription, such as random hexamer
priming or attachment of artificial poly(A) tails to the bacterial mRNA [42–46].
The use of random hexamer priming means that all RNA is converted to cDNA. As approximately
95 - 98 % of total RNA is ribosomal RNA (rRNA), to increase the depth of sequencing of mRNA
and bacterial small RNA (sRNA) transcripts, the rRNA fraction is often depleted [47]. This can
be carried out either by hybridisation of the rRNA to probes linked to magnet beads which al-
lows physical separation of the rRNA from the remainder of the RNA in solution using a magnet
(rRNA capture) [43, 45, 48], using exonuclease to digest transcripts with a 5’ monophosphate
group [49, 50], adding an artificial poly(A) tail to mRNA using E. coli poly(A) polymerase [46],
using duplex specific nucleases (DSN) post cDNA conversion [51] or by the use of antibodies to
capture RNAs associated with protein [52], (reviewed in [42]). A comparison of poly(A) capture
with other methods using eukaryotic RNA found that both magnetic RNA capture and DSN can
provide transcript expression quantification on a par with using the poly(A) capture method and
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magnetic RNA capture is as effective as poly(A) capture for rRNA removal and genome coverage
achieved with the sequenced transcripts [53].
The cDNA can be synthesised as either double stranded [43] or single stranded cDNA to pre-
serve the directionality of the gene transcripts [45, 54]. Massive parallel sequencing methods
can produce read length in the range of approximately 35 bp - 500 bp [55], but as most genes
are much larger than this, the cDNA transcripts are fragmented to enable their sequencing. The
fragmented DNA is amplified by polymerase chain reaction (PCR) and often size selected to pro-
duce a library that can be sequenced by the available technology [43, 45, 56]. The short reads
produced by sequencing are then reassembled to make transcripts which are mapped against
a reference genome to provide relative levels of expression for each gene. Several software
packages implementing algorithms for this purpose have been created and are freely available
such as Bowtie [57, 58], Burrows-Wheeler Alignment tool (BWA) [59] and Short Oligonucleotide
Analysis Package (SOAP) [60, 61]. It has also been possible to build transcripts and measure
expression without a reference genome [62].
Exploring the transcriptome using RNA-seq circumvents many of the limitations of microarrays,
such as cross hybridisation, signal saturation and the need to design probes for tiling arrays;
consequently the technique is likely to replace microarrays in large scale transcriptomic studies
[37]. A study by Marioni et al. found that there was a high correlation between the two tech-
niques in terms of detection of upregulated genes but also found that some genes exhibiting high
fluorescence on arrays had a low number of reads mapped to the genome, indicating possible
cross-hybridisation on the array [63]. In another study by Fu et al. in which microarrays and
RNA-seq were judged relative to a benchmark of protein levels, the authors found that expres-
sion levels quantified by RNA-seq correlated more accurately with the proteomics data compared
to microarrays [64].
Investigation into both eukaryotic and prokaryotic transcriptomes using RNA-seq has revealed
that both are more complex than previously thought [37, 42]. The impact that RNA-seq has had
on understanding of the bacterial transcriptome is discussed briefly below.
1.1.4.3 Understanding the prokaryotic transcriptome
The application of RNA-seq has enabled the development of an understanding of bacterial tran-
scriptomics on a genome-wide level [44]. The verification of predicted RNA start sites has been
investigated using RNA-seq by treatment of isolated RNA with tobacco acid pyrophosphatase
(TAP), this converts the triphosphate of the 5’ end of the transcript to a monophosphate to which
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an adapter is ligated [37, 49, 56, 65]. Progress is also being made into understanding the im-
portance of small non-coding RNAs (sRNA) and anti-sense RNAs as regulatory elements in
bacteria. Through deep sequencing of the Streptomyces coelicolor transcriptome, Vockenhuber
et al. discovered 63 sRNAs, of which 29 were cis anti-sense RNAs [65]. In another study, even
in the very well characterised organism, E. coli, seven novel sRNAs and 3 cis anti-sense RNAs
were identified using RNA-seq [66]. Some anti-sense RNAs have also been identified within the
5’ untranslated region in Anabaena sp. strain PCC 7120 [67].
Expression of operons has also been found to be more flexible than previously thought [37], with
several studies having identified new or alternatively expressed operons [65]. Furthermore, the
underlying mechanisms for physiological characteristics have been identified using RNA-seq,
such copper tolerance in Saccharomyces cerevisiae [68]. In a study by Cho et al. [69], sRNAs
which were expressed in response to ethanol stress were identified, raising the possibility of en-
gineering greater ethanol tolerance. These studies highlight the importance of this technique not
just for understanding the fundamental biology of micro-organisms but also for identifying targets
for metabolic engineering in order to create strains which combine the particular characteristics
required in an industrial organism.
1.1.5 Proteomic analyses
Further along in the biological hierarchy, the study of proteins at a system wide level - proteomics,
offers a different level of understanding of the cell. It is well known that the relationships between
central processes in the cell are not linear, for example, RNA molecules may be subjected to
post-transcriptional modifications and control mechanisms that can alter the amount of protein
produced from them. Accordingly, measurement of protein profiles, whilst not providing the reg-
ulatory information that can be obtained from transcriptomic analysis, provides a more direct
measure of the level of enzymes, transporters, transcription factors, etc within the cell. Tech-
niques for proteome analysis rest upon the use of profiling by mass spectrometry, with the mass
spectrometry "shotgun" technique having become the most dominant approach [70].
1.1.5.1 Mass spectrometry based protein profiling
Shotgun proteomics enables the analysis of a large number of different proteins within the cell.
Using this technique, proteins are purified from the cell and may be enriched for a certain char-
acteristic such as particular post-transcriptional modifications. They can then be fragmented into
peptides and subsequently further fragmented; both of these steps are optional however. The
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proteins or fragmented peptides are then analysed using mass spectrometry (MS) or tandem
mass spectrometry (MS/MS) [70].
Mass spectrometry analysis alone is not sufficient for quantification of different proteins and thus
different isotope based techniques have been developed to enable the quantification of proteins
such as stable isotope labelling by amino acids in cell culture (SILAC) [71], tandem mass tags
(TMT) [72] and isobaric tag for relative and absolute quantitation (iTRAQ) [73].
Several studies have demonstrated the development of strains being led by proteomic analy-
sis. For example, Pandhal et al. [74] used a multifaceted approach which included shotgun
proteomics to address glycosylation process in E. coli. Using iTRAQ, the authors identified
the enzyme isocitrate lyase (ICL) and, by extension, flux through the glyoxylate cycle to be im-
portant for glycosylation. Increasing the expression of ICL resulted in a three-fold increase in
the level of glycosylation. In another study by Juminaga et al. [75], proteomics analysis was
combined with metabolomics in order to increase L-tyrosine production. After initially creating
a strain for L-tyrosine production using rational metabolic engineering, titres were improved fur-
ther by using a combined proteomic and metabolomic approach, to highlight bottlenecks in the
L-tyrosine pathway. By increasing the availability of the precursor shikimate and its conversion
to L-tyrosine, the engineered strain was able to produce titres greater than 2.0 g litre-1 L-tyrosine.
1.1.6 Metabolic analysis
1.1.6.1 Metabolomics
Studying the metabolite profile of cells provides a more direct understanding of cellular physiol-
ogy compared to measuring genes, transcripts and proteins [76]. Much like the terms genome,
transcriptome and proteome, metabolome refers to the collection of small molecules that make
up metabolism in the cell [77]. At the systems level, metabolomics, much like proteomics, relies
on the application of mass spectrometry combined techniques, such as liquid chromatography
mass spectrometry (LC-MS) and gas chromatography mass spectrometry (GC-MS) to separate,
detect and identify complex mixtures of metabolites [78].
Metabolomic analysis focuses on the same level of biological hierarchy as fluxomic analyses,
although it is distinct as it refers solely to the identification and quantification of metabolites, pro-
viding a snap shot of metabolism at a given time. Fluxomic analysis by contrast studies the
temporal flow of metabolites [79]. Because of this, fluxomic data may be able to give greater
information about the active state of the cell; however metabolomic data can be modelled with
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genome sequence information in order to build metabolic networks and estimate metabolic fluxes
[80, 81].
Metabolomics has been applied in metabolic engineering strategies such as the engineering of
acetic acid and formic acid tolerance in S.cerevisiae [22]. In this study, the authors discovered
that pentose phosphate pathway metabolites were increased in response to the presence of
acetate, indicating a reduction in the rate of flux through this pathway. Overexpression of transal-
dolase and transketolase enabled the strain to produce a greater yield of ethanol in the presence
of acetate.
1.1.7 Fluxomic analyses
For each of the levels of system biology analysis covered up to this point, there is a directly mea-
surable set of molecules, the quantification or analysis of which is central to the technique. Flux-
omic analysis however is concerned with the flow of metabolites through the metabolic network.
As this is not a measurable quantity it must be calculated instead. There are two approaches to
fluxomic analysis, the first is a computational approach, using an in silico genome scale metabolic
model, namely flux balance analysis (FBA). The second is to use a combined experimental and
computational approach that makes use of isotopic tracers, such as 13C metabolic flux analysis
(13C-MFA).
1.1.7.1 Flux Balance Analysis
Flux balance analysis (FBA) is a means of computationally predicting the flow of metabolites
through a metabolic network enabling the estimation of a quantifiable feature of the cell such
as growth rate or production of a particular compound [82]. Briefly, the technique consists of
listing all the metabolic reactions in a stoichiometric matrix, the stoichiometries of the reactions
impose constraints on the potential flux through each reaction. Further constraints can be added
in terms of upper and lower bounds on reactions. An objective function is defined (such as max-
imum growth rate or production of a particular compound) and the optimal flux for achieving this
objective function can be calculated [82]. Specialised tools have been developed for the carrying
out of FBA, such as the Constraint Based Reconstruction and Analysis (COBRA) Toolbox for
use in Matlab [83] and Flux-balance Analysis based SIMUlations (FASIMU) [84]. Limitations in
FBA exist however, for example in the resolution of parallel pathways, which has led to the use
of isotopic tracers to determine the flux of molecules through more complex metabolic networks
[85–87]
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1.1.7.2 Steady state 13C Metabolic flux analysis
In contrast to FBA, 13C metabolic flux analysis (13C-MFA) is a combined computational and ex-
perimental approach to determining intracellular fluxes. A network model of cellular metabolism
is constructed. Cells are grown on a carbon-13 labelled substrate, which is subsequently taken
up into the cell and incorporated into cellular metabolites. Stable metabolites from the cell, gen-
erally proteinogenic amino acids, are then measured by mass spectrometry or nuclear magnetic
resonance (NMR) spectroscopy in order to gather isotopic data on the metabolites. The labelling
state of stable metabolites reflects the labelling state of the metabolites that precede them in a
metabolic network and therefore, the fluxes in the metabolic network [87]. As 13C-MFA is used
extensively in this study, the technique is elaborated in Section 1.2.
1.1.7.3 Variants on steady-state metabolic flux analysis
Since the development of steady state 13C-MFA, several related techniques, also employing
isotopic tracers, have been applied to the study of metabolism.
Dynamic metabolic flux analysis Metabolic flux analysis was first developed as a steady
state technique - that is cellular metabolism could only be studied when it was at steady state
and when the isotopic labelling of the cell was also at steady state. However, this puts limitations
on how metabolic processes can be studied. Recent developments have allowed 13C-MFA to be
applied to more dynamic systems.
Dynamic metabolic flux analysis (DMFA) aims to study time dependent changes in flux that oc-
cur in metabolism [88]. This is useful for, for example, monitoring the changes in metabolism
that occur during industrial fed-batch cultivation [88]. Several methods have been developed for
carrying out DMFA [88–91].
Isotopically non-stationary metabolic flux analysis In contrast to 13C-MFA, where both
metabolism and isotopic labelling are at steady state, and DMFA, in which labelling but not
metabolism, is at steady state, isotopically non-stationary 13C-MFA (INST-13C-MFA) [92] is a
technique in which isotopic labelling is not at steady state. This has enabled 13C-MFA to be
opened up to the analysis of biological systems in which achieving isotopic steady state is not
possible or difficult, such as in non-growing cells, during transient biological phenomena and in
genetically unstable strains [92]. The technique is based on rapid time course sampling of culture
as the isotopic label is being assimilated to cells [92, 93]. Flux information is calculated based
on the size of metabolite pools and the changing isotopic distribution in the metabolite pool over
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time [92].
The technique has been used to investigate the metabolism of E. coli producing 1,3-propanediol
[94] as well as photoautotrophic metabolism in Synechocystis [95]. It has been shown that in
combination with steady state 13C-MFA, INST-13C-MFA is able to increase the sensitivity of the
measured fluxes [96]. The technique remains reasonably specialist however as it is highly depen-
dent on the ability to sample the culture very rapidly (every few seconds) and detect metabolites
in very low concentrations (in the nM range) [92].
13C Isotopologue profiling analysis 13C Isotopologue profiling analysis (13C-IPA) is a tech-
nique that allows the study of metabolism without an existing metabolic network model [97, 98].
The technique has proved useful for the analysis of pathogenic bacteria which reside inside a
host cell environment, for which the application of standard 13C-MFA is unfeasible [98]. Using
this technique, cells are fed with a pulse of isotopically labelled substrate and, as with steady state
13C-MFA, stable metabolic isotopes, such as proteinogenic amino acids are measured by NMR
or GC-MS. Using the mass isotopomer distribution of the amino acids, the metabolic pathways
that have led to the production of the amino acid precursors, e.g pyruvate, are then deduced [98].
This has been applied to the study of Legionella pneumophila [99], E. coli and Salmonella en-
terica [98], as well as plants Artemisia annua [100] and tobacco [101], using carbon-13 labelled
CO2.
13C-flux spectral analysis 13C-flux spectral analysis (13C-FSA) is similar to 13C-IPA but uses
computational modelling to determine metabolic fluxes and thus can be considered an advance-
ment on existing 13C-IPA methodologies. The technique was developed by Beste et al. to study
interactions between Mycobacterium tuberculosis and its host cell [97]. The authors were able to
demonstrate using 13C-FSA that M. tuberculosis receives a mixture of substrates - amino acids,
C1 and C2 compounds, from its host cell which are incorporated into its own metabolic pathways
[97].
Topological metabolic analysis Topological metabolic analysis (TMA) is described by Baugh-
man et al. [102] as an alternative to both 13C metabolic flux analysis and flux balance analysis.
It is principally a mathematical approach to quantifying flux but incorporates some experimen-
tal data, specifically substrate uptake and metabolite efflux rates as well as metabolite efflux to
biomass. In contrast to the other experimental techniques discussed here it does not make use
of carbon-13 or other isotopes. A comparison of metabolic fluxes calculated using TMA to those
obtained using carbon-13 isotope data found that the technique performed favourably [102]. This
technique offers the possibility of obtaining sensitive flux information without the substantial cost
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of isotopically labelled substrate feeds.
1.2 13C Metabolic flux analysis
As discussed in the previous section (1.4.7.2-3), isotopic tracer experiments - such as steady
state 13C metabolic flux analysis (13C-MFA) provide a means to quantify cellular metabolic fluxes
[103]. 13C-MFA has emerged as an important tool in systems biology and has been applied
in metabolic studies and metabolic engineering of many organisms in recent years [79, 104].
Its versatility means that it has been applied to many different cell types both eukaryotic and
prokaryotic, including Arabidopsis thaliana, Pichia pastoris, hepatoma cells, Chinese hamster
ovary (CHO) cells, Mycobacterium bovis, M. tuberculosis, Corynebacterium glutamicum, Bacil-
lus subtilis, Klebsiella pneumoniae, Ethanoligenens harbinense and Basfia succiniciproducens
to name but a few [85, 105–115]. This versatility means that it is being applied in many fields and
finding application in immunological and medical research, biotechnology and agriculture.
Recent studies that have demonstrated the potential for 13C-MFA in biochemical systems include
the work by Beste et al. [85], who discovered a novel route for carbon dioxide assimilation in M.
tuberculosis using MFA. By feeding 13C labelled CO2 in the form of [13C]bicarbonate, the authors
were able to identify CO2 fixation via the anaplerotic reactions, which was the diverted to succinyl
CoA production. This discovery holds the potential for novel therapeutics for tuberculosis as this
pathway is not present in human hosts of M. tuberculosis.
In another study, a bacterium displaying endogenous capacity for high succinate yield, B. suc-
ciniciproducens, was engineered to produce a 45% increase in succinate yield. Competing fluxes
against succinate production were directly identified and deletion of genes within these pathways
resulted in the higher succinate yield [115].
In contrast to systems biology tools applied in the areas of transcriptomics, metabolomics and
proteomics, the technique does not involve quantification of cellular systems, but rather it can
provide time dependent maps of metabolism, usually in the form of flow of metabolites in moles
per gram of dry cell weight per hour [116]. It is concerned solely with the flow of metabolites
through a reaction network and does not require information on enzyme kinetics or concentra-
tions; calculations instead are based on the comparatively less data intensive stoichiometries of
metabolites and reactions [104].
The application of isotopic tracers to metabolic flux analysis evolved from stoichiometric metabolic
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flux analysis. In this original technique, the balance of metabolite pools is calculated by a series
of linear equations. Providing there are suitable measurable fluxes, that is the fluxes of uptake
and efflux from the cell, flux through the intracellular pathways can be determined by solving the
linear equations [117, 118]. There are however, many limitations on the type of reaction that can
be measured using this technique. Specifically: fluxes of parallel reactions and metabolic cycles
cannot be resolved without at least one constituent measured flux; bidirectional reaction steps,
where there is flux in both the forward and reverse directions simultaneously, cannot be resolved;
and several fluxes through central carbon metabolism cannot be resolved without additional bal-
ancing of cofactors [117]. In light of this, the use of isotopic tracers in metabolic flux analysis
was developed in order to provide the additional information required to resolve more complex
reaction steps [117].
To carry out 13C-MFA, cells are cultivated with labelled substrate and measurements taken of
isotopic labelling within the cell and external fluxes to provide constraints for computational mod-
elling of flux distribution (Fig. 1.2). As the technique combines both experimental methods and
in silico computation both of these are described separately below.
Figure 1.2: Principle of metabolic flux analysis. Cells are fed with a labelled substrate, in this
example a hexose with a carbon-13 atom in the first position in the carbon chain. The pattern
of scrambling of carbon atoms in metabolism means that only particular patterns of labelling in
metabolites are possible. The patterns observed along with the relative abundance of different
isotope isomers is indicative of the route that has produced the metabolite labelling pattern and
thus can be used to calculate flux through the metabolic pathways.
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1.2.1 Experimental methods in metabolic flux analyis
1.2.1.1 Organism cultivation
Cells are cultivated under conditions relevant for the biological analysis with labelled medium
feed. All carbon sources in this medium feed need to be in known quantities, as carbon not
accounted for will alter the mass isotopomer distribution of metabolites and thus may influence
the final flux outcome. A minimal medium is therefore used during growth on labelled carbon
sources [116].
The choice of substrate and isotopes used depends on the biological question being investigated.
Unsurprisingly, carbon-13 is the principal isotope used in 13C-MFA, however nitrogen-15 has also
been used in combination with carbon-13 isotopes to help resolve metabolic fluxes [119]. Fur-
thermore, the development of novel computational methods has made the computational aspect
of carrying out 13C-MFA with multiple isotopic tracers more feasible [86]. Many different carbon-
13 substrates have been used to determine specific metabolic fluxes. A summary of substrates
used in different studies is shown in Table 1.2.
The cells needs to reach isotopic steady state as well as metabolic steady state, which can be
achieved either by carrying out cultivation under chemostat conditions or by ensuring that sam-
pling is carried out during exponential growth, if the culture is grown in batch conditions [116].
Whether the culture is at metabolic steady state can be ascertained by monitoring culture optical
density (OD) and external metabolite and substrate concentrations. For steady state metabolic
flux analysis, the isotopic labelling of the metabolites must remain constant [116]. At this stage,
cells are harvested for internal metabolite analysis, and external medium is also taken for anal-
ysis of any external metabolites and any residual carbon sources not consumed by the culture.
Culture samples are also taken for measurement of total biomass.
Table 1.2: Isotopic tracers used in 13C metabolic flux analysis studies
Isotopes Organism Findings Reference
[U-13C]-glucose [U-
13C-15N]-aspartate
[U-13C-15N]-
glutamine
Plasmodium falci-
parum
The tricarboxylic acid cycle in P.
falciparum is branched and ob-
tains carbon from glutamate and
glutamine rather than glycolysis.
[119]
Continued on next page
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Istopes Organism Findings Reference
[1,2-13C]-glucose Thermus ther-
mophilus
No detectable oxidative pentose
phosphate pathway, non oxidative
pentose phosphate pathway was
active however. Most metabol-
ically important compound pro-
duced through TCA cycle and gly-
colysis.
[120]
[1-13C]-glucose
[2-13C]-glucose
[1,2-13C]-glucose
[U-13C]-glucose
C. glutamicum 97% of external succinate pro-
duced by the reductive TCA cy-
cle and only 5 % of carbon flux di-
verted through the pentose phos-
phate pathway.
[121]
[13C]-bicarbonate
[U-13C]-glycerol
M. tuberculosis Identified novel pathway for incor-
poration of CO2 into metabolism
via the glyoxylate cycle and
anaplerotic reactions.
[85]
[1-13C]-xylose C. acetobutylicum Increase in flux through the phos-
phoketolase pathway in response
to increased xylose concentration.
[122]
[U-13C]-glycerol
[13C]-methanol
P. pastoris Amino acids synthesised only dur-
ing growth on glycerol. Differ-
ent flux ratios shown at different
growth rates.
[123]
[1-13C]-glucose
[U-13C]-glucose
[1-13C]-fructose
C. glutamicum Decreased flux through the pen-
tose phosphate pathway when
growing on fructose compared to
glucose. Lower flux through pyru-
vate dehydrogenase and the TCA
cycle when grown on glucose
compared to fructose.
[124]
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1.2.1.2 Isotopomer measurement
Measurement of the isotope distributions of both intracellular and extracelluar metabolites can be
carried out using a mass spectrometry (MS) coupled technique or using nuclear magnetic reso-
nance (NMR) [117]. 1H NMR was the technique first used for 13C-MFA and this has since been
extended to include 13C NMR and 1H13C two-dimensional correlation spectroscopy (2D COSY)
NMR to increase the detail that can be obtained from experiments and to enable resolution of the
different metabolites without prior separation [117]. Mass spectrometry techniques can also pro-
vide suitable information for metabolic flux analysis and have become more widespread [125],
gas chromatography (GC)-MS, liquid chromatography (LC)-MS, also used with tandem mass
spectrometry (LC-MS/MS) and matrix-assisted laser desorption/ionization time-of-flight (MALDI-
TOF)-MS have all been found to be able to provide suitable information for 13C-MFA [117].
The most routinely analysed internal metabolites are proteinogenic amino acids, owing largely
to their relative stability and higher concentration compared to the many transient metabolites in
the cell [116, 125]. Other metabolites can also be measured and used in the isotopomer calcu-
lation, for example Bartek et al. used the isotopomers of a variety of sugars, pyruvate, phospho-
enolpyruvate, dihydroxyacetone phosphate, oxoglutarate and succinate [110]. Each metabolite
has a mass that is expected based on the molecular weight of the compound, the relative abun-
dance of this fragment is representative of the proportion of the metabolite for which the entire
carbon backbone is made up of carbon-12. In addition, there are further fragments with mass
(m) of m+1, m+2, m+3... etc, up to the number of carbons present in the metabolite backbone,
with each increase in mass indicative of an additional labelled carbon in the metabolite.
If using GC-MS, all isotopomer data needs to be corrected for naturally occurring isotopes within
the derivatization agent. Similarly, unlabelled biomass, for example from inoculation or remaining
in the chemostat culture after growth on the labelled substrate, needs to be accounted for before
isotopomer data is used in the flux modelling [116].
1.2.1.3 External metabolite quantification
In order to carry out global isotopomer balancing by 13C-MFA, that is to determine the overall flux
rates of metabolites, it is necessary to quantify the rate of uptake of substrate from the medium
and also efflux of fermentation products and other metabolites from the cell, to create an overall
stoichiometric balance. External metabolites such as fermentation products and amino acids
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can be measured by high performance liquid chromatography (HPLC) or enzymatic assays. To-
tal biomass in grams (g) of dry cell weight (DCW) is calculated based on the spectrophotometric
reading of the culture optical density (OD). All external carbon feed and metabolite concentra-
tions can then be converted to uptake and efflux rates, usually in units of mmols per g DCW per
hour [116].
1.2.1.4 Biomass analysis
Efflux of carbon to biomass is an important consideration and needs to be included in the
metabolic model in the same way as the loss of carbon frommetabolism through efflux of metabo-
lites from the cell. Calculation of the cell’s requirements for amino acids, carbohydrates, lipids and
nucleic acids can be carried out by cell fractionation and measurement of individual components
by various analytical techniques such as GC, HPLC and spectrophotometry [126]. Alternatively,
biosynthetic outputs can be quantified using carbon-14 radiolabelling of the culture and then
measuring the radioactive decay in different cell fractions using scintillation counting [105, 106].
1.2.1.5 Genetic analysis
Creation of a model of metabolism with which to carry out the isotopomer calculation for flux
analysis requires in depth knowledge of the genotype of the organism being investigated. In
model organisms such as E. coli, metabolism is relatively well documented in the literature and
there are several sequenced genomes freely available in databases. When working with non-
model organisms however, care should be taken to ensure that incorrect assumptions are not
made about the routes of metabolism within the organism. Genome sequencing and annotation
can provide the most comprehensive analysis of the enzymes present in the metabolism of the
organism.
1.2.2 Computational methods in metabolic flux analysis
With the development of the application of isotopic tracers in metabolic flux analysis, there has
been an accompanying increase in the complexity of metabolic flux calculations [127]. Methods
of flux calculation can be broadly grouped into two subsets - flux ratio analysis, which studies the
proportion of pathway fluxes that contribute to a single metabolite and global isotopomer balanc-
ing, which balances the isotopes of the metabolites across the entire cellular network, enabling
resolution of a flux distribution across the whole cell [128]. This latter method represents a more
mathematically complex problem and several advances have been made on initial techniques in
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order to simplify the calculation. These can be further divided into isotopomer, cumomer, ele-
mentary metabolite units (EMU) and fluxomer methods, each of which are discussed individually
below.
1.2.2.1 Flux ratio analysis
Flux ratio. The flux ratio method, sometimes referred to as METAFoR, has chiefly been ap-
plied to the 13C-MFA of model organisms and is the basis for the freely available 13C-MFA tool,
FiatFlux [129] (Section 1.2.3 Tools in 13C-MFA). It is distinct from other means of flux calculation
as it is not a method for global isotopomer balancing but rather aims to calculate the relative flux
between two converging pathways [128]. In order to carryout flux ratio analysis, a series of linear
equations must be written for the organism of interest in order to constrain the flux ratios [128].
Due to the requirements of this task, the technique has generally been applied to model organ-
isms for which metabolism is well documented such as E. coli [130, 131], B. subtilis [132, 133]
and S. cerevisiae [134–136]. Additionally, it has been applied to some less well characterised
organisms, such as P. putida [137, 138] and yeasts such as P. pastoris [123, 139] and P. stipitis
[135] and in one large scale study of various different bacterial species [140]. If sufficient flux
ratios can be determined, they can be combined to determine flux across the whole metabolic
network [128, 141].
The advantage of this technique is that it requires no measured fluxes for input and output rates
to the cell and no measurements of biomass outputs. Furthermore, the linearity of this flux esti-
mation method means that it is not iterative and thus does not have problems with finding local
rather than global best-fit solutions, as is associated with global isotopomer balancing [128]. The
notable limitations of this technique are it does not provide full flux distribution of the cell and
the level of knowledge required for metabolic model construction is such that it is poorly suited
to less well characterised organisms. It has been noted that even for model organisms experi-
mental evidence for network topology is often still required. Thus this becomes more pertinent
for the study of extremophilic organisms [131]. Furthermore it has been found that the use of
alternative carbon sources over standard labelled glucose, such as the cultivation of P. pastoris
on methanol / glycerol mixtures, can result in poor flux resolution when applied with metabolic
flux ratio analysis [107].
1.2.2.2 Global isotopomer balancing
Global isotopomer balancing methods have been applied to a more varied assortment of organ-
isms including plant cells [105, 106], micro-organisms [85, 107] and mammalian cell cultures
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[142]. In contrast to metabolic flux ratio analysis, global isotopomer balancing is a non-linear
system, which requires an iterative fitting procedure in order to find a best-fit flux solution to
the measured isotopic and flux data [127, 128]. This is a computationally more demanding
technique, which enables the determination of fluxes across the metabolic network as a whole.
Several methods have been developed in order to carry out the calculation, the first being the use
of isotopomer balancing but this has been refined with the development of cumomer, elementary
metabolite unit (EMU) and fluxomer approaches; these are detailed below. The technique is able
to provide a great deal of information regarding cellular metabolism, although limitations exist in
its ability to find local rather than global best fit solutions [128, 143, 144]. Strategies to overcome
this have been developed which include taking multiple starting points for flux estimation to en-
sure a global optimum has been reached [144].
Isotopomer. The term isotopomer refers to isotope isomers, i.e. molecules that differ only in
the molecular weight of their constituent atoms. A metabolite which contains 13C and 12C atoms
will have 2n isotopomers, were n is the number of carbon atoms present in the molecule (Fig.
1.3) [117]. The mass isotopomer distribution of a metabolite is the proportion of each isotopomer
that makes up the total pool of the metabolite (Fig 1.4) [117, 129].
Figure 1.3: A 3-carbon metabolite that is labelled with two different carbon isotopes, 12C and
13C, has 2n, therefore 8 isotopomers.
Figure 1.4: Each pool of metabolites within the cell is comprised of a vector of all the isotopomers
of that metabolite, termed the mass isotopomer distribution vector of the analyte (MDVα) . The
fractions of each isotopic weight (m0,m1) up to n carbon atoms in the metabolite, are generally
normalised so that their sum is equal to 1. Equation from [129]
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The isotopomer distribution of each metabolite is a product of the carbon atom transitions that
have taken place in each reaction that precedes the metabolite in the metabolic network. Thus
the mass isotopomer distribution is indicative of the carbon flux through metabolism [145]. The
flux through the metabolic network can be calculated from the isotopomers using isotopomer
mapping matrices, in which isotopomers are balanced like the balancing of metabolites in stoi-
chiometric metabolic flux analysis [86, 146].
Cumomer. Cumomers are cumulative isotopomers; accordingly, each cumomer represents a
collection of isotopomers, which are grouped based on the positions of carbon-13 atoms (not
carbon-12 atoms) within the isotopomers. Grouping the isotopomers in this way enables some of
the isotopomers to be excluded from the calculation when constructing the cumomer network for
carrying out balance equations. As a result, flux calculation with cumomers is simpler than that
carried out with isotopomers [147]. Cumomers have been implemented in the software package
13CFLUX [148]. The cumomer method has however still been noted as being a slow means of
calculation, which has led to the development of further techniques to speed up the calculation
process [86, 93, 149].
Elementary metabolite unit (EMU). The elementary metabolite unit was developed by An-
toniewicz et al. [86] and has been implemented in several software packages for 13C-MFA (see
1.2.3 Tools in metabolic flux analysis below). The EMU can be considered as a molecular sub-
division of a metabolite consisting only of the atoms which appear in the product of any given
reaction (Fig. 1.5). In this manner, only those atoms which contribute to the isotopomer measure-
ments are included in calculations. This results in an increase in the speed of calculation relative
to the isotopomer and cumomer methods without any loss of data. Flux calculation therefore be-
comes a two stage process whereby initially the relevant atoms are determined based on carbon
atom transitions (note it is not necessary for the atoms to be chemically bonded) and secondly
flux estimation is carried out based on the constructed EMUs rather than the isotopomers [86].
The method has also been developed further for application in non-stationary flux analysis [93].
The benefit of the EMU system is the shortened computational time relative to isotopomer or cu-
momer methods and the resultant ability to employ multiple isotopic tracers in the flux calculation
procedure [86].
Fluxomer As existing means of flux calculation using isotopic data have been noted for their
limitations, firstly in their propensity to reach local rather than global best-fit solutions and sec-
ondly in the relatively long computational times, recent developments have seen the introduction
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Figure 1.5: The elementary metabolite unit (EMU). In a cleavage reaction from a 4 carbon
metabolite (A) to a 3 carbon metabolite (B), only carbon atoms in positions 1, 2 and 3 of metabo-
lite (A) affect the mass isotopomer distribution of metabolite (B). The size of the EMU therefore is
3, resulting in 23 = 8 different isotopomers to be used in calculation rather than the 24 = 16 which
would result from using the entire metabolite, creating a simpler calculation. Figure adapted from
Antoniewicz et al. (2007) [86].
of the fluxomer method of 13C-MFA, which has been shown to improve on the cumomer and
EMU methods both in terms of calculation time and flux precision [149]. The method combines
the isotopomer and flux variables to make a single variable ("fluxomer"), which is then imple-
mented in a fluxomer iterative algorithm for carrying out flux optimisation. Srour et al. state that
this enables the use of all isotopomers in computation in an efficient manner. In practice, this
also results in a more defined network and negates the need for initial free fluxes in the metabolic
model. This method does however, exhibit limitations in determining bi-directional fluxes and has
yet to be adopted as a standard means of flux determination.
1.2.3 Tools for metabolic flux analysis
Metabolic flux analysis began as a rather specialist field as it spans techniques in biology and
computational and mathematical modelling. Increasingly however, tools are being developed to
open up the field to the non-expert which means greater accessibility for those who specialise in
biological systems.
These tools can be employed in several steps of the 13C-MFA workflow, the principal one being
that which facilitates isotopomer modelling for flux calculation. Additionally however, there are
tools which have been developed for planning isotope labelling experiments and correction for
naturally occurring isotopes.
Major tools that have been developed for carrying out isotopomer modelling use differing meth-
ods of computation. 13CFLUX [127] makes use of the isotopomer and cumomer methods. It has
been employed extensively in the 13C-MFA field in different cell types such as M. tuberculosis
[85] and Arabidopsis [106]. The software introduced the *.ftbl format for metabolic flux model
construction which has since been employed in other systems, such as the IsoDesign software
for optimising the substrate isotope mixture [150]. The workflow for 13C-MFA experiments within
the 13CFLUX framework has been extensively documented [87, 116, 127, 144, 147, 151]. Ma-
45
jor advantages of the 13CFLUX system are the flexibility to determine all inputs, outputs and
metabolic network topology as required by the user, ability to carry out flux estimation based on
LC-MS/MS, GC-MS or NMR data and the user-friendly nature of the XML model format.
13CFLUX2, the successor to 13CFLUX employs the same framework but uses EMU and cumo-
mer based algorithms for flux estimation, reducing the computational workload. The developers
created an XML based language, FluxML to enable the inclusion of 13C-MFA features such as
modelling of atom mappings [148]. The software suite is comprised of a number of programs to
facilitate: proofreading of metabolic models to check syntax; initial flux space sampling, to pro-
duce starting fluxes; flux estimation; and statistical analysis of fluxes. Flux estimation is carried
out using the cumomer and EMU methods [148]. As the EMU method of flux computation is the
most efficient currently available and the 13CFLUX2 workflow provides ample flexibility and sup-
port for flux analysis of non-model organisms, 13CFLUX2 was applied in this study. Similar tools
such as Metran [152], OpenFlux [153] and INCA (Isotopomer network compartmental analysis)
[154] have also been developed making use of the EMU algorithm. FiatFlux, by contrast [129]
uses the flux ratio analysis method.
Certain tools provide particular functions, for example FiatFlux has been designed as a multi-
function tool designed to automate several stages of the metabolic flux analysis workflow. This
includes the extraction of relevant isotopomer mass fragments from GC-MS common data for-
mat (.cdf) files, the correction for naturally occurring isotopes and unlabelled biomass and the
isotopomer modelling [129]. Most recently INCA (Isotopomer network compartmental analysis)
was developed in order to provide a means of carrying out both isotopically steady state and
non-steady state metabolic flux analysis [154].
1.2.4 Creating a model for 13C-MFA global isotopomer balancing
Several components are required in order to create complete models for use in 13C-MFA (Fig.
1.6). Initially, construction is reliant on known data about the organism. This can be sourced
from genome sequencing and annotation, together with published and experimental data which
provide information on active metabolic pathways in the organism. From this information a topo-
logical network is formed which generally will detail the reactions of central carbon metabolism,
amino acid synthesis reactions as well as any further reactions of particular interest.
This network should then be constrained to reduce the potential flux solution space and enable
flux calculation [116]. As the use of isotopic labelling in metabolic flux analysis enables the res-
olution of bidirectional reactions within the metabolic network, fluxes can be divided into net and
exchange fluxes [155]. Net fluxes represent the overall flux from one metabolite to another and
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Figure 1.6: A metabolic model of 13C-MFA within the 13CFLUX2 framework consists of several
different components: metabolic network topology detailing reactions and carbon atom transi-
tions; constraints on the network, these can be thermodynamic constraints, equalities and in-
equalities that express a known value or direction of a reaction and stoichiometric constraints; in-
put substrates, that is the carbon sources that are available to culture and can enter metabolism;
measured fluxes both into and out of the cell and isotopomer data measured from proteinogenic
amino acids or other metabolites; free fluxes, these provide a set of starting fluxes from which
the iterative flux fitting procedure can begin.
exchange fluxes represent the bidirectional flux going back and forth between the two metabo-
lites [87]. Consequently, constraints are also defined in terms of net and exchange fluxes, for
example a constrained exchange flux of 0 can be used to set a thermodynamically irreversible
reaction to be unidirectional within the model and net constraints can be used to set a flux of
known value, such as output of metabolites to biomass [127].
All carbon substrates taken up by the cell need to be accounted for due to the effect each can
have on the mass isotopomer distribution of the metabolites. This includes all labelled and un-
labelled carbon sources and CO2 that may be assimilated into metabolism by carboxylation re-
actions, such as through anaplerotic reactions. The inputted carbon pools need to be defined in
terms of their mass isotopomer distribution. Any unlabelled substrate needs to be included with
a 1.13 % natural abundance of carbon-13. Additionally, any labelled substrate must be included
with its purity taken into account; usually this is approximately 99 % [127].
The two forms of measured data: i) isotopic labelling distribution within metabolites such as
proteinogenic amino acids and ii) measured fluxes such as uptake of the substrates and efflux
of fermentation products are included. Often, all measured fluxes are normalised to a substrate
uptake rate of 100 to enable easier interpretation of the fluxes and comparison between datasets.
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Finally, models can also include a set of free fluxes. Free fluxes represent the degrees of free-
dom with the metabolic network, that is the fluxes which are independent variables [87]. These
are then changed in the iterative flux fitting procedure to the best-fit values for the overall flux
distribution.
1.3 The Genus Geobacillus
Geobacillus spp. form a group of thermophilic, rod shaped, gram positive bacteria. The mem-
bers of the genus are either facultative anaerobes or obligate aerobes and grow optimally within
the range of 45 °C to 70 °C [156]. Species of this genus have been isolated from a wide range
of environments and geographical locations [157], this includes waste compost [158], oilfields
[159, 160], hot water springs [161], food and food processing environments [162], the environs
of active volcanoes [163] and hydrothermal marine vents [164].
1.3.1 Applications of Geobacillus spp.
Members of the genus have important applications in biotechnology. One important function is as
a source of a number of thermostable enzymes. Thermostable enzymes are of key industrial im-
portance due to their innate stability relative to their mesophilic counterparts [165]. Geobacillus
species in particular have been identified as sources of hemicellulases [166], lipase for biodiesel
production [167], xylanases [168–170] and a reverse transcriptase for application in RNA-seq
[171]. The environments that these species have evolved in have produced robust and highly
specific enzymes that makes them well adapted for use in industrial processes [165].
Geobacillus spp. are also being investigated and applied as microbial cell factories for production
of important chemicals. Geobacillus sp. AY 946034 has been identified as having an eugenol
degradation pathway that includes the metabolic intermediates of coniferyl alcohol, ferulic acid
and vanillin acid, offering a potential platform for the production of these aromatic compounds
that are normally derived from petroleum [172]. Additionally, species of Geobacillus have been
found to be able to degrade alkanes [173, 174].
Within the field of biofuel production, Geobacillus spp. have also been identified for bioethanol
production [12, 175] with G. thermoglucosidasius having undergone considerable metabolic en-
gineering to create a strain which produced ethanol as its major fermentation product [12]. G.
thermoglucosidasius has also been engineered for isobutanol production [176].
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1.3.2 Geobacillus thermoglucosidasius
G. thermoglucosidasius, sometimes referred to as G. thermoglucosidans [177], is a facultative
anaerobe which consumes both hexose and pentose sugars and undergoes mixed acid fermen-
tation in oxygen limited conditions. The wild type strain makes formic acid, lactic acid, succinic
acid and ethanol as fermentation products as well as producing acetic acid [12], (Fig. 1.7).
Figure 1.7: Schematic representation of fermentation pathways in G. thermoglucosidasius. Ab-
breviations: ldh, lactate dehydrogenase; pfl, pyruvate formate lyase; pdh, pyruvate dehydroge-
nase; AcDH, acetaldehyde dehydrogenase pta, phosphotransacetylase; ak, acetate kinase; adh,
alcohol dehydrogenase. Figure adapted from [12].
Because G. thermoglucosidasius has endogenous capacity for both hexose and pentose sugar
metabolism, it has been identified as potential organism for the production of renewable chem-
icals from lignocellulosic biomass [12]. In plant cells lignocellulosic biomass primarily serves a
structural function as part of the cell wall and thus is a relatively rigid material. It is comprised
of three major fractions - cellulose, hemicellulose and lignin (Fig. 1.8). Cellulose is chemically
the simplest of the three fractions being formed exclusively of glucose linked by β(1-4) glycosidic
bonds [178]. Hemicellulose, likewise is comprised of a carbohydrate backbone, which varies in
composition but typically it is rich in pentose sugars. Lignin does not contain reducing sugars
but is a complex polymer of three aromatic alcohols - p-coumaryl alcohol, coniferyl alcohol and
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sinapyl alcohol - in variable ratios [179].
Figure 1.8: The structure and composition of lignocellulosic biomass. The three main con-
stituents cellulose, hemicellulose and lignin constitute 40-50 %, 25-35 % and 15-20 % of the
total mass of lignocellulose respectively [180]. Cellulose forms the main component and is a
repeating polysaccharide of glucose molecules; hemicellulose forms a less regular polymer of
pentose and hexose sugars, including, amongst others, glucose and xylose as building blocks;
lignin is a complex polymer of the aromatic alcohols p-coumaryl alcohol, coniferyl alcohol and
sinapyl alcohol. Lignin and hemicellulose surround the rigid structure of the cellulose polymers
forming a rigid structure called a microfibril [179–181]. Figure adapted from [181] and [180].
For lignocellulosic biomass to be used as a feed stock in industrial chemical production, pro-
duction strains need to be able to metabolise the variety of sugars that it provides. G. ther-
moglucosidasius, along with other thermophilic bacteria, for example, Clostridium thermocellum,
Thermoanaerobacterium ethanolicus, T. saccharolyticum have all been found to be able to fer-
ment cellobiose, glucose and xylose, constituting the major breakdown products of lignocellulose
[14, 156, 182–184].
The structure of lignocellulose means that the sugars contained within it are in highly polymerised
forms and inaccessible for direct fermentation, a characteristic that is often referred to as the re-
calcitrance of lignocellulosic biomass and which needs to be overcome in order to convert the
sugars to useful products [185]. G. thermoglucosdiasius has shown ability to break down cellu-
lose polymers as it encodes some endogenous cellulases and has shown capacity for engineer-
ing to enhance this, making it a potential organism for consolidated bioprocessing [186].
Further advantages are also conferred to industrial production processes by the use of a ther-
mophilic production strain over a mesophile. In addition to their ability to metabolise a wider
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range of substrates than, for example, yeast, thermophilic bacteria have been noted as poten-
tially advantageous organisms for bioethanol production for several other reasons. By carrying
out fermentations at high temperatures ethanol, can be continually stripped from the fermentation
broth, preventing build up to levels that are toxic for the cells and aiding downstream process-
ing; there is a reduced risk of contamination by competing micro-organisms in the fermentation
process as mesophiles will not be able to grow at the higher fermentation temperatures; there
is a reduction in production energy input by the removal of cooling steps which are required
during mesophilic fermentations following pretreatment of feedstocks; finally, some thermophilic
organisms can exhibit increased robustness to environmental change compared to mesophilic
organisms [187, 188].
Biofuel production in the species has recently been extended to the production of isobutanol
[176]. Lin and coworkers [176] were able to produce isobutanol yields of 3.3 g L-1 and 0.6 g L-1
from glucose and cellobiose respectively by coexpression of acetolactate synthase from B. sub-
tilis and 2-ketoisovalerate decarboxylase from Lactococcus lactis, which overlap with enzymes
of the valine synthesis pathway to produce an isobutanol synthesis pathway.
1.3.3 Engineering for bioethanol production
G. thermoglucosidasius has undergone substantial metabolic engineering to develop a strain
which produces ethanol as its major fermentation product [12]. Wild type G. thermoglucosdasius
produces lactate as its major fermentation product. This was changed in strain NCIMB 11955
(wt) by disruption of the lactate dehydrogenase (ldhA) gene, producing strain TM89 (∆ldh), which
exhibits greater ethanol production relative to the wild type. Further development has added to
the ethanol yield by disruption of the pyruvate formate lyase (pflB) gene and up regulation of the
pyruvate dehydrogenase (pdh) operon under anaerobic conditions using the promoter from the
ldh gene [12]. The engineered strain, TM242 (∆ldh↑pdh∆pfl), produces ethanol yields of over
90 % of the theoretical maximum but has maintained capacity to metabolise glucose, pentoses
and cellobiose [12].
Alterations have also been carried out in G. thermoglucosidasius wild type strain DL33 (wt), to
produce strains equivalent to those developed from NCIMB 11955 (wt). Deletion of ldhA in DL33
(wt) produced strain DL44 (∆ldh) and deletion of the pfl gene as well as upregulation of the pdh
operon resulted in strain DL66 (∆ldh∆pfl↑pdh), which, like TM242 (∆ldh↑pdh∆pfl), produces
ethanol as its primary fermentation product [189].
Investigation into DL66 (∆ldh∆pfl↑pdh) and the corresponding NCIMB 11955 (wt) mutant strain,
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TM242 (∆ldh↑pdh∆pfl) has found phenotypic differences between the higher ethanol yielding
strains and their wild type counterparts that extend beyond their fermentation product profiles.
DL66 (∆ldh∆pfl↑pdh) grown aerobically on glucose in chemostat cultivation has a maximum
growth rate (µmax h-1) of 54 % of that of DL44 (∆ldh). When grown on xylose µmax h-1 of DL66
(∆ldh∆pfl↑pdh) drops to 20 % of that of DL44 (∆ldh) [189]. Furthermore, anaerobically DL66
(∆ldh∆pfl↑pdh) exhibits poor growth on minimal medium but growth can be stimulated by the
addition of yeast extract to the media [189], indicating an un-met nutritional requirement in this
mutant strain.
This project will investigate wild-type and engineered G. thermoglucosidasius using both tran-
scriptomic analysis and 13C-MFA. A previous study of wild type G. thermoglucosidasius using
13C-MFA by Tang et al. [190] established that the organism uses Emden-Meyerhoff-Parnas gly-
colysis, the TCA cycle, pentose phosphate pathway, glyoxylate cycle and anaplerotic reactions.
The authors found a decrease in flux through both the oxidative pentose phosphate pathway and
TCA cycle during micro-aerobic growth compared to aerobic growth. This study has built upon
the previous work by carrying out 13C-MFA in strain DL33 (wt) and comparing this to flux in the
engineered strains DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh).
1.4 Aims and objectives
The overall aim of this project was the application of systems biology tools to understand the
complex metabolic physiology of G. thermoglucosidasius mutants and identify targets for further
rational engineering of the organism. The objectives that were set to achieve this were as follows:
• Develop a fuller understanding of the metabolic genotype of the organism through genome
sequencing and apply this knowledge in the construction of metabolic models which can
be used for 13C metabolic flux analysis.
• Apply RNA-seq and 13C metabolic flux analysis to the wild-type and mutant strains of G.
thermoglucosidasius to build upon existing knowledge of the organism’s metabolism.
• By comparative analysis of the different strains and between different growth conditions,
understand the underlying reasons for observed differences in the growth of the wild type
and engineered strains.
• Use this knowledge to guide rational metabolic engineering of the strains for iterative de-
velopment of the organism.
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2Materials and methods
2.1 Storage and maintenance of strains
2.1.1 Strains used in this study
G. thermoglucosidasius strains used in this study are shown in Table 2.1.
Table 2.1: Geobacillus thermoglucosidasius strains used in this study
Strain Description Reference
Geobacillus thermoglucosidasius strains
NCIMB 11955 wild type isolate NCIMB Ltd, Aberdeen, UK
DL33 wild type isolate Simon Baker, Birbeck College
DL44 ∆ldh variant of DL33 Taylor (2007) [191]
DL66 ∆ldh∆pfl ↑pdh variant of DL33 Bartosiak-Jentys (2010) [189]
2.1.2 Frozen glycerol stocks
Long term storage of bacterial strains was in 25% (v/v) glycerol stocks at -80°C. Stocks were
made by the addition of 750 µl of 50 % (v/v) autoclaved glycerol solution to 750 µl fresh culture
in a 2 ml cryogenic vial (Thermo Scientific Nalgene, Loughborough, UK) and immediately trans-
ferring to a -80°C freezer.
2.1.3 Growth of bacterial strains on agar plates
Agar plates containing solid growth medium were made by adding 16 g L-1 agar to culture
medium (medium compositions described in Section 2.2) and pouring into petri dishes (Thermo
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Scientific Nalgene, Loughborough, UK).
Working plates were made from frozen glycerol stocks of G. thermoglucosidasius by streak-
ing culture onto plates pre-warmed to 55 °C using an inoculation loop and incubating at 55 °C
overnight to enable growth of the culture. Plates were stored at 4 °C when not in use and for up
to 4 weeks before being discarded.
2.1.4 Sterilisation
All glass cultivation vessels were sterilised by autoclaving at 121°for 20-40 minutes prior to use.
Small medium volumes were either filter sterilsed into a sterile vessel using a 0.2 µl filter unit
(Thermo Scientific Nalgene, Loughborough, UK) or autoclaved at 121 °C for 20-40 minutes,
with non autoclaveable components, such as vitamins, amino acids and reducing sugars filter
sterilised through a 0.2 µm Minisart syringe filter (Sartorius Stedim, Goettigen, Germany) and
aseptically added to medium.
Large medium volumes for bioreactors were sterilised by autoclaving, with reducing sugars be-
ing autoclaved separately to prevent a Maillard reaction with other medium components and non
autoclaveable components, such as vitamins and amino acids being filter sterilised using a 0.2
µm Minisart syringe filter and then aseptically added to the medium.
Bioreactors were sterilised by autoclaving, with all tubing such as feed line and waste line as well
as inoculation flask and base flask, at 121 °C for 40 minutes prior to a cultivation and for 1 hour
post cultivation. All openings on the bioreactor vessel and tubing, such as a the end of the waste
feed line were covered with cotton wool and aluminium foil.
Disposable loops and spreaders were used for culturing of G. thermoglucosidasius to prevent
contamination of culturing tools with spores.
2.1.5 Centrifugation of bacterial cultures
Small culture volumes of less than 2.0 ml were centrifuged in an AccuSpin™ Micro (Fisher
Scientific, Leicestershire, UK) bench top microcentrifuge at either room temperature or 4 °C, de-
pending on the protocol requirements, at 10,000 x g or greater. Larger culture volumes of up to
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50 ml were centrifuged in an Eppendorf 5810-R centrifuge fitted with an A-4-62 rotor (Eppendorf
UK Ltd, Histon, UK) at 4 °C or room temperature.
2.1.6 Optical density analysis
Culture optical density (OD) at 600 nm was routinely used to monitor bacterial growth. OD was
measured in triplicate on either a plate reader Bio-Tek Synergy HT (Bedfordshire, UK) or a spec-
trophotometer Shimadzu UK UV-1601 (Milton Keynes, UK). Typically cultures were diluted prior
to analysis to prevent OD being greater than 1 AU.
2.2 Media used in this study
2.2.1 Tryptone glycerol pyruvate (TGP) medium
Rich medium used for routine culture of G. thermoglucosidasius was TGP, consisting of tryptone
17 g L-1, soy peptone 3 g L-1, NaCl 5 g L-1, K2HPO4 2.5 g L-1, with post autoclave additions of
glycerol 4 ml L-1, sodium pyruvate 4 g L-1, which were filter sterilised. For solid medium, 16 g L-1
agar was included.
2.2.2 Ammonium salts medium (ASM)
Ammonium salts medium (ASM) was used for cultivation of G. thermoglucosidasius in mini-
mal medium. ASM consisted of 20 mM NaH2PO4.2H2O; 10 mM K2SO4; 8 mM citric acid;
5 mM MgSO4.7H2O; 0.08 mM CaCl2.2H2O; 0.5 % (v/v) trace element solution (0.5 % (v/v)
H2SO4; 5 mM ZnSO4.7H2O; 20 mM FeSO4.7H2O; 10 mM MnSO4.H2O; 1 mM CuSO4.5H2O;
2 mM CoSO4.7H2O; 3.37 mM NiSO4.6H2O; 1.29 mM H3BO3); 1.6 µM Na2MoO4.2H2O; 25 mM
(NH4)2SO4; 12 µM biotin.
The carbon source in the medium routinely came from the addition of 0.5 % or 1 % (w/v) glucose.
Where alternative sources of carbon have been used this has been noted in the results sections.
Additionally, the use of further supplementation to aid growth, including yeast extract, tryptone
and amino acids has been noted separately in results sections.
In chemostat cultivations pH was maintained by the automated addition of KOH. Medium used for
batch cultivation in shake flasks was adjusted to pH 7.0 prior to autoclaving. pH was maintained
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in shake flasks by the inclusion of a buffer solution of 40 mM BisTris; 40 mM HEPES; 20 mM
PIPES which had been separately adjusted to pH 7.0 and filter sterilised.
2.3 Bacterial cultivation
2.3.1 Cultivation in shake flasks and Hungate tubes
Small scale cultivations were carried out in 250 ml Erlenmeyer Flasks, 50 or 15 ml centrifuge
tubes or Hungate tube for anaerobic cultures.
Erlenmeyer Flasks contained 50 ml of culture medium; 50 ml centrifuge tubes contained 5 ml
of culture medium; 15 ml centrifuge tubes contained 12 ml of culture medium to create a micro-
aerobic environment and Hungate tubes contained 12 ml of culture medium. The remaining
approximate 3 ml of headspace above the medium level in Hungate tubes was sparged with
compressed nitrogen gas, through a 0.2 µm Minisart syringe filter (Sartorius Stedim, Goettigen,
Germany) and syringe needle, with an additional syringe needle for exit gas from the Hungate
tube, for 10 minutes to remove air from the headspace and create an anaerobic environment. All
medium was pre-warmed to 55 °C prior to inoculation.
Seed cultures for the inoculation of other cultures were prepared for by inoculation from a work-
ing agar plate of G. thermoglucosidasius growing on TGP medium. Single colonies were used to
inoculate 5 ml of pre warmed TGP medium in a 50 ml centrifuge tube to make the seed culture.
50 µl of seed culture was used to inoculate 5 ml cultures, 100 µl was used for micro-aerobic
cultures and 1 ml of seed culture was used to inoculate both 250 ml Erlenmeyer flasks and 15 ml
Hungate tubes. Inoculum was administered via a pipette to aerobic and micro-aerobic cultures
and via 1 ml syringe and needle to anaerobic cultures in Hungate tubes.
All batch cultivations were carried out at 55 °C and and shaken at 250 rpm. Micro-aerobic and
anaerobic cultivations were shaken horizontally to enable maximum agitation.
2.3.2 Cultivation in bioreactors
2.3.2.1 1.5 Litre chemostat cultivations
The set up of the bioreactor consisted of 1.5 L Applikon (Worcestershire, UK) reactor vessel; Ap-
plikon (Worcestershire, UK) control unit which was comprised of Bio Console ADI 1025 and Bio
Controller ADI 1010; the bioreactor off gas composition was analysed using a Tandem LC gas
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analyser (Magellan Instruments Ltd, Limpenhoe, UK). Media and waste feeds were controlled by
Masterflex console drive model 7518-00 (Cole Palmer, Hanwell, UK).
Prior to sterilisation, the pH probe was calibrated using buffers at pH 4.0 and pH 7.0. Medium
delivered to the vessel was automatically adjusted to pH 7.0 by addition of 4.5 M KOH and main-
tained by the Applikon control unit. A correction of the pH of the medium in the bioreactor vessel
was carried out by sampling after it had been raised to pH 7.0 and the pH probe calibration ad-
justed if necessary. The bioreactor internal temperature was maintained at 66 °C by the passing
of heated water through an external bioreactor jacket under the automatic control of the Applikon
control unit.
Nitrogen or compressed air, which had passed through a 0.2 µM MiniSart filter (Sartorious Ste-
dim, Goettigen, Germany), was delivered to the reaction vessel via an internal aeration bar; gas
flow was controlled by rotamer valves on the Applikon control unit. The rate of gas delivered to
the vessel was measured by the time taken to pass a soap bubble through a burette. The tandem
LC gas analyser was calibrated prior to use using a calibration gas of 18.11 % oxygen and 3.03
% carbon dioxide (BOC Ltd, Surrey, UK).
Agitation of culture came from a top drive agitator fitted with two six-bladed Rushton impellers
at 400 rpm. Agitation of feed medium was by a magnetic follower inside the media vessel and
external magnetic stirrer.
A working culture size of 1.2 L was grown in the 1.5 L reaction vessel. The vessel was inoculated
using 50 ml of overnight culture grown in TGP medium in a 250 ml Erlenmeyer flask. The biore-
actor culture was established by batch growth before continuous culture was begun. Medium
flow rates for continuous culture were calculated by timing the movement of the meniscus of
the medium through a 5 ml glass pipette before medium was diverted to the reactor vessel. At
least three reactor working volumes were passed through the reactor under constant conditions
before the culture was considered to be in steady state, which was confirmed by spectrophoto-
metric measurement of optical density (OD) 600 nm and analysis of external metabolites by high
performance liquid chromatography (HPLC).
2.3.2.2 Small scale chemostat cultivations
A small scale bioreactor, which has been described previously [189], was used in all cultivations
in this study that required carbon-13 labelled substrate. The bioreactor set-up consisted of a
bespoke reactor vessel (Soham Scientific, Soham, UK) which had an internal working volume
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of 45 ml. Control and monitoring of culture conditions was by a Bio Console ADI 1025 and Bio
Controller ADI 1010 (both Applikon, Worcestershire, UK); analysis of off gas from the reactor
vessel was with a Tandem LC gas analyser (Magellan Instruments Ltd, Limpenhoe, UK) which
had been calibrated as previously described for a 1.5 L reaction vessel. Redox and pH levels
were monitored by probes (Broadley-James, Silsoe, UK) immersed in culture medium. The pH
probe was calibrated prior to autoclaving of the reactor vessel with buffers at pH 4.0 and pH
7.0. A sample from the bioreactor medium was externally checked for pH post autoclaving and
the calibration of the probe adjusted accordingly. Redox was measured using an HPT63 redox
transmitter (LTH Electronics, Luton, UK).
Media and waste feeds were delivered by two separate Watson-Marlow Pumps Group (Falmouth,
UK) 101U peristaltic pumps. Media feed was delivered into the reactor vessel through a 22 gauge
316 stainless steel needle (Sigma-Aldrich, Dorset, UK), which was positioned immediately ad-
jacent to the reactor internal wall so that medium was delivered to the chemostat in a gradual
stream rather than discrete drops, avoiding the cycling of feast-famine conditions in the reactor
vessel, to which the fermentor would be particularly prone due to the small working volume.
Compressed air and nitrogen, which had passed through a 0.2 µM MiniSart filter (Sartorious Ste-
dim, Goettigen, Germany) to ensure sterility, were delivered to the vessel by an internal gas loop
and gas flow was controlled by rotamer valves on the Applikon control unit. Agitation to both the
culture vessel and the medium was achieved by an internal magnetic follower bar and external
magnetic stirrer.
Maintenance of neutral pH was achieved by the addition of 0.9 M KOH under the control of the
Applikon control unit. KOH feed was delivered to the reactor via a 22 gauge 316 stainless steel
needle (Sigma-Aldrich, Dorset, UK). Temperature was automatically maintained by Applikon con-
trol unit at 66 °C throughout cultivations by the supply of heated water to an integral glass jacket
on the reactor vessel.
Protocols for the measurement of gas and medium flow rates were the same for the small scale
bioreactor as for the 1.5 L bioreactor.
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2.4 Molecular biology techniques
2.4.1 Storage of RNA and DNA
RNA samples were stored at -80 °C in either elution buffer of extraction kits or TE buffer (10mM
Tris-HCL pH 7.5, 1mM EDTA) treated with diethylpyrocarbonate (DEPC) (Sigma-Aldrich, Dorset,
UK). DEPC was added to TE buffer at a concentration of 0.1 % (v/v) and incubated for 12 hours
at 37 °C before being autoclaved.
All DNA samples were stored at -20 °C or -80 °C in the extraction kit buffer elution buffer.
2.4.2 Polymerase chain reaction
Analytical polymerase chain reaction (PCR) was carried out using primers from existing labora-
tory stocks, originally supplied by Invitrogen (Paisley, UK), details in Table 2.2. Reactions were
carried out using REDTaq ReadyMix PCR Reaction Mix (Sigma-Aldrich, Dorset UK) containing
MgCl2, reaction buffer, deoxynucleotides and Taq DNA Polymerase.
2.4.3 Primers
Primers used in this study are displayed in Table 2.2. All primers were ordered from Invitrogen
(Paisley, UK).
Table 2.2: Primer sequences used in this study
Primer name 5’ - 3’ Sequence Target
27F AGA GTT TGA TCM TGG CTC
AG
16S genomic DNA. Used in this
study to assess presence of DNA
in RNA samples.
1492R TAC GGY TAC CTT GTT ACG
ACT T
16S genomic DNA. Used in this
study to assess presence of DNA
in RNA samples.
2.4.4 Agarose gel electrophoresis
RNA and DNA were routinely analysed by agarose gel electrophoresis. Gels were made from 0.8
% (w/v) agarose dissolved in 1 x Tris Base, acetic acid and EDTA (TAE) buffer by microwaving
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for approximately 80 seconds at 800 watts. 1 x working volumes of TAE buffer were made from
dilution of a 50 x stock solution. The stock solution consisted of Tris Base 242 g L-1, glacial acetic
acid 57.1 ml L -1, 0.5 M EDTA 100 ml L-1, pH 8. DNA and RNA were visualised using SYBR safe
DNA gel stain (Invitrogen, Paisley UK) diluted 5 µl in 100 ml agarose gel solution.
Samples mixed with 5 x loading buffer for loading into the gel consisting of glycerol 30% (v/v) and
bromophenol blue 0.25% (w/v). 5 µl GeneRuler 1 kb DNA ladder (Fermentas, York, UK) or 2 log
ladder (New England Biolabs, Hale, UK) was used to ascertain DNA size. Electrophoresis was
carried out at 100-120 volts for approximately 40 minutes to separate DNA. Gels were visualised
on a UV illuminator and photographed on a Syngene G:Box ChemiHR system (Syngene, Cam-
bridge, UK) or a BioDoc-ITTM System (UVP, CA, USA) gel imaging system.
2.4.5 Isolation of genomic DNA
An overnight culture was grown in a 50 ml centrifuge tube at 55°C in a shaking orbital incubator
at 250 rpm. Cells were collected by centrifugation at 21 000 x g for 3 minutes and genomic DNA
was extracted using the Ultraclean® Microbial DNA Isolation kit from Mo Bio Laboratories, Inc
(Cambio Ltd, Cambridge, UK) according to the manufacturers protocol. Purified DNA was eluted
in 50 µl elution buffer supplied with kit (10 mM Tris buffer).
The DNA was concentrated for sequencing by precipitation in 5µl 5M NaCl and 100 µl 100 %
cold ethanol and inverted several times to mix. Samples were incubated at -20 °C for 30 minutes
and then centrifuged at 10,000 x g for 15 minutes to pellet the DNA. Excess liquid was decanted
and any remaining liquid in the samples left to air dry before being resuspended in elution buffer
(10 mM Tris buffer).
2.4.6 RNA stabilisation
RNA in G. thermoglucosidasius cultures was stabilised using RNAprotect Bacteria Reagent
(Qiagen, Crawley, UK). Cultures in mid-logarithmic growth were added to twice the volume of
RNAprotect Bacteria and mixed by vortexing for 5 seconds. Samples in RNAprotect bacteria
were incubated for 5 minutes at room temperature. The culture was then centrifuged for 10 min-
utes at 3220 x g. The supernatant was discarded and the pellet either immediately processed for
RNA extraction or stored at -80 °C for later extraction.
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2.4.7 RNA extraction
Various methods were used for the extraction of RNA from G. thermoglucosidasius in this study.
Where each method has been applied it has been noted in the results section.
2.4.7.1 Qiagen RNeasy Bacteria Mini Kit
RNeasy Bacteria Mini Kit (both Qiagen, Crawley, UK) was used according to the manufacturer’s
protocol, with the following alteration: cells were lysed in 3 mg ml-1 lysozyme in RNase free TE
buffer, decreased from 15 mg ml-1. The kit uses lysozyme in tris-EDTA buffer in order to lyse
the bacterial cells. Nucleic acids are then separated from other cell components by binding to a
silica-membrane spin column.
2.4.7.2 Ambion mirVana miRNA Isolation kit
Ambion (Paisley, UK) mirVana miRNA Isolation kit was used according to the manufacturer’s
protocol. The kit enables purification of total RNA including small RNA by fractionation of cellular
components using acid phenol chloroform and then separation of nucleic acids using a glass
fibre filter spin column.
2.4.7.3 Ambion RiboPure Bacteria kit
The Ambion (Paisley, UK) RiboPure - Bacteria kit was used according to manufacturer’s protocol,
including optimal treatment of extracted RNA with DNase I to remove residual DNA according to
the kit manufacturer’s protocol. The kit uses zirconia beads to lyse cells and an organic extraction
and spin column to isolate nucleic acids.
2.4.7.4 Extraction in TNS-PAS buffer
Triisopropylnaphthalene sulfonic acid (TNS)- p-4-aminosalicyclic acid (PAS) RNA extractions
were carried out according to the protocol published by Sharkey et al. [192].
Day cultures of G. thermoglucosidasius were grown at 55 °C. For the RNA extraction, cultures
were cooled for 15 minutes in an ice bath then 200 µl of culture was added to 1 ml of lysis buffer.
1 ml of lysis buffer consisted of approximately 0.5 g of RNase free zirconia beans (Ambion, Pais-
ley, UK) and 50 mg ml-1 lysozyme in TE buffer. Culture and lysis buffer were vortexed for 40
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seconds and then sample cooled in an ice bath. Samples were centrifuged at 14,000 x g for 8
minutes at 4 °C. The resultant supernatant was transferred to a clean microcentrifuge tube and
placed in an ice bath.
750 µl TNS-PAS buffer consisting of 1% TNS (sodium salt), 6% PAS (sodium salt), 200 mM
TRIS-HCl, 25 mM EDTA, and 250 mM NaCl (pH 7.8) was added to each sample, vortexed and
incubated in an ice bath for 25 minutes. Samples were centrifuged at 10,000 x g for 8 min at
4 °C, and the supernatant added to one volume of phenol:chloroform:isoamyl alcohol (Ambion,
Paisely, UK) and gently mixed. Samples were then centrifuged at 14,000 x g for 10 minutes at
room temperature.
Following centrifugation, 2 volumes of ice-cold ethanol were added to the samples, which were
then incubated at -70 °C for 3 hours to precipitate the RNA. Samples were centrifuged at 16,000
x g for 25 minutes at 4 °C, the supernatant was decanted and the pellet air dried on ice. The
pellet was resuspended in 30 µl of sterile RNase-free water (Hyclone, Fisher Scientific, Leices-
tershire, UK).
2.4.7.5 Hot phenol RNA extraction
Hot phenol RNA extractions were carried out according to the protocol published by Atshan et al.
[193].
1 ml of bacterial cell culture was pelleted by centrifugation at 8, 000 x g for 3 minutes at 4 °C
in a microcentrifuge. The pellet was then resuspended in 100 µl of RNase free water (Hyclone,
Fisher Scientific, Leicestershire, UK). The samples were vortexed for 3 minutes and 100 µl phe-
nol:chloroform:isoamyl alcohol (Ambiom, Paisely, UK) was added. Samples were vortexed for
a further 1 minute and then incubated at 70 °C for 30 minutes in a heat block inside of a fume
hood, vortexing was repeated at 5 minute intervals during this incubation period.
Samples were centrifuged at 12,000 x g for 10 minutes and 100 µl from the top aqueous phase in
the microcentrifuge tube was transferred into a clean microcentrifuge tube. 700 µl of buffer RLT
from the RNeasy Protect Bacteria Mini Kit (Qiagen, Crawley, UK) was added to the samples. The
remainder of the protocol was carried out as described in the RNeasy Protect Bacteria Mini Kit
(Qiagen, Crawley, UK) manufacturer’s protocol.
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2.4.8 DNase treatment of RNA
In order to remove co-purified DNA, extracted RNA was incubated with DNase I and DNase I
buffer (Fermentas, York, UK or Ambion Paisley, UK) at 37 °C for 30 minutes to remove residual
DNA contamination to below PCR detectable levels. DNase was removed by re-elution through
RNeasy MIni Kit spin column or by addition DNase Inactivation Reagent (Ambion, Paisley, UK).
Inactivation reagent equal to 20 % of the total sample volume was added to the samples and then
vortexed. Samples were incubated at room temperature for two minutes before centrifuging in
a microcentrifuge to pellet the inactivation reagent and DNase I and the supernatant containing
the RNA transferred to a clean, RNase free micro centrifuge tube.
2.4.9 RNA quality assessment
RNA for sequencing was assessed for quality and quantity using the Bio-Rad (Hertfordshire, UK)
Experion system. Analysis was carried out using the Bio-Rad (Hertfordshire, UK) Experion RNA
StdSens kit according to manufacturer’s protocol and Prokaryotic RNA StdSens system settings.
RNA quality was assessed by 23S / 16S ribosomal RNA ratio, with a ratio of 2.0 being optimal.
Quantitation of RNA was verified using using Bio-Tek (Bedfordshire, UK) Synergy HT plate reader
by measuring absorbance at 260 nm and multiplying by 40 to obtain ng µl-1 or using a NanoDrop
1000 (Thermo scientific, Loughborough, UK). Samples were checked for contamination by pro-
tein and organic compounds by measuring ratios of absorbances at 260 nm / 280 nm and 260
nm / 230 nm respectively.
RNA samples were checked for DNA contamination using PCR with primers for genomic 16S
DNA available from existing laboratory stocks and running the product of the PCR reaction in an
agarose gel to check for a positive amplification of DNA.
2.5 Genome sequencing
Sequencing was carried out by Source BioScience (Nottingham, UK). The library was prepared
using Nextera Sample prep and sequencing carried out as 150 bp paired end reads on the Ilu-
mina MiSeq Next Generation Sequencing System. Bioinformatic read assembly into multiple
contigs was carried out by Source BioScience.
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2.5.1 Genome annotation
The sequenced genome was automatically annotated using the Rapid Annotation using Subsys-
tem Technology (RAST) server [194] using the bacteria domain and the genetic code for Bacteria,
Archaea, prokaryotic viruses and chloroplast proteins (Table 11 of NCBI genetic codes).
The automatically annotated genome sequence was manually curated for missing annotations
by comparison with the annotated genome sequence of G. thermoglucosidasius strain TM242
(∆ldh↑pdh∆pfl), which had previously been manually curated. For any enzyme in central carbon
metabolism or amino acid biosynthesis pathways annotated in the TM242 (∆ldh↑pdh∆pfl) se-
quence but not in the DL33 (wt) sequence, the nucleotide sequence from the TM242 (∆ldh↑pdh∆pfl)
genome was aligned against the DL33 (wt) genome sequence using the Basic Alignment Search
Tool (BLAST) [195] on the RAST server to determine the presence or absence of this enzyme in
the DL33 (wt) sequence.
2.5.2 Genomic alignment and analysis
Assembled contigs from sequencing provided by Source BioScience (Nottingham, UK) were as-
sembled and reordered based on the G. thermoglucosidasius TM242 (∆ldh↑pdh∆pfl) genome
sequence using the ProgressiveMauve algorithm with default parameters [196].
2.6 RNA-seq
RNA-seq was carried out on a SOLiD platform at the DeepSeq facility at the University of Notting-
ham. Total RNA was ribodepleted and cDNA libraries for sequencing constructed by DeepSeq.
Sequencing was carried out to a depth of approximately 0.3 gigabases. Reads from sequencing
were assembled to transcripts and converted to reads per kilobase per million reads (RPKM)
values by DeepSeq.
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2.7 Chromatographic techniques
2.7.1 High performance liquid chromatography analysis (HPLC) analysis
of sugars, organic acids and ethanol
Extracellular concentrations of glucose and the metabolites acetate, lactate, formate, ethanol,
pyruvate and succinate in the supernatant of cultures were analysed using high performance
liquid chromatography (HPLC). 1 ml of culture was pelleted by centrifugation in a microcentrifuge
and the supernatant transferred to a chomatorgraphy vial (Thermo Fisher Scientific, Loughbor-
ough, UK) and proceeded to direct analysis or stored at -20 °C for later analysis.
Samples were analysed on a Jasco HPLC system (Essex, UK), which consisted of the following
components: a PU2080 plus pump, AS-2051 plus intelligent sampler, a UV075 plus UV/Vis spec-
trophotometer measuring absorbance at a wavelength of 210 nm, a RI-2031 plus refractive index
(RI) detector, a column thermostat jetstream and oven which was set at 35 °C for all sample runs
and an LCnetII ADC adaptor which coordinates between the HPLC equipment and acquisition
software. An Aminex HPX87H ion exclusion column (300 x 7.8 mm) (BioRad, Hemel Hempstead,
UK) was used to separate compounds and Chrompass data acquisition software (Jasco, Essex,
UK) was used for equipment control and data acquisition.
A 10 µl volume of the sample was injected into the HPLC system and carried by the mobile
phase, 10 mM sulphuric acid, at a flow rate of 0.6 ml min-1. Compounds were separated over an
elution time of 25 minutes.
Metabolite concentrations were quantified by carrying out linear regression analysis using stan-
dards at concentrations of each compound 1 mM, 10 mM, 20 mM, 30 mM, 40 mM and 50 mM
in water, with the exception of acetate, for which standards at concentrations of 1 mM, 20 mM.
40mM, 60 mM, 80 mM and 100 mM were used.
External concentrations of citrate were quantified using HPLC by TMO Renewables Ltd (Guild-
ford, UK).
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2.7.2 High performance liquid chromatography analysis (HPLC) analysis
of amino acids
External concentrations of amino acids were analysed using HPLC by TMO Renewables Ltd
(Guildford, UK).
2.7.3 Gas chromatography mass spectrometry (GC-MS) analysis of intra-
cellular proteinogenic amino acids
Gas chromatography mass spectrometry (GC-MS) analysis of cell pellets from 13C metabolic
flux analysis chemostat cultivations was carried out as described by [116]. Further details are
provided below.
2.7.3.1 Culture sampling
1 ml samples were removed from chemostat cultivations in the small scale bioreactor in technical
triplicate using a 1 ml sterile syringe. Cells were immediately pelleted by spinning at 15 800 x g
at 4 °C and washed with isotonic buffer (0.9 % NaCl). Cell pellets were either stored at -20 °C or
proceeded to immediate hydrolysis and derivatisation.
2.7.3.2 Cell hydrolysis
Cells were hydrolysed by resuspending in 200 µl 6 M HCl and then transferred to screw capped
cryogenic tubes. Tubes were sealed tightly to prevent evaporation and were baked in an oven
for 12 - 24 hrs at 105 °C. The hydrolysed cell solution was then dried at 95 °C under a constant
stream of air provided by a fume hood for 8 hours. The dried hydrolysate was then stored at
room temperature prior to derivatization for GC-MS.
2.7.3.3 Derivatization of proteinogenic amino acids
All derivatization steps were carried out in a fume hood. In order to derivatize proteinogenic
amino acids for GC-MS analysis, the dried hydrolysate was incubated at 95 °C in open tubes in
order to remove any residual moisture in the samples. The hydrolysate was then partly resus-
pended in 20 µl dimethylformamide (DMF) which could interfere with the derivatization process.
Resuspension of the entire culture was not necessary as GC-MS for 13C-metabolic flux analysis
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relies upon the relative intensities of the different mass weights with the mass isotopomer distri-
bution rather than total amino acid content and resuspension of the entire cell hydrolysate may
be detrimental to the downstream process [116].
The resuspended hydrolysate was added to 20 µl N-tertbutyldimethylsilyl-N-methyltrifluoroacetamide
(MTBSTFA) with 1% (w/v) tertbutyldimethyl-chlorosilane (TBDMSCI) (Sigma-Aldrich, Dorset, UK)
derivatization reagent. The suspension was baked for an hour at 85 °C in a well sealed tube to
prevent evaporation. Finally the samples were transferred to a chromatography vial with a glass
insert (Thermo Fisher, Scientific, Chromacol, Hertfordshire, UK) and proceeded immediately to
GC-MS analysis.
2.7.3.4 Gas chromatography mass spectrometry
For analysis of the derivatized amino acids an Agilent 5975C Series GC/MSD gas chromato-
graph with a polydimethylsiloxane GC column coupled, with a mass spectrometer (GC-MS) (Ag-
ilent Technologies UK Limited, Stockport, UK) was used.
Prior to sample analysis the GC-MS was tuned to a full width at half maximum (FWHM) peak
width of 0.40- 0.45 a.m.u. in the mass range of 180 to 550 mass to charge ratio (m/z). 1 µl of
sample was injected into the GC-MS in split mode 1:10 with helium carrier gas at a rate of 1.5 ml
min-1. The inlet liner containing glass wool was set to a temperature of 230 °C. Oven temperature
was set at 160 °C for 1 minute before ramping to 310 °C at a rate of 20 °C min-1. Temperature
was held at 310 °C for 0.5 minutes. Compound detection was carried out in full scan mode in the
mass range 180 to 550 m/z, with 2-4 scans sec-1, a source temperature of 230 °C, a transfer line
temperature of 280 °C and a solvent delay time of 2.7 minutes. The injector needle was cleaned
with hexane and ethyl acetate three times before measurement commencement and twice fol-
lowing every measurement thereafter.
The raw GC-MS data was converted to common data format (CDF) using the acquisition soft-
ware for further processing of the isotope data.
2.7.4 Gas chromatography mass spectrometry (GC-MS) analysis of extra-
cellular compounds
GC-MS was used to to analyse the mass isotopomer distribution of external amino acids and
organic acids in the culture supernatant.
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2.7.4.1 Culture sampling
Samples were taken from chemostat cultures at isotopic and metabolic steady state at the same
time as sampling of biomass for analysis of intracellular metabolites. The culture was centrifuged
to pellet biomass. Supernatant was removed and freeze dried to preserve for later analysis.
2.7.4.2 Freeze drying
The culture supernatants were aliquoted to 2 ml cryogenic vials and then frozen in a -80 °C
freezer. Samples were then transferred to a Scanvac CoolSafe (Labogene, Lynge, Denmark)
at -110 °C for overnight freeze drying. Freeze dried samples were stored at room temperature
before further analysis.
2.7.4.3 Derivatization
The freeze dried sample supernatant was resuspended in water and transferred to 1.5 ml silanized
glass chromatography vials (Thermo Scientific, Loughborough, UK). 20 µl of 20 mgml-1 methoxyamine
hydrochloride (Sigma-aldrich, Poole, UK) in pyridine was added, the samples were then incu-
bated at 37 °C and shaken at 900 rpm for 1.5 hours. 80 µl MTBSTFA with 1 % (w/w) TBDMSCI
(Thermo Scientific, Loughborough, UK) was added and the samples were incubated for a further
30 minutes at 37 °C and 900 rpm. Samples were centrifuged to pellet insoluble material and the
supernatant transferred to a glass vial with insert and proceeded to immediate GC-MS analysis.
2.7.4.4 GC-MS analysis
Analysis was carried out using an Agilent 5975C Series GC/MSD gas chromatograph coupled
with a mass spectrometer (GC-MS) (Agilent Technologies UK Limited, Stockport, UK) using the
settings and library detailed by Kind et al. [197].
Mass isotopomer distributions of compounds were extracted from mass spectrometry data files
and corrected for naturally occurring isotopes using GavinIso, a version of the GAVIN program
[198] developed for isotopic data (G. Tredwell, V. Behrends, unpublished).
68
2.8 Computational methods
2.8.1 Correction for naturally occurring isotopes
All GC-MS data of proteinogenic amino acids was corrected for naturally occurring isotopes in
the derivatization agent and unlabelled biomass in the samples using FiatFlux [129], IsoCor [199]
and Matlab MS Correction Tool (MSCorr) [200].
2.8.1.1 FiatFlux
FiatFlux is operated in Matlab [129]. The program was launched using the command »ratio in
the Matlab command window (Matlab version R2011b). CDF files exported from the GC-MS
acquisition software were converted to *.ff files using the commands in the FiatFlux GUI:
Data > Convert Quad-CDF > Data > Load
The glucose labelled feed ratio was set on the FiatFlux interface. Amino acids were auto assigned
and then verified based on GC elution times and reassigned if necessary. Unlabelled biomass
was calculated by exp(−Dt), where D is the dilution rate of the continuous culture and t is
the length of time that the culture has grown on the labelled substrate [116]. Corrected and
normalised mass isotopomer distributions were exported to a spreadsheet by selecting:
Menu > Report
2.8.1.2 IsoCor
Signal intensities of m/z from 180 through to 570 for each amino acid were exported to text files
using Matlab and the intensities for the required mass fragments manually extracted for mass
correction in the IsoCor program.
IsoCor [199] was launched as a standalone program on a Windows system. Structures of all the
metabolites of interest were added to the metabolites.dat text file and corresponding derivatiza-
tion fragments were added to the derivatives.dat file. Raw GC-MS m/z intensities were loaded
using the IsoCor GUI and the corresponding metabolite and derivative settings were selected for
each fragment, the input substrate was set at 99 % purity, corresponding to the purity of the [13C]
glucose substrate and the calculation run.
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2.8.1.3 Matlab MS Correction Tool
The Matlab MS Correction Tool [200] GUI was launched in Matlab using command » MSCorr in
the Matlab Command Window. Amino acid structures and defined fragments were loaded using
a pre-existing list (S. Masakapalli, unpublished). Unlabelled biomass proportion was calculated
as described for mass correction with FiatFlux. Raw GC-MS intensities from m/z 180 to 570,
which had previously been extracted in Matlab were loaded as plain text files and the relevant
amino acid and mass fragment selected for correction and the calculation run.
2.8.2 Model construction
All metabolic flux calculation was carried out using the 13CFLUX2 suite of software programs
[148] on a Linux system running Ubuntu 12.04. All commands were run in the Ubuntu command
line. Each program and command used in this study is described in detail in the 13CFLUX2
reference manual [201].
Metabolic network models were written in Extensible Markup Language (XML) in the 13CFLUX2
model format and notation as devised by Wiechert et al. [87, 148]. All models contained metabo-
lite pools, metabolic model reaction network with carbon atom transitions, constraints on net and
exchange fluxes, input pools to the cell from the surrounding environment, GC-MS input groups
and mass isotopomer distributions, measured cellular effluxes and influxes and free (starting)
fluxes.
Metabolic models were constructed from an example model of E. coli metabolism provided with
the 13CFLUX2 software for this purpose. The existing network was compared to the annotated
genome sequence of G. thermoglucosidasius and reactions added and removed where neces-
sary. Carbon atom transitions were determined using textbook biochemistry, the KEGG Reaction
Pair (RPAIR) Database and previously published reactions networks [106, 110, 202].
Mass isotopomer distributions were entered in the models in their normalised form so that the
total intensity of all the mass weights within a mass fragment M+0, M+1, ... M+n for n carbon
atoms, equaled one.
The syntax of the models was checked using the program fmllint by running the command fmllint
-i <model>.fml -o <model>_.fml and a signature generated for each model using the command
fmlsign -i <model>.fml -o <model>_.fml.
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For the linear flux optimisation procedure, free fluxes were selected based on reasonable as-
sumptions of cellular metabolism as well as available input substrates to the cell and measured
effluxes from the cell. These assumed fluxes were then optimised by sampling the central space
of the model and writing a new model with the optimised starting fluxes using the command ss-
canner -i <model>.fml -o <model>_niff.fml.
2.8.3 Model simulation
Models were simulated to check for a functioning model and that the given free fluxes provided a
feasible starting point for the iterative flux optimisation procedure using the command fwdsim -i
<model>_niff.fml -o <model>.fwd. Sensitivities of the fluxes were obtained by using the ’-s’ option
with this command.
2.8.4 Linear flux fitting procedure
Fitting of optimised models was initiated using the command fitfluxes -i <model>_niff.fml -o
<model>_opt.fwd. Up to 1000 iterations of flux distributions were carried out of each model
as allowed by the fitfluxes program.
2.8.5 Multiple simulations flux fitting proceedure
Starting models <model>.fml had an initial set of free fluxes set by using the sscanner program
to sample the centre of the flux solution space to create a new file <model>_niff.fml. From these
initial free fluxes, a set (n = 100) of random starting fluxes were generated for the flux fitting pro-
cedure using ssampler program and were written to a hierarchal data format file (*.hdf5). Multiple
fitting procedures (n = 100), each with 1000 iterations, were started using the <model>_niff.fml
and the random free fluxes stored in the *.hdf5 file using the multifit program.
Fluxes in the multiple flux simulation files generated by multifit were converted to a single comma
separated variable file using the program fwdsim2csv. Only flux simulations where the final least-
squares residuals passed a χ2 test at a 95 % confidence interval were used to calculate average
flux and standard deviation of flux.
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2.8.6 Statistical analysis of flux distribution
Goodness-of-fit of the final flux distributions generated by the fitfluxes and multifit programs were
assessed using a χ2 test. Degrees of freedom of the flux model was calculated as m − f − g
wherem is number of mass isotopomer groups, f is the number free fluxes and g is the number
of isotopomer measurement groups. The χ2 value for the given degrees of freedom was calcu-
lated at a 0.95 confidence interval using a χ2 calculator.
Where the residuum (difference between the observed and simulated isotopomer distributions
and measured fluxes) generated by the fitfluxes program fell below the χ2 value for the given
degrees of freedom at a 0.95 confidence interval, the generated flux distribution was considered
to be statistically reliable. Where the residuum was above the χ2 value, the flux distribution was
considered to represent a local flux distribution.
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3Sequencing of the DL33 (wt) genome and defining
conditions for 13C metabolic flux analysis
3.1 Introduction
In order to investigate an organism using 13C-metabolic flux analysis, there are certain require-
ments which must be fulfilled. There must be sufficient knowledge of the metabolic network of
the organism so that organism specific metabolic models can be created. This is particularly
pertinent for non-model organisms such as G. thermoglucosidasius for which there is generally
relatively little available information on the organism’s metabolism or genome sequences com-
pared to better characterised organisms. It is also very important that there is a minimal and
defined medium that can support steady state growth of the organism under the conditions to be
investigated using metabolic flux analysis, as carbon sources within the medium which have not
been accounted for will perturb the isotopomer distributions within the network.
In order to carry out 13C-MFA in G. thermoglucosidasius, this chapter therefore describes studies
to fulfil these criteria by the following means:
• Sequencing and annotation of the DL33 (wt) genome to serve as the basis for metabolic
network topology in 13C-MFA models.
• Defining a medium which can support the growth of all three strains, DL33 (wt), DL44 ∆ldh
and DL66 (∆ldh∆pfl↑pdh), in which all components are in defined quantities.
• Define different physiological conditions, which could be used to investigate metabolic flux
of all three strains under different aeration levels.
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3.2 Sequencing of the genome of wild-type DL33
Strain DL33 is a wild type Geobacillus thermoglucosidasius strain formerly known as SB2, which
had been previously isolated by Simon Baker, Birbeck College (unpublished). This wild type
strain has served as the background for production of mutant strains, which have been engi-
neered for higher ethanol production. This includes a lactate dehydrogenase (ldh) knock out
strain, DL44 (∆ldh) described in [203] and [12] and a high yielding ethanol producing strain
DL66 (∆ldh∆pfl↑pdh) [189], which were investigated in this study. As the parent strain, the in-
formation in the annotated genome sequence of DL33 (wt) can be used for construction of all
metabolic models.
Whilst other strains of G. thermoglucosidasius have undergone whole genome sequencing, no-
tably, the TM242 (∆ldh↑pdh∆pfl) mutant of wild type G. thermoglucosidasius strain NCIMB
11955 (wt), described by Cripps et al. [12] (TMO Renewables, Ltd), G. thermoglucosidans strain
TNO-09.020 [204] (GenBank accession number NZ_CM001483) and G. thermoglucosidasius
C56-YS93 GenBank accession number NC_015660), to date the DL33 (wt) strain has not.
3.2.1 Isolation of genomic DNA
Genomic DNA was extracted from a DL33 (wt) day culture, which had been seeded from an
overnight culture. The culture was grown in TGP medium at 55 °C with orbital shaking at 250
rpm. DNA was extracted using the UltraClean Microbial DNA Isolation Kit from MoBio Laborato-
ries Inc (Cambio, Cambridge, UK) according to the manufacturers instructions and concentrated
by NaCl and ethanol precipitation. Purity and quantity of the DNA was measured by absorbance
at 230 nm, 260 nm and 280 nm using a Thermo Scientific NanoDrop 1000 Spectrophotometer
(Fig 3.1). The ratio of absorbances at 260 nm and 280 nm (260/280) and 260 nm and 230 nm
(260/230) were measured as 1.92 and 3.23 respectively.
Figure 3.1: Analysis of DL33 (wt) genomic DNA for sequencing using a Nanodrop spectropho-
tometer.
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3.2.2 Genome sequencing
Sequencing was carried out by Source BioScience (Nottingham, UK). The library was prepared
using a Nextera DNA Sample preparation kit and sequencing carried out on an Ilumina MiSeq
Next Generation Sequencing System. Sequencing produced 11,821,689 paired end reads rang-
ing in length between 35 and 151 base pairs. Bioinformatic read assembly to multiple contigs was
carried out by Source BioScience. Final read assembly resulted in a 3.77 Mb genome sequence
consisting of 516 separate contigs.
3.2.3 Annotation and curation
The set of contigs was automatically annotated using the Rapid Annotation using Subsystem
Technology (RAST) server [194]. The annotation identified that 394 of the contigs contained pro-
tein encoding genes, between them encoding 4213 sequences. A further 70 sequences were
identified as encoding RNA molecules. The GC content of the genome was 43.8 %.
Table 3.1: Gene annotations missing from the automated RAST annotation of the DL33 (wt)
strain genome sequence. Genes were identified by aligning translated amino acids sequences
from the TM242 (∆ldh↑pdh∆pfl) genome against the predicted open reading frames in the DL33
(wt) sequence using BLAST [195].
Name EC number Major pathway Blast E Value
3-hydroxyacyl-CoA dehy-
drogenase
1.1.1.35 Isoleucine and valine
degradation
0
glyceraldehyde-3-
phosphate dehydrogenase
(NAD(P)+)
1.2.1.59 Glycolysis gluconeogene-
sis
0
phosphogluconate de-
hydrogenase (NADP+-
dependent, decarboxylat-
ing)
1.1.1.44 Pentose phosphate path-
way
0
6-phospho-3-
hexuloisomerase;
5.3.1.27 Pentose phosphate path-
way
1.00E-96
3-hexulose-6-phosphate
synthase;
4.1.2.43 Pentose phosphate path-
way
1.00E-113
Phosphoserine phos-
phatase
3.1.3.3 Serine biosynthesis 1.00E-163
The RAST annotation system is a wholly automated system, consequently there is potential
for annotation of some genes to be missed. In light of this, the pathways of central carbon
metabolism and amino acid biosynthesis which were relevant to the construction of metabolic flux
models were manually curated. Six gene were found to have not been annotated in the DL33
(wt) sequence compared to the TM242 (∆ldh↑pdh∆pfl) genome sequence (Table 3.1). The
translated amino acid sequences from the TM242 (∆ldh↑pdh∆pfl) annotated genome of these
six genes were aligned against predicted open reading frames in the DL33 (wt) sequence using
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the Basic Local Alignment Search Tool (BLAST) [195] on the RAST server and e-values used to
positively identify the genes present in the DL33 (wt) genome which had not been annotated.
3.2.4 Features of the DL33 genome
The major pathways of central carbon metabolism were investigated as these are those of
principle importance for metabolic flux models. G. thermoglucosidasius uses the Embden-
Meyerhof pathway of glycolysis, all associated genes for which were automatically annotated
in the DL33 (wt) sequence. In common with TM242 (∆ldh↑pdh∆pfl), the genome sequence
of strain DL33 (wt) encodes a glyceraldehyde-3-phosphate dehydrogenase which has been re-
ported to use both NADP+ and NAD+ as electron acceptors (EC 1.2.1.59) [205, 206] as well
as the more common NAD+ linked glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12).
Notably, the genome sequence does encode several of the enzymes necessary for the Entner-
Doudoroff Pathway, specifically glucose 1-dehydrogenase (EC 1.1.1.47), glucose-6-phosphate
dehydrogenase (EC 1.1.1.49), 2-dehydro-3-deoxy-phosphogluconate aldolase (EC 4.1.2.14) and
2-dehydro-3-deoxy- gluconokinase (EC 2.7.1.45) but does not have genes encoding the com-
plete pathway.
In the TCA cycle, the genome sequence reveals that the organism encodes both an oxoglutarate
dehydrogenase complex (OGDC) and an oxoglutarate synthase (EC 1.2.7.3). Unlike the OGDC,
the latter does not require NAD+ as a cofactor and does not rely upon the dihydrolipoamide dehy-
drogenase subunit (EC. 1.8.1.4) of the pyruvate dehydrogenase complex and instead mediates
electron transport using a ferredoxin; this mechanism has been reported previously in anaerobic
thermophilic organisms suggesting that this alternative enzyme functions in the absence of oxy-
gen [207, 208].
In the pentose phosphate pathway, DL33 (wt) appears to lack 6-phosphogluconolactonase (EC
3.1.1.31) which is required for the oxidative, NADPH producing branch of the pathway, (Fig.
3.2). This seems to be common in other G. thermoglucosidasius strains, with the cognate gene
missing from strains TM242 (∆ldh↑pdh∆pfl), C56-YS93 and TNO-09020. Furthermore, it is
also missing in other members of the Geobacillus genus with none of the G. kaustophilus, G.
thermodenitricans and G. thermoleovorans genome sequences in the KEGG Pathway database
containing this gene annotation. However, most strains of the related mesophilic, related genus
Bacillus have retained this enzyme although B. halodurans B. pseudofirmus are notable ex-
ceptions to this rule. Alignment of the B. subtilis sequence encoding for this enzyme with G.
thermoglucosidasius genomes using the blastn algorithm with either megablast or discontiguous
megablast programs did not yield any matches, which suggests it is unlikely that this enzyme had
been missed in the annotation of these genomes. It is possible that the oxidative pentose phos-
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phate pathway is still functioning in these species however but is dependent on the thermolability
of 6-phospho-D-glucono-1,5-lactone for its conversion to 6-phospho-D-gluconate.
Figure 3.2: G. thermoglucosidasius DL33 (wt) pentose phosphate pathway enzymes encoded
in the genome sequence. Pentose phosphate pathway enzymes are shown in pink, while EM
glycolysis enzymes are shown in yellow. The full oxidative branch of pentose phosphate pathway
is incomplete as a gene encoding 6-phosphogluconolactonase (EC 3.1.1.31) is not present in
the genome sequence. Image generated using KEGG data mapping [209]
If flux through the oxidative pentose phosphate pathway is absent or restricted due to the lack of
a gene encoding 6-phosphogluconolactonase (EC 3.1.1.31), other genes will be needed by the
organism for reduction of NADPH. One possible candidate is NADP+ linked glyceraldehyde-3-
phosphate dehydrogenase (EC 1.2.1.59) in glycolysis. As this is a parallel reaction to the NAD+
dependent oxidoreductase (EC. 1.2.1.12), the cell should be able to use the enzyme most able
to meet its metabolic requirements. In addition, DL33 (wt) encodes both an NADP+ linked isoc-
itrate dehydrogenase (EC. 1.1.1.42) in the TCA cycle and an NADP+ linked malic enzyme (EC
1.1.1.40) providing further reactions for NADPH reduction.
Strain DL33 (wt) encodes three enzymes in total contributing to anaplerotic reactions, enabling
full interconversion between oxaloacetate, malate, phosphoenol pyruvate and pyruvate, (Fig 3.3).
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Figure 3.3: Anaplerotic enzymes encoded in the genome sequence of G. thermoglucosidasius
DL33 (wt). Image generated using KEGG data mapping [209]
The overall network of G. thermoglucosidasius central carbon metabolism based on the DL33
(wt) genome sequence is shown in Fig. 3.4.
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Figure 3.4: The overall network of G. thermoglucosidasius central carbon metabolism based on
the DL33 (wt) genome sequence. Abbreviations are shown on abbreviations list on pages 17-20.
79
3.2.5 Contig alignment against an assembled Geobacillus thermoglucosi-
dasius genome
Sequencing of the DL33 (wt) genome produced 516 contigs. In an effort to organise this large
number of contigs into a probable order, the fasta sequence was aligned against the TM242
(∆ldh↑pdh∆pfl) genome, which is comprised of 3 contigs, providing a good framework for as-
sembly. The genome sequences were aligned using the progressiveMauve algorithm with default
parameters [196].
The algorithm produced 8 iterations of potential alignment before reaching a final consensus.
A graphical representation of this alignment is shown in Fig. 3.5. The alignment produced 30
locally collinear blocks (LCB) - regions within the genomes in which no rearrangement has taken
place between the two sequences. As the majority of the genomes can be aligned to one an-
other - i.e. most of the sequence of both genomes was assigned to an LCB, the strains show
little divergence from one another. There were however smaller regions outside the LCBs which
could not be aligned between the strains. These were largely shorter contigs of the DL33 (wt)
genome of less than 100 nts each. One small region of the DL33 (wt) genome can be seen to
exist in the reverse complement to the equivalent region of TM242 (∆ldh↑pdh∆pfl) .
Figure 3.5: Alignment of the G. thermoglucosidasius DL33 (wt) and TM242 (∆ldh↑pdh∆pfl)
genome sequences using the progressiveMauve algorithm. Upper genome is strain TM242
(∆ldh↑pdh∆pfl), which provided the backbone for arrangement of the DL33 strain fasta se-
quence, shown in the lower genome. Each block represents a region of sequence similarity
between the two genomes, with the extent to which the block is shaded representing the similar-
ity profile (degree of sequence similarity) between the two regions. A block below the length of
the genome is in the reverse compliment orientation in the DL33 (wt) genome sequence relative
to the TM242 (∆ldh↑pdh∆pfl) genome sequence.
The level of homology with in each LCB is represented by the degree to which blocks are shaded
(the "similarity profile"). Several areas on the alignment have gaps in the similarity profile. These
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regions are indicative of single nucleotide polymorphisms (SNPs) between the two strains. The
number of SNPs across the whole DL33 genome relative to TM242 (∆ldh↑pdh∆pfl) are 26,338,
(Table 3.2).
Table 3.2: SNPs between the sequenced DL33 (wt) genome and the TM242 (∆ldh↑pdh∆pfl)
reference genome
SNP Count SNP Count SNP Count SNP Count
Ac 1231 Ca 1069 Ga 4371 Ta 975
Ag 4558 Cg 598 Gc 566 Tc 4503
An 142 Cn 139 Gn 136 Tg 1296
At 993 Ct 4515 Gt 1159 Tn 87
Total 26 338
In order to assess where SNPs between the genomes may have had physiological implications,
DL33 (wt) strain sequence was compared to the reference sequence of TM242 (∆ldh↑pdh∆pfl)
for proteins where sequence homology was lower than 90 % using sequence based compari-
son on the RAST server. In total, 755 protein coding genes were identified that fell below the
threshold. However, excluding all genes identified as hypothetical or unknown proteins, which
have no information associated with them regarding their function, reduced the total 327. Of
these proteins, a large majority were transporters, mobile element proteins and transcription reg-
ulators. None of the proteins were those associated with central metabolism and amino acid
production or uptake, which could give rise to differences in flux analysis in the DL33 (wt) strain
or its engineered counterparts and the NCIMB 11955 strain and its corresponding mutants. It is
noteworthy that three genes from TM242 (∆ldh↑pdh∆pfl), which have been annotated as alco-
hol dehydrogenase have no equivalents in DL33 (wt). These were short fragments of 43, 55 and
80 bp in length however, not full genes, and thus are likely to be mis-annotations of the TM242
(∆ldh↑pdh∆pfl) genome sequence.
3.3 Anaerobic growth of G. thermoglucosidasius and nutri-
tional requirements
The ability of G. thermoglucosidasius to undergo fermentative growth is well documented [12,
158, 190, 210]. However, strain DL33 (wt) and the engineered strains which have been devel-
oped from it cannot maintain steady growth in the complete absence of oxygen. Enforcement of
strict anaerobic conditions of G. thermoglucosdasius in continuous culture, such as by sparging
of the culture with nitrogen gas, results in culture wash out even if the culture medium contains
rich sources of nutrients. It remains to be established whether this as a consequence of a nutri-
ent deficiency or an absolute need for oxygen for maintenance of growth in these strains.
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Growth of the strains undergoing fermentative metabolism is achievable in low oxygen conditions
providing the culture medium contains sufficient nutrient sources, which can come from the ad-
dition of yeast extract and tryptone. This presents a problem in 13C-MFA where all sources of
carbon need to be accounted for to allow analysis of the measured mass isotopic distributions of
metabolites. Tryptone and yeast extract are complex and variable nutrient sources, which would
add an unknown quantity of unlabelled carbon source to a medium in which they are included.
Therefore culture medium needs to be defined in terms of carbon sources, which is as minimal
as possible to minimise the complexity of isotopomer modelling.
In order to understand production of ethanol in terms of metabolic flux of the wild type and en-
gineered strains of G. thermoglucosidasius, the medium needs to be able to support all strains
undergoing fermentative growth, in a low oxygen condition at metabolic steady state. It has
been hypothesised that G. thermoglucosidasius may not be able to meet its metabolic needs
for thiamine pyrophosphate under anaerobic conditions and this may be at least partly respon-
sible for the metabolic stress experienced by the cell. The genome sequence of both DL33 (wt)
and TM242 (∆ldh↑pdh∆pfl) indicate that the pathway for thiamine biosynthesis in G. thermoglu-
cosidasius uses a glycine oxidase (EC 1.4.3.19) to form the thiazole component of thiamine (K.
Eley, personal communication) and consequently thiamine supply may be limited in anaerobic
conditions. This is turn would limit synthesis of thiamine pyrophosphate, a cofactor important
for the functioning of the pyruvate dehydrogenase complex (PDH) and the OGDC, oxoglutarate
synthase as well as for the degradation of L-valine, L-isoleucine and L-leucine.
To investigate the affect thiamine may have on anaerobic growth, strain DL66 (∆ldh∆pfl↑pdh)
was chosen as this strain has an upregulated pdh gene and therefore has a higher thiamine
pyrophosphate requirement under anaerobic conditions than the other strains. The strain was
cultivated aerobically as a continuous culture in 1.5 L bioreactor set up as described in Section
2.3.2.1 at a dilution rate of 0.05 hr-1 in ASM with 1.0 % (w/v) glucose, 0.1 % (w/v) tryptone and 0.1
% (w/v) yeast extract and allowed to reach steady state before culture conditions were changed
to anaerobic by sparging the reactor with nitrogen gas. Wash out of the culture was observed,
indicated by a drop in OD 600 nm and consequently the culture was changed from chemostat
cultivation to batch to prevent total culture wash out. The batch cultivation was supplemented
with 12 µM thiamine pyrophosphate, which resulted in a pulse of ethanol production and greater
consumption of glucose, detected by HPLC analysis of the culture medium supernatant, (Fig.
3.6), suggesting that the presence of thiamine pyrophosphate aided flux through the PDH. Re-
turning the culture to continuous growth at a dilution rate of 0.05 hr-1 with medium not containing
thiamine pyrophosphate resulted in a reduction of ethanol synthesis and culture OD 600 nm and
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an increase in residual glucose that was not consumed by the culture.
Figure 3.6: Effect of thiamine pyrophosphate on DL66 (∆ldh∆pfl↑pdh) ethanol production. DL66
(∆ldh∆pfl↑pdh) cultured on ASM with 1.0 % (w/v) glucose, 0.1 % (w/v) tryptone and 0.1 %
(w/v) yeast extract, under anaerobic batch conditions in a bioreactor. Addition of 12 µM thiamine
pyrophosphate resulted in a pulse of ethanol production. Glucose and metabolites were analysed
by HPLC.
.
To see whether increased capacity for ethanol production in the presence of thiamine pyrophos-
phate resulted in greater biomass production, washout experiments of DL66 (∆ldh∆pfl↑pdh)
both with and without thiamine pyrophosphate were carried out. Cells were cultured in ASM with
1.0 % (w/v) glucose, 0.1 % (w/v) tryptone and 0.1 % (w/v) yeast extract in a 1.5 L bioreactor
set up as described in Section 2.3.2.1 The culture was allowed to establish steady state growth
under aerobic conditions at a dilution rate of 0.05 hr-1 before being switched to anaerobic con-
ditions; culture wash out was monitored by the measuring of culture OD at 600 nm. The rate of
wash out was slightly decreased in the presence of thiamine pyrophosphate but the effect was
not substantial enough to prevent eventual culture wash out (Fig. 3.7).
Figure 3.7: Effect of thiamine pyrophosphate on DL66 biomass production in anaerobic contin-
uous cultivation at a dilution rate of 0.05 hr-1. DL66 (∆ldh∆pfl↑pdh) grown on ASM with 1.0 %
(w/v) glucose, 0.1 % (w/v) tryptone and 0.1 % (w/v) yeast extract with (green) and without (blue)
12 µM thiamine pyrophosphate. Rate of wash out slightly reduced in presence of thiamine but
the culture cannot be maintained either with or without thiamine.
These results indicate that additional thiamine pyrophosphate can increase both ethanol and
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biomass production in strain DL66 (∆ldh↑pdh∆pfl) but not sufficiently so to allow the organism
to grow under anaerobic conditions in a continuous culture without eventual wash out of the cul-
ture, even at a dilution rate of 0.05 hr-1. It may be that there are further compounds required
by the strain; to assess this, wash out rates were recorded for the culture with additional media
supplementation as follows: 0.5 % (w/v) yeast extract; 0.5 % (w/v) tryptone; combined 0.25 %
(w/v) yeast extract and 0.25 % (w/v) tryptone, (Table 3.3). This supplementation was in addition
to the base medium of ASM with 1 % (w/v) glucose, 0.1 % tryptone (w/v) and 0.1 % (w/v) yeast
extract. Each condition also contained 12 µM thiamine pyrophosphate. Inclusion of additional
yeast extract alone produced the slowest growth rate of 0.020 hr-1. Tryptone alone increased
this slightly to a growth rate of 0.026 hr-1 revealing that the culture has an un-met amino acid
requirement. Interestingly, increasing both the yeast extract and tryptone content caused a much
greater increase in growth rate to 0.042 hr-1, indicating that there is more than one compound
that is important for anaerobic growth that was not being met in a minimal medium formulation.
Table 3.3: Growth rates of DL66 (∆ldh∆pfl↑pdh) with 12 µM thiamine pyrophosphate and addi-
tional media supplements. Cultivations in a 1.5 L bioreactor under anaerobic conditions in ASM
with 1.0 % (w/v) glucose, 0.1 % (w/v) tryptone and 0.1 % (w/v) yeast extract as base media.
Media supplement Growth rate (µ= hr-1)
0.5 % yeast extract 0.020
0.5 % tryptone 0.026
0.25 % yeast extract and 0.25 % tryptone 0.042
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3.4 Defining conditions for aerobic and non aerobic growth
in 13C metabolic flux analysis studies
Previous flux ratio analysis by Bartosiak-Jentys [189] found that strain DL44 (∆ldh) was able to
achieve steady state growth and produce fermentation products, indicating that the strain was
undergoing fermentative metabolism, in a small scale (50 ml) chemostat with compressed air de-
livered at a rate of 0.5 vvm. This rate of aeration represented the lowest achievable aeration with
this chemostat set up, which had very poor oxygen transfer efficiency. As with growth in 1.5 L
chemostats, delivering of nitrogen to culture in the small scale chemostat resulted in wash out of
the culture. In the same study, with aeration at 12 vvm no fermentation products were detectable
in the extracellular medium indicating that the strain was undergoing aerobic growth.
The previous study found that for steady state to be achievable in a minimal medium, the strain
needed to be supplemented with five amino acids L-glutamate, L-isoleucine, L-methionine, L-
serine and L-valine [189]. Investigation in the industrial strain counterparts to the strains used
in this study, NCIMB 11955 (wt), TM89 (∆ldh) and TM242 (∆ldh ↑pdh∆pfl), has found that
these strains can grown on a minimal medium with a reduced set of amino acids consisting of L-
glutamate, L-serine, L-threonine (R. Cripps, personal communication). As reducing the number
carbon sources in the medium simplifies metabolic flux analysis, the reduced number of amino
acids was used in the present study. The three amino acids were included at a typical concen-
tration at which they would be found in tryptone as described previously [189], combined with
ammonium salts medium (ASM), 12 µM thiamine and glucose to create the minimal medium
used for 13C metabolic flux analysis of the strains (Table 3.4).
Table 3.4: Components of the medium used for 13C-MFA. Amino acid concentrations are equiv-
alent to those found in a medium containing 1% tryptone, as established previously [189].
Component Concentration
Ammonium salts medium See Section 2.2.2
Biotin 12 µM
Thiamine / thiamine pyrophosphate 12 µM
L-glutamate 953 µM
L-serine 428 µM
L-threonine 336 µM
Glucose 0.5 %
All three strains were cultivated in a small scale chemostat, as described in Section 2.3.2.2, at
aeration levels of 0.5 vvm and 12 vmm of compressed air in order to study fermentative and
aerobic growth respectively. Additionally, a further condition was used in order to give a greater
overview of metabolism, using 1.5 vvm of compressed air (micro-aerobic) so that the strains
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would still form fermentation products but to a lesser degree. HPLC analysis of the extracellular
medium was carried out as described in Section 2.7.1 to determine the concentration of extra-
cellular metabolites and residual glucose in the medium and biomass production was monitored
by measuring optical density at 600 nm using a spectrophotometer. Cultivations were carried
out in biological triplicate, with the exception of the DL33 (wt) micro-aerobic condition which was
carried out in duplicate.
Within each level of aeration - aerobic, micro-aerobic and fermentative - there was little varia-
tion between the strains in terms of biomass production, although there was greater variation
between replicates in the higher aeration conditions (Table 3.5). For each strain culture OD 600
nm increased with increased aeration.
Table 3.5: Strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) undergoing aerobic, micro-
aerobic and fermentative growth.
Strain Aeration Average OD
600 nm
Standard er-
ror
DL33 (wt) aerobic 3.65 ±0.58
DL33 (wt) micro-aerobic 1.51 ±0.13
DL33 (wt) fermentative 0.96 ±0.08
DL44 (∆ldh) aerobic 4.15 ±0.54
DL44 (∆ldh) micro-aerobic 1.38 ±0.16
DL44 (∆ldh) fermentative 0.79 ±0.06
DL66 (∆ldh∆pfl↑pdh) aerobic 3.44 ±0.42
DL66 (∆ldh∆pfl↑pdh) micro-aerobic 1.51 ±0.15
DL66 (∆ldh∆pfl↑pdh) fermentative 0.86 ±0.04
The three levels of aeration were found to be distinct in terms of the amount of ethanol that
was produced under each condition (Fig. 3.8 A). No ethanol was produced by any strain under
the aerobic conditions while the amount of ethanol produced under fermentative conditions was
greater than under the micro-aerobic condition in all strains. Due to the low rate of ethanol pro-
duction in DL33 (wt), micro-aerobic growth of this strain also produced no detectable ethanol.
The aerobic and micro-aerobic conditions in this strain were still distinguishable, however, as
under the micro-aerobic condition the strain still produced both lactate and formate, whereas
neither of these were present during aerobic growth (Fig 3.7 E and F).
Pyruvate (Fig. 3.8 C), succinate (Fig 3.8 D) and formate (Fig. 3.8 E) were all detectable in the
culture medium in varying concentrations under both the fermentative and micro-aerobic con-
ditions; these showed a lot of variability both between replicates and conditions but the total
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Figure 3.8: HPLC analysis of strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) under-
going aerobic, micro-aerobic and fermentative growth. Values represent averages of biological
replicate data sets; error bars show standard error of biological replicate data sets. A. Ethanol,
B. Acetate, C. Pyruvate, D. Succinate, E. Formate, F. Lactate
concentration of each was very low, so the variability seen represented only small changes in
concentration. Acetate, however, was also highly variable but, as this was at a higher concen-
tration than the other metabolites, this suggests problems in accurately reproducing conditions
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within the small scale chemostat which used a magnetic stirrer and follower for agitation.
Figure 3.9: Residual glucose in cultivations of strains DL33 (wt), DL44 (∆ldh) and DL66
(∆ldh∆pfl↑pdh) undergoing aerobic, micro-aerobic and fermentative growth. Values represent
averages of biological replicate data sets; error bars show standard error of biological replicate
data sets. Glucose concentrations were determined by HPLC analysis.
Both of the engineered strains had some residual glucose remaining in the extracellular medium,
which was not consumed by the culture when undergoing fermentative growth (Fig. 3. 9). This
was also quite variable between replicate data sets. The wild type strain consumed all of the
glucose under each condition however, indicating that this strain was possibly undergoing less
redox stress than the engineered strains. This is also suggested by the average biomass produc-
tion of the wild type strain, which was slightly higher than that of engineered strains (Table 3.5).
The possibility of fully anaerobic growth (with nitrogen sparging) with the amino acid supple-
mentation used here was assessed to see if a more anaerobic condition could be used when
studying the strains using 13C metabolic flux analysis. Strain DL33 (wt) was chosen as it was the
least likely to undergo metabolic stress in the absence of oxygen. It was cultivated in the small
chemostat on the established medium, initially in batch culture without any gas sparging before
being switched to a dilution rate of 0.1 hr-1 and sparging with nitrogen at a rate of 1.77 vvm. The
culture had almost entirely washed out within 20 hours of the commencement of sparging with
nitrogen (Fig. 3.10).
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Figure 3.10: Wash out of strain DL33 (wt) under nitrogen sparging. Strain DL33 (wt) was culti-
vated in a scale chemostat on 13C-MFA medium, initially in batch culture with no gas sparging
before being switched to continuous cultivation at a dilution rate of 0.1 hr-1 and sparged with
nitrogen gas at a rate of 1.77 vvm. The culture almost entirely washed out within 20 hours of
commencement of sparging.
3.5 Assessment of amino acid requirements
In order to assess whether there was an absolute requirement for the three supplemented amino
acids in the DL33 (wt) derived strains, the physiological impact of their withdrawal from the
medium was assessed in a chemostat culture. DL66 (∆ldh∆pfl↑pdh) was cultivated under fer-
mentative conditions (0.5 vvm compressed air) on the samemedium formulation described above
(Table 3.4). The culture was grown to steady state before amino acids were individually removed
in turn from the culture feed and the culture was allowed to reach steady state again without the
amino acid. Biomass production was measured by OD 600 nm and external metabolites were
measured using HPLC.
Of the three amino acids, only the removal of serine from the medium affected ethanologenesis
and biomass production. At steady state in the new medium the extracellular ethanol concentra-
tion dropped from 19 mM to 6 mM with the removal of serine, other metabolites however were
relatively unaffected, (Fig. 3.11). OD 600 nm also reduced from 0.92 AU in the presence of
serine to 0.60 AU in its absence. Removal of threonine did not result in loss of biomass or de-
creased ethanol production but instead resulted in small increases in both extracellular ethanol
and OD 600 nm, (Fig. 3.12). However, these were not in proportion to one another. The amount
of ethanol produced per AU of biomass (specific ethanol production) decreased slightly with the
removal of threonine, with 9.6 mM ethanol produced per OD 600 nm AU in the presence of threo-
nine and 8.7 mM ethanol produced per OD 600 nm AU in its absence. Finally, removing glutamic
acid from the culture medium resulted in a small drop in OD 600 nm of about 0.2 AU (Fig. 3.13);
the extracellular ethanol concentration however increased from 15 mM in the presence of glu-
tamic acid to 21 mM in its absence.
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Figure 3.11: Effect on strain DL66 (∆ldh∆pfl↑pdh) of the removal of serine from the culture
medium. DL66 (∆ldh∆pfl↑pdh) cells were cultivated in a small chemostat at 0.5 vvm aeration
and dilution rate of 0.1 D hr-1. Removal of serine resulted in concomitant reduction in biomass
output and ethanol production was approximately three-fold higher in the presence of serine than
without. Other metabolites, however, were largely unaffected.
Figure 3.12: Effect on strain DL66 (∆ldh∆pfl↑pdh) of the removal of threonine from the culture
medium. DL66 (∆ldh∆pfl↑pdh) cells were cultivated in a small chemostat at 0.5 vvm aeration
and dilution rate of 0.1 D hr-1. Removal of threonine gave a small increase in net efflux of ethanol
by the culture and on the culture OD 600 nm; succinate, acetate and pyruvate however remained
largely unchanged.
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Figure 3.13: Effect on strain DL66 (∆ldh∆pfl↑pdh) of the removal of glutamate from the culture
medium. DL66 (∆ldh∆pfl↑pdh) cells were cultivated in a small chemostat at 0.5 vvm aeration
and dilution rate of 0.1 D hr-1. Removal of glutamic acid resulted in a small drop in culture OD
600 nm and an increase in steady state ethanol concentration.
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3.6 Discussion
Sequencing of the genome of strain DL33 (wt) has provided the detailed information necessary
for metabolic model construction. The sequence has revealed that DL33 (wt) does not encode a
6-phosphogluconolactonase in the oxidative branch of the pentose phosphate pathway. This po-
tentially limits generation of NADPH, however the strain also encodes several reversible NADP+
dependent enzymes in central carbon metabolism which provide an alternative means of gen-
erating NADPH, namely a NADP+ dependent glyceraldehyde-3-phosphate dehydrogenase, a
NADP+ dependent malic enzyme and a NADP+ dependent isocitrate dehydrogenase. Whilst G.
thermoglucosidasius has an NAD(+) kinase for conversion of NAD+ to NADP+ (EC 2.7.1.23),
it does not encode either a Re/Si- or Si-specific transhydrogenase (EC 1.6.1.2 and EC 1.6.1.1
respectively) in the DL33 (wt) genome sequence. It may be however that the flux does proceed
through the oxidative branch of the pentose phosphate pathway and the reaction from glucono-
1,5-lactone 6-phosphate to 6-phospho-D-gluconate is occurring spontaneously at high tempera-
ture.
Comparison of the sequence with that of the industrial strain TM242 (∆ldh∆pfl↑pdh), indicates
that the differences between the strains are small and do not affect the complement of enzymes
relevant to 13Cmetabolic flux analysis, specifically those in central carbon metabolism and amino
acid synthesis. Consequently differential flux between the DL33 (wt) DL44 (∆ldh) and DL66
(∆ldh∆pfl↑pdh) should also be indicative of differences in the industrial strains, NCMBI 11955
(wt), TM89 (∆ldh) and TM242 (∆ldh∆pfl↑pdh).
Analysis of the growth of DL66 (∆ldh∆pfl↑pdh) under various supplementation indicated that the
nutrient demands of the strain were not fully met by a completely minimal medium during anaero-
bic growth. Addition of 12 µM thiamine pyrophosphate to the culture medium enhanced the level
of ethanol produced by this strain and thus thiamine or thiamine pyrophosphate (both were found
to be effective) was included in the final medium for 13C-MFA. Whilst the culture growth rate could
be increased by addition of the rich medium components yeast extract and tryptone, this was not
substantial enough to prevent washout under anaerobic (nitrogen sparged) conditions, suggest-
ing that the strains may not be able to grow under completely anaerobic conditions regardless
of medium composition. The addition of excess yeast extract and tryptone combined produced
the most pronounced effect on slowing the rate of culture wash out under anaerobic conditions
however, indicating that some complex medium ingredients still may be able to enhance the fer-
mentative growth of the organism, if not support it completely. The need for two complex nutrient
sources for this effect to become apparent indicates that there are multiple compounds required
by the organism and consequently the identification of all components would be a complex task.
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The minimal medium described in this chapter however was able to support growth of all three
strains undergoing fermentative metabolism under a low oxygen conditions and therefore can be
used for 13C-MFA investigation into the strains and is comparable to that used for the industrial
strains. The development of a true defined medium remains a avenue for investigation in G.
thermoglucosidasius. Of particular interest would be to determine the specific components of
tryptone and yeast extract which have been found to synergistically augment the growth rate of
DL66 (∆ldh∆pfl↑pdh) in this study.
Previous investigation has shown the importance of L-glutamic acid, L-isoleucine, L-methionine,
L-serine and L-valine to support growth of strain DL44 (∆ldh) [189]. In this study, however,
only L-serine proved to be an absolute requirement for maintaining steady state growth at a di-
lution rate of 0.1 hr-1 of DL66 (∆ldh∆pfl↑pdh). It is noteworthy that the genome sequence of
the DL33 (wt) genome sequence contains the full pathway for serine biosynthesis. The need
therefore for serine to be supplemented under fermentative growth suggests that there may be
a redox imbalance at very low oxygen levels. Production of serine requires NAD+ for conver-
sion of 3-phosphoglycerate to 3-phosphohydroxypyruvate by phosphoglycerate dehydrogenase
(EC 1.1.1.95) (Fig 3.14). This is a reversible reaction so the net flux through this step (forwards-
backwards) will depend on the NAD+/NADH ratio. Under fermentative conditions, particularly in
an engineered strain, this ratio will probably reduce, with a consequent reduction in flux to serine.
Figure 3.14: Serine biosynthesis route in G. thermoglucosdasius
Biosynthesis of threonine also requires both NAD+ and NADP+ but removal of threonine from
the culture did not negatively impact upon growth. This difference may be in part due to the cellu-
lar requirements for the amino acids, Tang et al. [190] measured G. thermoglucosidasius amino
acids requirements of serine, glycine and tryptophan, for which serine is a metabolic precursor
at 0.271, 0.342 and 0.054 mmoles per g DCW respectively. However, cellular requirements for
L-threonine and L-isoleucine are 0.256 mmoles g DCW each, thus there is a higher total biomass
requirement for serine. Surprisingly, removal of threonine from the culture slightly enhanced cell
growth, it may be that supplementation with threonine inhibits another pathway by feed-back in-
hibition. Aspartate kinase (EC 2.7.2.4) is common to the biosynthetic pathways of both threonine
and lysine and is known to be inhibited in the presence of threonine [211], thus it may be that
threonine was inhibiting lysine production even at the low levels used in the medium in this study,
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which was negatively affecting growth. Removal of glutamate from the medium did not markedly
affect the culture; OD 600 nm was slightly reduced and there was a small increase in ethanol
yield. The reason for this is not apparent but it may be that the supplementation of glutamate to
the culture medium affects the redox balance of the cells.
There are two possible explanations between the difference in amino acid requirements identi-
fied here and in the previous study. Firstly, anaerobic up regulation of expression of the pyruvate
dehydrogenase complex (pdh) in strain DL66 (∆ldh∆pfl↑pdh) is likely to increase flux to the TCA
cycle, providing an increased supply of metabolic precursors for amino acids that are produced
from the TCA cycle, which may aid threonine and glutamate de novo synthesis in strain DL66
(∆ldh∆pfl↑pdh) compared to strain DL44 (∆ldh) which was used in the previous study. Sec-
ondly, inclusion of thiamine in the medium, as a component of the cofactor of several enzymes
including PDH and OGDC, may have aided biosynthesis if this was previously a scarce resource
within the cell. Finally, it is possible that because PFL in strain DL44 (∆ldh) cannot provide suffi-
cient flux from pyruvate to acetyl CoA and pyruvate is excreted in this strain to a greater degree
in this strain, creating a redox imbalance in the cell.
The final formulation of 428 µM L-serine, 336 µM L-threonine and 953 µM L-glutamate, with 12
µM thiamine in addition to the existing medium components for G. thermoglucosidasius of ASM,
glucose and 12 µM biotin was found to be able to support steady state growth of all three strains
DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) under all conditions. This medium is suitable
for 13C-MFA as additional carbon sources have been minimised and all can be accounted for.
Whilst DL66 (∆ldh∆pfl↑pdh) was able to survive on a more minimal medium formulation without
threonine and glutamate, the three amino acid supplement was used for 13C-MFA in later chap-
ters of this study so that conditions were as comparable to those used for the industrial strain as
possible.
The three separate levels of aeration of 0.5 vvm, 1.5 vvm and 12 vvm delivered to the bioreactor
vessel, produced three different fermentation profiles in the strains with the aerobic condition
producing no fermentation products at all in any strain, the micro-aerobic condition producing a
low amount of fermentation products in each strain and the fermentative condition producing a
greater amount of fermentation products. This provides a range of metabolic states for studying
metabolism in these strains using 13C-MFA.
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4Isotopic labelling of Geobacillus
thermoglucosidasius using [U-13C] glucose
4.1 Introduction
An important consideration when carrying out 13C metabolic flux analysis is the optimum isotopic
labelling to use in the culture feed. The choice is motivated by two factors: the cost of the iso-
tope and the metabolic fluxes to be resolved, as both of these will vary with the isotope used.
At current costs, shown in Table 4.1 for isotopically labelled glucose, uniformly labelled glucose
(D-(U-13C) glucose), D-[1-13C] and D-[2-13C] glucose have the lowest cost per gram; costs for
other positionally labelled isomers vary considerably with the position of the 13C isotope in the
carbon skeleton.
Table 4.1: Variable cost of isotopically labelled glucose. Prices correct as of April 2014. Source:
Omicron Biochemicals, Inc. Indiana, USA.
Isotope Price per gram (USD $)
D-[U-13C] glucose 220
D-[1-13C] glucose 175
D-[2-13C] glucose 200
D-[3-13C] glucose 1200
D-[4-13C] glucose 1600
D-[5-13C] glucose 1700
D-[6-13C] glucose 700
At the time of these experiments, [U-13C] glucose had previously been previously used to provide
an initial flux ratio analysis of strain DL44 (∆ldh) [189]. This chapter continues and extends the
previous study, by carrying out similar [U13C] glucose studies in the three strains DL33 (wt), DL44
(∆ldh) and DL66 (∆ldh∆pfl↑pdh) using the 13C-MFA medium and conditions set out in Chapter
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3.
The use of [U-13C] glucose as the sole isotope has been applied on 13C-MFA studies of other
organisms including yeast [136, 212], E. coli [130] and other bacteria [137].
4.2 Isotope labelling experiments
As described in Chapter 3, the three strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh),
were each grown under aerobic, micro-aerobic and fermentative growth, to form a matrix con-
taining 9 conditions (Fig. 4.1), in which comparisons can be made between strains as well as
aerobic and anaerobic metabolism.
Figure 4.1: Matrix of conditions used for 13C-MFA with [U-13C] glucose
All cultivations were carried out in the small scale bioreactor, set up as described in Section
2.3.2.2. Glucose was included in the medium at a total concentration of 0.5 % (w/v) and using
an isotope ratio of 20:80 [U-13C] glucose to [U-12C] glucose as described in the previous study
[189]. Cultures were considered to be at steady state after three volume changes, which was
confirmed by measurement of cell biomass by OD 600 nm and HPLC analysis of the culture su-
pernatant for external metabolites. Cells were cultivated at a dilution rate of 0.1 hr-1. Cultivations
were carried out in triplicate with the exception of the DL33 (wt) micro-aerobic condition which
was carried out in duplicate.
4.3 GC-MS analysis of proteinogenic amino acids
Cells were harvested at steady state in triplicate aliquots of 1 ml as described in Section 2.7.3.1.
All cell biomass hydrolysis, amino acid derivatization and GC-MS analysis was carried out as
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described in Section 2.7.3.
In order to identify proteinogenic amino acids and their isotopic labelling patterns, the GC-MS
data were exported to standard common data format (CDF) using propriety Agilent acquisition
software and manually inspected with the software Peacock-GC-MS [213]; an example chro-
matogram showing total ion count (TIC) is shown in Fig. 4.2. Amino acids were identified ac-
cording to their GC retention time and mass spectrometic fragmentation pattern, particularly the
M-15, M-57, M-85, M-159 and f302 fragments based on their TBDMS derivatives, (Appendix A,
Table A.1).
Overall each amino acid had a strong enough m/z ratio for the peak to be readily visible on the
TIC, with the exception of methionine which was not observable on the TIC. Closer inspection
by highlighting retention times with the highest intensities for the M-57, M-85 and M-159, m/z
ratios of 320, 292 and 218 for the M+0 weight (unlabelled) fragments of methionine, indicated a
high intensity at a retention time of approximately 5.66 minutes. Inspection of all of the m/z ratios
at this retention time confirmed the presence of methionine 2 TBDMS fragments, (Fig 4.3 B),
accompanied by considerable noise. Consequently methionine was excluded from further anal-
yses as the poor signal to noise ratio may introduce error to the mass isotopomer distribution.
Comparatively, other mass fragments, for example leucine (Fig. 4.3 A) were readily identifiable
on the TIC and had a high signal to noise ratio.
Neither cysteine or tryptophan were visible as these were destroyed in the cell hydrolysis process.
Similarly, neither arginine or asparginine are detectable, which is in keeping with the original pro-
tocol detailing this method [116].
For each amino acid, intensities of m/z ratios from 180 to 570, were extracted from the *.cdf files
using Matlab and exported to text files for further processing.
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Figure 4.3: GC-MS identification of amino acids based on detected mass fragments. Amino
acids, such as (A.) leucine, were readily resolvable on the TIC with a high signal to noise ratio.
(B.) Methionine did not produce a readily visible peak on the GC-MS TIC; however highlighting the
m/z intensities of M+0 isotopes of the M-57, M-85 and M-159 fragments of methionine revealed
the presence of methionine at a retention time of 5.66 min, but with substantial overlap with other
compounds.
4.4 Mass isotopomer fragment validation and extent of la-
belling analysis
4.4.1 Correction for naturally occurring isotopes
Raw GC-MS intensities from mass fragments require processing to remove the contribution of
naturally occurring isotopes before their use in 13C metabolic flux models. Naturally occurring
isotopes can be introduced to a sample from two sources: 1) unlabelled biomass which is still
present in the bioreactor from before switching to a labelled feed and 2) from atoms introduced
to the samples from the GC-MS derivatization agent. By convention intensities within the mass
isotopomer distribution are also generally normalised to 1, as calculated flux is affected only by
the relative intensities of isotopomers within each mass isotopomer distribution and not stand
alone intensities.
Several different tools are available for the automated correction for naturally occurring isotopes,
which will also normalise the vector of mass isotopomer distribution to 1. In this study 3 different
tools were assessed for their application to this task FiatFlux [129], IsoCor [199] and Matlab
MS Correction Tool (MSCorr) [200]. Only mass fragments that had previously been verified as
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suitable for application in 13C metabolic flux analysis were used in this study; these are detailed
in Table 4.2.
Table 4.2: GC-MS mass fragments used in this study, which had pre-
viously been verified for application in 13C-MFA
Amino acid Mass fragment Reference
Alanine M-57 [214–216]
Glycine M-57 [214, 215]
Valine M-57 [215, 216]
Leucine M-85 [214, 215]
Isoleucine M-159 [214, 215]
Proline M-85 [215, 216]
Serine M-57 [214, 215]
Threonine M-57 [214, 215]
Phenylalanine M-57 [214, 215]
Aspartate M-57 [214, 216]
Glutamate M-57 [214]
Lysine M-57 [214]
Histidine M-57 [214]
4.4.1.1 FiatFlux
FiatFlux [129] provides an automated means of carrying out flux ratio analysis using precon-
figured Escherichia, Bacillus or yeast models or a generic master model. It can also be used
however, in the extraction of mass isotopomer distributions from raw GC-MS data and for the
direct export of mass corrected and normalised amino acid fragment identities.
Mass correction was carried out in the Ratio module of FiatFlux, which was launched using the
command »ratio in the main Matlab window. *.cdf files were converted to FiatFlux (*.ff) readable
files using the following commands in the GUI: Data > Convert Quad-CDF > Data > Load
The master model of reactions was selected and the proportion of [U-13C] glucose to [U-12C]
glucose was set to 20:80. Auto assignment of amino acids by FiatFlux was verified based on
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the GC elution time in comparison with the identified amino acid derivatives on the same chro-
matograms, which had been determined manually using the Peacock software [213] based on
their mass spectromic fragmentation patterns. Where necessary, amino acids were reassigned
to the correct peak on the TIC. Generally, only leucine needed regular reassignment. The fraction
of unlabelled biomass entered into the cultivation was calculated according to exp(−Dt), where
D is the dilution rate of the continuous culture (0.1 hr-1) and t is the time from commencement of
labelled feed to sampling, as described by Zamboni et al. [116]. Corrected and normalised mass
fragments were exported by selecting Menu > Report .
4.4.1.2 IsoCor
IsoCor is a standalone program designed for correction of mass spectrometic data arising from
any isotopic labelling experiments, including 13C-MFA [199]. As such, it is a very flexible tool,
with the capacity for the user to enter the metabolites of interest, relevant derivatives and all iso-
topes in their relative abundances in plain text files, enabling correction to be carried out on data
containing any metabolite or isotope.
Structures of all the metabolites of interest (Table 4.2) were added to themetabolites.dat file and
the corresponding derivatization fragments, which differ from the original metabolite depending
on the number of TBDMS groups added to the metabolite during the derivatization process, were
added to the derivatives.dat file, (Appendix A, Table A.2). IsoCor is preconfigured for the ele-
ments hydrogen, nitrogen, carbon, silicon and sulphur and the natural relative abundance of their
stable isotopes, thus no other isotopes were added.
Raw GC-MS m/z intensities for the relevant metabolite fragments were entered as single inputs
in text files that had been previously extracted from *.cdf files using Matlab. The corresponding
metabolite and derivative settings were selected for each fragment, the input substrate was set
at 99 % purity, corresponding to the purity of the [U-13C] glucose substrate and the calculation
run.
4.4.1.3 Matlab MS Correction Tool
The Matlab MS Correction Tool was produced by Wahl and co-workers, specifically for correc-
tion for naturally occurring isotopes in 13C-MFA experiments [200]. The Matlab MS Correction
Tool GUI was launched in Matlab using command » MSCorr in the Matlab Command Window.
Amino acid structures and defined fragments were loaded using pre-existing list provided by S.
Masakapalli. Unlabelled biomass proportion was calculated as described for mass correction
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with FiatFlux (Section 4.4.1.1) and entered in the GUI.
Raw GC-MS intensities from m/z 180 to 570. which had previously been extracted in Matlab were
loaded as plain text files, the relevant amino acid and mass fragment selected for correction and
the calculation run.
4.4.1.4 Variability between methods
Representative data sets for analysis were taken from each of the DL33 (wt), DL44 (∆ldh) and
DL66 (∆ldh∆pfl↑pdh) aerobic and DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) fermen-
tative conditions. Using each of the three correction tools, the mass isotopomer distribution was
extracted for each of the fragments in Table 4.2.
The standard deviation for the calculated intensity by all three methods was calculated for each
isotopomer weight (M+0, M+1, M+2...M+n) for each mass fragment. Those weights with the
greatest variability between tools, defined by a standard deviation greater than 0.3, are sum-
marised in Table 4.3
Table 4.3: Variation in mass spectrometric fragment weights between different methods for cor-
rection for naturally occurring isotopes
Fragment Strain FiatFlux MassCorr IsoCor Average StdDev
A M-57 M+0 DL33 Ferm 0.588 0.762 0.797 0.716 0.112
A M-57 M+0 DL66 Ferm 0.569 0.750 0.778 0.699 0.134
L M-85 M+0 DL33 Ferm 0.665 0.520 0.567 0.584 0.074
L M-85 M+0 DL44 Ferm 0.643 0.502 0.640 0.595 0.080
L M-85 M+0 DL66 Ferm 0.548 0.488 0.520 0.519 0.030
I M-159 M+0 DL33 Aero 0.386 0.496 0.525 0.469 0.074
F M-57 M+0 DL33 Ferm 0.443 0.442 0.509 0.464 0.038
K M-57 M+0 DL33 Aero 0.451 0.449 0.503 0.468 0.031
K M-57 M+0 DL33 Ferm 0.591 0.586 0.670 0.616 0.047
K M-57 M+0 DL44 Ferm 0.528 0.522 0.585 0.545 0.035
K M-57 M+0 DL66 Ferm 0.536 0.531 0.599 0.555 0.038
K M-57 M+1 DL33 Ferm 0.111 0.117 0.051 0.093 0.037
K M-57 M+1 DL66 Ferm 0.136 0.140 0.085 0.120 0.030
H M-57 M+0 DL33 Aero 0.547 0.520 0.582 0.550 0.031
H M-57 M+0 DL44 Aero 0.512 0.564 0.607 0.561 0.048
H M-57 M+0 DL33 Ferm 0.571 0.602 0.657 0.610 0.044
H M-57 M+0 DL44 Ferm 0.542 0.564 0.604 0.570 0.031
H M-57 M+0 DL66 Ferm 0.565 0.601 0.646 0.604 0.041
The three methods generally show high reproducibility in isotope correction for glycine, valine,
proline, serine, threonine, aspartic acid and glutamic acid. Of the remaining amino acids, it was
mostly the M+0 weight of each fragment which showed the highest variability, as at a labelled feed
proportion of 20% [U-13C] glucose, the highest intensity fragment will be the unlabelled fragment
and thus this will also be the most variable. Each of alanine, leucine, isoleucine, phenylalanine,
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lysine and histidine have an M+0 weight which for which the standard deviation of intensity be-
tween different correction tools was greater than 0.3. Additionally, lysine has two M+1 weights
in the DL33 (wt) and DL66 (∆ldh∆pfl↑pdh) fermentative conditions, which also fit this criterion,
indicating a high variability between the mass correction methods for this amino acid.
The proportion of unlabelled fragment was consistently higher in the IsoCor corrected data. This
is due to the lack of an option in IsoCor to specify the proportion of unlabelled biomass present
in the samples and so this was not included in the calculation.
The corrected intensity generated by FiatFlux also varies considerably from that of MassCorr
and IsoCor in many of the fragments. Analysis of other fragments of the amino acids in question
suggest that this is due to incorrect assignment of these amino acids in the automated process
carried out by FiatFlux as many of these additional fragments were not picked up. FiatFlux
does not provide any visual representation of mass spectrometry m/z intensities so it is hard to
manually reassign any mislabelled amino acids, as this needs to be carried out based on gas
chromatography retention time rather than unique mass spectrometry patterns.
As FiatFlux did not provide a function for the reliable assignment of amino acids and IsoCor did
not include the proportion of unlabelled biomass, the Matlab MS Correction Tool provided the
most reliable means of correcting for naturally occurring isotopes and was the method used sub-
sequently in this study.
4.4.2 MS quality assessment by redundant metabolites
In order to verify the reliability of the mass spectrometry data the mass isotopomer distribu-
tions of tyrosine and phenylalanine were compared. Tyrosine and phenylalanine are structurally
similar and produced via the same metabolic pathway and thus whilst they have different gas
chromatography retention times, their mass spectrometry fragments and mass isotopomer distri-
butions should be equivalent to one another and can be used to assess the reliability of GC-MS
data of amino acids [217].
The intensities of m/z of the M-57 fragment of tyrsoine and phenylalanine of each dataset were
mass corrected using the MassCorr correction tool and the mass isotopomer distributions com-
pared based on the Pearson product-moment correlation coefficient of the two data sets.
For each condition, the correlation between the M-57 fragment of tyrosine and phenylalanine was
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greater than 99 %, with little variation between replicate datasets, indicating an acceptable level
of reproducibility and reliability of the mass isotopomer distributions (Table 4.4). As these two
mass fragments are equivalent, only mass isotopomer distribution of phenylalanine was used for
labelling assessment and inclusion in metabolic models.
Table 4.4: Correlation between the mass isotopomer distribution of redundant M-57 tyrosine and
M-57 phenylalanine mass spectrometry fragments.
Strain Aeration Correlation
coefficient
Standard
deviation
DL33 (wt) aerobic 1.000 ±0.000
DL33 (wt) micro-aerobic 0.999 ±0.000
DL33 (wt) fermentative 0.999 ±0.001
DL44 (∆ldh) aerobic 1.000 ±0.000
DL44 (∆ldh) micro-aerobic 0.999 ±0.001
DL44 (∆ldh) fermentative 0.995 ±0.002
DL66 (∆ldh∆pfl↑pdh) aerobic 1.000 ±0.000
DL66 (∆ldh∆pfl↑pdh) micro-aerobic 0.996 ±0.003
DL66 (∆ldh∆pfl↑pdh) fermentative 0.997 ±0.003
4.4.3 Mass isotopomer distribution of amino acids using [U-13C] glucose
Extracted mass isotopomer distributions from the GC-MS data were assessed firstly for the over-
all proportion of carbon labelling in the amino acid and secondly for the distribution of labelling
within a fragment, i.e. the relative intensities of the M+0, M+1, M+2... M+n weights within each
mass fragment.
With an input feed of 20 % [U-13C] glucose, amino acids which have been generated exclusively
from central carbon metabolic flux should have a 20 % carbon-13 content at isotopic steady state.
Conversely those which have been derived wholly or partly from the supplemented amino acids
glutamate, threonine and serine in the medium should have a carbon-13 content of less than 20
%.
Figure 4.4 shows that each of the supplemented amino acids were labelled to some degree un-
der all three conditions, indicating that each strain has the capacity to at least partially meet its
requirement for these three amino acids through de novo synthesis. Generally, higher aeration
conditions produce a higher proportion of amino acid labelling in these three amino acids. There
are two potential reasons for this: firstly, as the higher aeration conditions produce a higher
biomass yield, a constant supplemented amino acid concentration means that there was less of
the supplemented amino acid available per gram of dry cell weight; secondly the greater aeration
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may aid the de novo synthesis of the amino acids due to, for example, an increased ability to
oxidise cofactors.
Figure 4.4: Proportion of labelling of proteinogenic amino acids glutamic acid, serine and
threonine after feeding with 20 % [U-13C] glucose in DL33 (wt), DL44 (∆ldh) and DL66
(∆ldh∆pfl↑pdh). All three amino acids had been supplemented into the culture medium. La-
belling in these proteinogenic amino acids however, indicates that the strains are able to syn-
thesis the amino acids de novo under all three conditions. Error bars represent standard error
between biological replicate data sets.
The proportion of labelling in serine under aerobic conditions was upward of 17 % in each strain
indicating that synthesis of this amino acid was unlikely to have been hindered during aerobic
growth in any strain. Whilst it has been previously shown that removal of serine from the culture
medium resulted in a substantial decrease in the optical density of strain DL66 (∆ldh∆pfl↑pdh)
(Chapter 3, Fig. 3.11), isotopomer analysis here showed that approximately 9 % of all serine was
13C labelled under fermentative growth. This indicates that the amount of supplemented amino
acid, whilst sufficient for supporting steady state growth did not meet the full requirements of the
culture and a fraction of the serine was still being synthesised de novo.
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Notably, the proportion of labelling of serine in DL44 (∆ldh) under the micro-aerobic condition
was roughly equivalent to that of all strains during aerobic growth. The biomass output of DL44
(∆ldh) under micro-aerobic conditions was approximately equivalent to that of the other strains,
(Chapter 3, Table 3.5), thus the increase in serine production is not as result of a higher g DCW
of cells for a fixed concentration of amino acid but rather represents of greater flux to this amino
acid in this strain, which may have resulted from disruption of the ldh gene in this strain.
Under the fermentative condition however, DL44 (∆ldh) showed no greater capacity for de novo
serine synthesis than the other strains, with the labelling proportion under this condition being
slightly below that of the wild type (DL33). Furthermore, serine labelling was slightly lower in
DL66 (∆ldh∆pfl↑pdh) than it was in DL44 (∆ldh), suggesting a greater need for amino acid sup-
plementation in this strain and a potential barrier to de novo synthesis under anaerobic growth
due to changes in intracellular redox balance.
Under aerobic conditions, the proportion of glutamic acid that was labelled was high in all strains
at around 19 % this proportion decreases however with decreasing aeration levels in all three
strains. The differences in glutamate labelling within a condition but between strains were min-
imal with only the labelling of DL66 (∆ldh∆pfl↑pdh) under fermentative growth being out of the
range of that DL44 (∆ldh) under the same condition. It was however approximately equivalent to
that of DL33 (wt) suggesting that upregulation of the pdh gene reinstated the ability of this strain
to synthesise glutamate.
Threonine exhibited the lowest proportion of carbon-13 labelling of all the amino acids; even
under aerobic conditions 13C labelling did not go above 15 % in any strain. As with serine,
the proportion of threonine labelling in DL44 (∆ldh) was roughly equivalent under micro-aerobic
conditions and aerobic growth. Likewise this is indicative of either an increased capacity or re-
quirement for this strain to synthesise the amino acid de novo.
The labelling proportions of the remaining amino acids, which were not supplemented directly
into the culture medium are summarised in Fig. 4.5. Those amino acids which are produced
directly from the upper half of central carbon metabolism - namely alanine, valine and leucine all
had a labelling proportion of approximately 20 %, indicating that the cells were at isotopic steady
state. Others however show less than 20 % labelling, indicative of unlabelled carbon entering
either from the supplemented amino acids, CO2 or citric acid from the medium.
Some of the amino acids with reduced labelling, namely glycine, proline and isoleucine are all
106
Figure 4.5: Proportion of labelling of proteinogenic non supplemented amino acids after feeding
cells with 20 % [U-13C] glucose.
directly produced from the supplemented serine, glutamic acid and threonine respectively and
thus could be partially produced from central carbon metabolism and partly from the supple-
mented amino acids in the culture medium. Others however are more ambiguous; both lysine
and aspartate fell below 20 % labelling in all three conditions and all three strains. Additional
carbon-12 could be entering the amino acids from unlabelled glutamic acid and citric acid from
the medium, or there could be a reversal of the reaction from aspartate to threonine. However,
the latter seems unlikely as this reaction is considered to be unidirectional from aspartate to thre-
onine under physiological conditions.
The proportion of labelling in phenylalanine was consistently at 20 % in all strains under all con-
ditions, suggesting that there was reasonably consistent flux through transketolase and transal-
dolase under all conditions. Conversely however histidine labelling was one of the most variable
of all the amino acids, suggesting that flux through other reactions of the pentose phosphate
pathway was dependent on aeration. Interestingly the labelling of histidine in the mutant strains
under micro-aerobic and fermentative conditions was higher than that of the wild type strain, per-
haps indicating increased use of the pentose phosphate pathway in these strains.
When looking at the mass isotopomer distributions of each fragment, that is the relative inten-
sities of the M+0, M+1, M+2... M+n weights within a fragment, differences between conditions
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Figure 4.6: Mass isotopomer distributions of supplemented amino acids and their direct
metabolic descendants after cultivation on 20 % [U-13C] glucose. A) serine M-57 fragment. B)
glycine M-57 fragment. C) glutamic acid M-57 fragment. D) proline M-85 fragment. E) threonine
M-57 fragment. F) isoleucine M-159. Error bars represent standard error between biological
replicate data sets.
and strains are apparent. The mass isotopomer distributions of the supplemented amino acids
serine, threonine and glutamic acid are reflected in those of their metabolic descendants glycine,
isoleucine and proline (Fig. 4.6), confirming the suggested diversion of the supplemented amino
acids into other metabolites. The mass isotopomer distribution of these amino acids under the
micro-aerobic condition of DL44 (∆ldh) was comparable to that of all strains undergoing aerobic
growth, with a decreased M+0 weight and an increase in the M+2 weight.
The same affect is visible in phenylalanine and histidine (Fig. 4.7) with the M+0 weight reduced in
the micro-aerobic conditions of DL44 (∆ldh). As with overall labelling proportion, histidine shows
more variation in its mass isotopomer distribution across strains and conditions relative to that of
phenylalanine suggesting that oxidative pentose phosphate pathway flux is more variable than
that of non oxidative pentose phosphate pathway flux.
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Figure 4.7: Mass isotopomer distributions of A) histidine M-57 and B) phenylalanine M-57 mass
spectrometry fragments after cultivation on 20 % [U-13C] glucose. Error bars represent standard
error between biological replicate data sets.
The amino acids which are formed directly from the end of glycolysis, namely valine, alanine and
leucine show comparatively little variability in mass isotopomer distributions between the strains.
As glycolysis is fundamental for both energetics and the formation of anabolic precursors, it is
unlikely that alteration of fermentation pathways would substantially affect this when glucose is
the major carbon source. However, there were noticeable differences between conditions, par-
ticularly in alanine, where although the amount of total amino acid that was labelled remained
relatively constant regardless of aeration level, the distribution of labelling between different iso-
topomer weights changed. The M+1 weight decreased and the M+0 and M+3 weights increased
under lower aeration. A larger M+3 weight in alanine is suggestive of U-13C glucose being chan-
nelled directly though glycolysis without any scrambling of the carbon backbone perhaps due to
reduced use of the oxidative pentose phosphate pathway.
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Figure 4.8: Mass isotopomer distributions of A) valine M-57 B) alanine M-57 and C) leucine M-85
mass spectrometry fragments after cultivation on 20 % [U-13C] glucose. Error bars represent
standard error between biological replicate data sets.
Aspartate and lysine both had an increased M+0 weight in lower levels of aeration (Fig. 4.9). Both
of these amino acids are derived from the TCA cycle; under fermentative growth, less carbon en-
ters the TCA cycle from glycolysis as it is diverted to fermentation products, thus the isotopomer
distribution of these amino acids were more influenced by unlabelled citrate and glutamate in the
medium under fermentative growth than aerobic. As found in other amino acids, DL44 (∆ldh)
had a smaller M+0 weigh than those of the other two strains, although this difference is less
pronounced than seen with the other amino acids.
Figure 4.9: Mass isotopomer distributions of A) lysine M-57 and B) aspartic acid M-57 mass
spectrometry fragments after cultivation on 20 % [U-13C] glucose. Error bars represent standard
error between biological replicate data sets.
It is noteworthy that there was some variability in the mass isotopomer distributions under all
three conditions but most noticeably under micro-aerobic and fermentative conditions, indicated
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by error bars on each graph representing standard error. This was apparent too in the OD 600
nm of cultures and external metabolites detected by HPLC analysis (Chapter 3, Table 3.5 and
Fig. 3.8). This reflects the difficulty in exact replication of conditions in the small scale chemo-
stat, which is likely to be a result of the method of agitation used in the reactor vessel (external
magnetic stirrer and internal follower). Consequently, each data set was separately modelled for
flux calculation to prevent the introduction of error to the analysis.
4.5 External amino acid concentrations
In order to establish a) the extent to which the supplemented amino acids were consumed by the
cultures and b) whether any amino acids were secreted from the cell, the external amino acid
concentrations in the cell culture broth were measured at TMO Renewables Ltd by derivatization
and HPLC analysis.
From all strains and all of the conditions tested, only trace amounts of the three supplemented
amino acids were detected indicating that these were being almost entirely metabolised by the
cells.
Figure 4.10: Concentration of external alanine in G. thermoglucosidasius cultures in strains DL33
(wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) under aerobic, micro-aerobic and fermentative con-
ditions. Error bars represent standard error between biological replicate data sets.
However, the analysis revealed that substantial amounts of alanine were being produced by the
cells and accumulating in the culture medium in concentrations varying with both strain and con-
dition (Fig. 4.10). Only low concentrations of alanine were detectable under aerobic conditions
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in all three strains, however this increased noticeably under both micro-aerobic and fermentative
conditions in all strains. Alanine efflux was greatest under the micro-aerobic conditions of DL44
(∆ldh) and the fermentative conditions of both DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh).
Alanine synthesis in G. thermoglucosidasius uses a dehydrogenase reaction (EC 1.4.1.1) from
pyruvate (Fig. 4.11). This reaction requires NADH as a cofactor and hence regenerates NAD+.
In the absence of oxygen, oxidative phosphorylation cannot take place and the regeneration of
NAD+ for other cellular functions must involve an endogenous electron acceptor, i.e. the pro-
duction of fermentation products. In this instance, given the efflux of alanine is highest under the
micro-aerobic and fermentative conditions, alanine appears to be functioning as a fermentation
product for the purpose of NAD+ regeneration by all strains to varying degrees.
Figure 4.11: Alanine synthesis in G. thermoglucosidasius occurs via dehydrogenation reaction,
producing alanine and NAD+ from pyruvate, ammonia and NADH.
Reductive amination regenerating NAD+ is not unusual in amino acid synthesis, it also occurs in
in tyrosine, phenylalanine and valine biosynthesis for example, however the position of alanine
in the metabolic network as a direct product from pyruvate (Fig. 4.12) makes this reaction a
relatively efficient conduit for NAD+ regeneration.
Figure 4.12: Reactions from the pyruvate node which feed into NAD+ regenerating reactions in
reaction networks of a) DL33 (wt), enzymes are as follows: 1. alanine dehydrogenase; 2. pyru-
vate formate lyase; 3 acetolactate synthase; 4. lactate dehydrogenase. b) DL66 (∆ldh∆pfl↑pdh),
enzymes are as follows: 1. alanine dehydrogenase; 2. pyruvate dehydrogenase complex; 3 ace-
tolactate synthase.
The difference in the amount of alanine secreted by each of the strains potentially reflects the
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individual requirements of each strain for regeneration of NAD+ as a result of alterations to the
fermentation pathways. It may also be affected by the relative Km of the enzymes at the pyruvate
node in each strain.
As the engineered strains have access to excess pyruvate and conversion of this to alanine helps
to alleviate redox stress on the cell, it is metabolically favourable for the cell to utilise alanine as
a fermentation product. In terms of carbon loss, this reaction is no more expensive for the cell
than using lactate as a fermentation product, (which is the main fermentation product of the wild
type organism), as both have three carbons, although this may put stress on the cell if nitrogen is
in short supply as it includes the concomitant loss of an amine group from the cell. Upregulation
of the pdh has substantially reduced flux to alanine in DL66 (∆ldh∆pfl↑pdh) relative to DL44
(∆ldh) but it is still above that of the wild type, revealing a potential target in this strain for further
engineering for increased ethanol yield.
4.6 Discussion
The isotopic labelling of the wild type and engineered strains of G. thermoglucosidasius de-
scribed here has produced mass isotopomer distributions in the proteinogenic amino acids which
has revealed potential differences in metabolic flux between the strains and between different lev-
els of aeration.
The three strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) were largely similar in their
amino acid mass isotopomer distributions under aerobic growth. Aerobically, the altered geno-
type of the strains should make little difference to their phenotype as the genetic manipulations
are to fermentation pathways. The possible exception to this is strain DL66 (∆ldh∆pfl↑pdh), in
which the impact under aerobic conditions on the strain of having an anaerobic promoter con-
trolling the pdh gene had not been previously investigated. The aerobic mass isotopomers here
suggest that this is unlikely to have substantially affected metabolic flux of the strains as the
aerobic mass isotopomer distributions of DL33 (wt) and DL44 (∆ldh) are highly similar to that of
DL66 (∆ldh∆pfl↑pdh). The mass isotopomer distribution of of serine in DL33 (wt) under aerobic
growth had larger M+0 and M+3 weights and decreased M+1 weight compared to the engineered
strains. This may translate to a difference in metabolic flux but could also be an anomaly as the
other mass isotopomer distributions, which importantly included glycine, did not exhibit any major
differences between the strains aerobically.
Under the micro-aerobic and fermentative conditions, the mass isotopomer distributions differed
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between the three strains. The labelling pattern also differed in the same strain grown under the
different levels of aeration. Previous flux ratio analysis by Bartosiak-Jentys [189] demonstrated
that aerobically 55 % of phosphoenol pyruvate originated from glycolysis and fermentatively this
increased to 65 %; the remaining flux in each case was diverted via the pentose phosphate
pathway. Tang et al [190] also demonstrated an increase in flux through glycolysis in G. ther-
moglucosidasius wild type strain M10EXG. Both the mass isotopomer distributions of alanine
and valine in the present study showed a decrease in the M+1 weight in each strain grown un-
der fermentative conditions compared to the mass isotopomers produced during aerobic growth.
This suggests a reduction in scrambling of the carbon skeleton of the metabolites which could
have been caused but a reduction of pentose phosphate pathway flux under fermentative condi-
tions as described in the previous studies.
Strain DL44 (∆ldh) investigated in Bartosiak-Jentys [189] exhibited an increase in flux from
phosphenolpyruvate and pyruvate to oxaloacetate under fermentative growth compared to aero-
bic growth. By contrast, Tang et al [190] showed that this decreased in the M10EXG (wt) strain.
In the present study many differences were observed in the mass isotopomer distributions of the
amino acids between the wild type strain DL33 (wt) and DL44 (∆ldh), which are most apparent in
the micro-aerobic condition. In serine, glycine, glutamate, proline, histidine and to a lesser extent
phenylalanine, the mass isotopomer distribution of DL44 (∆ldh) was different to that of the other
two strains with a reduced M+0 weight. This may have been a result of the slight differences in
biomass outputs by the strains (Chapter 3, Table 3.5), particularly as it is the mass isotopomer
distributions of the supplemented amino acids and their metabolic descendants which are mostly
affected. It could also suggest a difference in flux between the two strains which could explain
the contrasting differences in flux found in the previous studies [189, 190] which can be looked
at through modelling of these data (Chapter 5).
Labelling proportions of the mass isotopomer distributions here show that cells were harvested at
isotopic steady state, indicated by 20 % labelling proportion in those amino acids not affected by
the uptake of supplemented amino acids. The presence of some additional (greater than 80 %)
unlabelled carbon in some of the amino acids, not just those which had been supplemented but
also those which are produced from the supplemented amino acids, highlights the importance of
including all sources of carbon available to the cells in modelling of intracellular metabolic flux,
as well as all the potential reactions for which additional carbon sources may be substrates.
All strains, even under reduced oxygen conditions, contained carbon-13 in the carbon backbone
of serine, threonine and glutamic acid, indicating that the cells are synthesising a fraction of
these amino acids de novo even if, particularly in the case of serine, this is not to a sufficient
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degree to support steady state growth. This has also indicated that the amount of amino acid
supplemented to the cultivations in this study was not substantial enough to shut down de novo
synthesis of the amino acids.
Analysis of the culture medium for amino acids has revealed that substantial quantities of ala-
nine are produced during fermentative and micro-aerobic growth. Alanine production is linked
with NAD+ regeneration and thus alanine was produced as a fermentation product under these
conditions. The use of alanine as a fermentation product has been previously documented in
thermophilic bacteria, namely Clostridium [218], Pyrococcus furiousus [219], Thermocococcus
profundus [220] and members of the order Thermotogales [221] but to date not in Geobacillus
spp. This serves as a potential target for further engineering of strain DL66 (∆ldh∆pfl↑pdh) as
replacement of the alanine dehydrogenase gene with a transaminase counterpart could drive
carbon flux to ethanol for NAD+ regeneration, without making the organism auxotrophic for L-
alanine. This would also prevent unnecessary loss of nitrogen from the cell.
The mass isotopomer distributions described here have been used in refinement of metabolic
flux models in the next chapter and have also been used to produced preliminary flux data for
each of the strains.
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513C-metabolic flux analysis of Geobacillus
thermoglucosidasius using [U-13C] glucose
In order to extend the carbon labelling studies described in Chapter 4 into calculated metabolic
flux rates, the isotopic data must be combined with further information in metabolic models to
carry out the flux calculation. For global isotopomer fitting, a metabolic network is required de-
tailing carbon atoms transitions between metabolites as well as constraints for biomass output
and other considerations such as thermodynamic constraints and measured fluxes for uptake
and efflux rates of metabolites from the cell. All flux analysis in this study was carried out using
the 13CFLUX2 suite of software tools [148].
5.1 13CFLUX2
13CFLUX2, like its predecessor 13CFLUX is a suite of software programs for carrying out mass
isotopomer flux calculation. All the programs are run from the linux command line and can be
used to process 13C-MFA models written in an XML-based language, termed FluxML, which has
been created by the developers of 13CFLUX2. In this study, all calculation was carried out on a
Linux system running Ubuntu 12.04.
Models in the FluxML format consisted of the following components:
1. The reaction network, divided into a) metabolite pools of all the metabolites in the network
and the number of carbon atoms in each molecule and b) a list of reactions with their
corresponding substrates and products and carbon atom transitions, which are detailed
using an alphabetical notation.
2. A list of constraints on the network.
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3. A list of the input pools of both labelled and unlabelled substrates, each of which is written
as a set of isotopomers and their relative abundances.
4. A definition of each datum inputted to the model, consisting of both GC-MS data of mass
isotopomer distributions and any measured flux values.
5. Free fluxes. These were reasonable flux estimates of the major pathways which are used
as starting fluxes in the iterative flux fitting process.
5.2 Defining the network topology of Geobacillus thermoglu-
cosidasius and model construction.
Construction of the first G. thermoglucosidasius metabolic flux model was made by editing the
reactions in an existing E. coli 13CFLUX2 metabolic flux model, which had been provided with
the software for this purpose. This model provided the fundamental reactions and carbon atom
transitions of Embden-Meyerhof glycolysis, gluconeogenesis, anaplerotic reactions, TCA cycle,
the glyoxylate cycle, pentose phosphate pathway and major fluxes to cellular biomass as well as
uptake of glucose.
All reactions in the existing metabolic network were manually verified against the genome se-
quence of DL33 (wt) (Chapter 3) to determine their inclusion or exclusion from the G. thermoglu-
cosidasius models. Additional reactions were included for cellular uptake and degradation of
serine, threonine glutamate and citrate. Uptake reactions were also created for CO2 and a fur-
ther one-carbon metabolite, designated ’CX’, which is implicated in one carbon metabolism in the
synthesis of glycine and histidine, as previously described in [106]. The uptake reactions for one-
carbon metabolites, prevented the reactions that produce and consume these metabolites being
stochiometrically linked, as under physiological conditions this would not necessarily be the case.
Several amino acid synthesis reactions were added to the network to contribute to biomass out-
put, namely those for cysteine, methionine, tryptophan and arginine. Whilst these amino acids
did not contribute to overall flux calculation from isotopomer distributions their inclusion enabled
their respective contributions to biomass to be included in the models. Additionally a reaction for
the production of histidine was included to aid flux estimation of the pentose phosphate pathway
and glycine synthesis from serine has been included to help determine the fate of unlabelled
serine included in the culture medium; the mass isotopomer distributions of these two amino
acids were included in the flux calculation. Further reactions were added to include fermentation
pathways in the models for fermentative and micro-aerobic growth and for the catabolism of the
supplemented amino acids. Tyrosine and phenylalanine were included as a single metabolite as
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the mass isotopomer distributions of these amino acids are equivalent. The mass isotopomer
distribution of phenylalanine from GC-MS data was used for calculations involving this metabo-
lite. Succinate and fumarate, which were designated as a single metabolite in the original model
were divided into separate metabolites to allow for the efflux of succinate under micro-aerobic
and fermentative growth (Table 5.1).
Table 5.1: Pathways and metabolites included in G. thermoglucosida-
sius reaction network for 13C-MFA, in addition to those in existing E.
coli model
Metabolite
abbrev.
Compound, Pathway
Lac Lactic acid, fermentation pathways (not DL44 (∆ldh)
and DL66 (∆ldh∆pfl↑pdh)
For Formic acid, fermentation pathways (not DL66
(∆ldh∆pfl↑pdh))
Eth Ethanol, fermentation pathways
Ace Acetate, fermentation pathways
Suc Succinate, TCA cycle and fermentation pathways. Di-
vided from combined Succinate / fumarate metabolite
to enable efflux of succinate as fermentation product
CIT Extracellular citrate, carbon uptake from medium
SER Extracellular serine, carbon uptake from medium
THR Extracellular threonine, carbon uptake from medium
GLU Extracellular glutamic acid, carbon uptake from
medium
TyrPhe Tyrosine and phenylalanine, combined metabolite cre-
ated from existing separate metabolites due to the re-
dundancy of the mass spectrometry fragments of these
metabolites
CX Single carbon compound, used for production of 5,10-
Methylene-THF in glycine synthesis and C1 incorpora-
tion during histidine biosynthesis
His Histidine, amino acid biosynthesis
Gly Glycine, amino acid biosynthesis
Arg Arginine, amino acid biosynthesis
Trp Tryptophan, amino acid biosynthesis
Continued on next page
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Metabolite
abbrev.
Compound, Pathway
Met Methionine, amino acid biosynthesis
co2 External carbon dioxide, used for carbon uptake for
carboxylation reactions
cx External single carbon compound, used for uptake of
CX
PYR/OAA Carboxylation reaction from pyruvate to oxaloacetate,
representing reaction carried out by pyruvate carboxy-
lase (EC 6.4.1.1).
In order to avoid futile cycling of metabolites in the iterative flux flitting procedure, gluconeogenic
reactions were removed and the glycolytic reactions for conversion of fructose-6-phosphate to
fructose-1,6-bisphosphate and phosphoenolpyruvate to pyruvate were set to be bidirectional.
In the anaplerotic reactions, the unidirectional reaction from phosphoenolpyruvate to oxaloac-
etate by phosphoenolpyruvate carboxylase (EC 4.1.1.31) was removed as this enzyme is not
present in G. thermoglucosidasius, however the bidirectional version of this reaction was kept as
the organism has encodes an enzyme that carries out this reaction (Chapter 3, Fig. 3.3). The
unidirectional carboxylation of pyruvate to oxaloacetate was also added.
The syntax used for the construction of the models in this study has been documented previously
by developers of 13CFLUX2 [87]. Carbon atom transitions for new pathways were determined
using the KEGG reactant pair alignments database (RPAIR), previously published metabolic flux
models [106, 110, 202] and textbook biochemistry.
Reactions were condensed when either multiple reactions take place without any scrambling of
the carbon backbone of the molecules, or parallel reactions exist, carried out by separate en-
zymes, in which there is no difference in either the substrates or products (excluding cofactors),
to reduce the size of the network. For example, this latter scenario was relevant to the reactions
carried out by the NADP+ and NAD+ dependent glyceraldehyde-3-phosphate dehydrogenases
in glycolysis, EC 1.2.1.59 and EC 1.2.1.12 respectively.
Unlike many organisms, including E. coli, G. thermoglucosidasius has additional reactions in the
pentose phosphate pathway which enable the conversion of fructose-6-phosphate to ribulose-5-
119
phosphate via arabino-Hex-3-ulose-6-phosphate, (Chapter 3, Fig 3.2). In the forward direction,
that creates ribulose-5-phosphate as the product, this pathway is indistinguishable from the ox-
idative branch of the pentose phosphate pathway, as both pathways result in the same carbon
atom configuration in ribulose-5-phosphate. Unlike the oxidative pentose phosphate pathway
however these reactions are reversible, thus giving rise to the potential for the carboxylation of
unlabelled CO2 making the reverse flux through this pathway resolvable. However, the label feed
of 20 % [U-13C] glucose and 80 % [U-12C] glucose being used was not able to reliably resolve
the pentose phosphate pathway (S. Masakapalli, unpublished) and thus this pathway was omitted
from the analysis of this particular feed. It was, however, an important consideration for further
investigations.
5.2.1 Constraints
The reaction network was constrained in order to reduce the potential solution space of the cal-
culated flux distribution. Constraints were made based on a) thermodynamic considerations,
that is the reversibility of a reaction under physiological conditions; b) stoichiometries such as the
relative concentrations of carbon sources in the culture medium or c) carbon output to biomass.
Each reaction has a net flux representing the overall flux from one metabolite to another, which
can be positive or negative, with negative fluxes indicating a net reversal of the reaction. Addi-
tionally, each reaction has an exchange - or xch flux, which represents the amount of interchange
between the substrate and product of the reaction, with an xch flux of 0 indicating complete uni-
directionality of the reaction [87, 127]. Constraints therefore were subdivided into net and xch.
5.2.1.1 Net
Net constraints were used to set the stoichiometries of labelled to unlabelled glucose in the up-
take reactions. In reactions where symmetrical substrates meant that there were two possible
orientations in which products could be formed, such as the conversion of succinate to fumarate,
stoichiometries were set so that the two orientations were produced in equal amounts. Addi-
tionally net constraints were used to set efflux to biomass. The biomass requirements for amino
acids used were those which had been measured for G. thermoglucosidasius strain NCIB 11955
(S. Masakapalli, unpublished). Further biomass requirements for metabolic intermediates were
included from previously published studies in G. thermoglucosidasius [190] and Bacillus subtilis
[222] (Appendix E, Table E.1). The values for efflux to biomass were normalised to the rate of
uptake of glucose (see Section 5.2.3.1). Finally, uptake of amino acids and the efflux of alanine,
which had been measured by HPLC analysis (Chapter 4, Fig 4.10) were entered as net con-
straints. All net constraints were entered in units of mmoles per g of dry cell weight per hour
(mmoles g DCW-1 hr-1). The conversion factor for OD 600 nm to g DCW of 1 AU at OD 600 nm
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was equal to 0.25g of DCW per litre of culture, was taken from calculation in DL33 (wt) carried
out in a previous study [191].
5.2.1.2 Xch
By default, all uptake and efflux reactions are treated as unidirectional by the 13CFLUX2 software
and thus these exchange fluxes were omitted from the models. In addition to this, all those
reactions for which the backwards reaction would be thermodynamically unfavourable in vivo
were also constrained to be unidirectional such as the conversion of phosphoenolpyruvate to
oxaloacetate by pyruvate carboxylase (EC 6.4.1.1) and the first reaction in the oxidative pentose
phosphate pathway.
5.2.2 Carbon inputs
Input substrates were defined as pools, detailing the number of input carbon atoms and labelling
pattern of the substrate, taking into account, the natural carbon-13 labelling which can occur in
each. The two major sources of carbon used in this study, [U-13C] glucose at 99 % purity and
[U-12C] glucose were already included on the original E. coli model. Further pools were added
for serine, threonine and glutamic acid, which are all present in the medium, and CO2 and CX
for one-carbon metabolism. Additionally citric acid is present in ASM at a concentration of 8 mM
as a chelating agent. HPLC of the culture medium showed that this can this can be taken up by
the cell so an uptake of citrate reaction was included and a citrate uptake isotopomer pool as well.
The mass isotopomer distribution of input pools was calculated based on a natural occurrence
of carbon-13 of 1.13 %. Only isotopomers with one additional carbon-13 were included in the
mass isotopomer distribution as the probability of two or more naturally occurring carbon-13
atoms within an unlabelled substrate, at approximately 0.2 % for a six carbon molecule, is below
the precision of most mass spectrometry instruments and therefore would not interfere with the
analysis [127].
5.2.3 Input data
Two forms of data were inputted to the model to be used to ascertain the fit of simulated flux
distributions: 1) the mass isotopomer distributions measured by GC-MS. 2) The measured fluxes
of carbon into and out of the cell.
Mass isotopomer distributions These consisted of the TBDMS derivatives of the mass frag-
ments detailed in Chapter 4, Table 4.2 and discussed in Chapter 4. These were corrected for
naturally occurring isotopes and normalised to one using the Matlab Mass Correction Tool.
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Measured fluxes Measured uptake of glucose and citrate into the cell as well of efflux of fer-
mentation products, pyruvate and acetate were measured by HPLC analysis, (Chapter 3, Fig.
3.8 and 3.9). Measured fluxes were converted to units of mmoles g DCW-1 hr-1 based on the
OD 600 nm measurements. Values for each culture were normalised such that the total glucose
uptake rate was 100 to enable comparison of fluxes to be made between strains and conditions.
5.2.3.1 Free fluxes
Free fluxes were chosen to represent reasonable estimates of fluxes in all pathways. The chosen
free fluxes were then optimised using the program sscanner, which searches for free fluxes by
determining the centre of the flux solution space [201].
5.2.4 Simulation
The components of the models for each strain under aerobic, micro-aerobic and fermentative
growth are summarised in Table 5.2.
Table 5.2: Components of each model for strains grown on 20 % [U-
13C] glucose and 80 % [U-12C] glucose under aerobic, micro-aerobic
and fermentative conditions
Component DL33 (wt) DL44 (∆ldh) DL66 (∆ldh∆pfl↑pdh)
Aerobic
Metabolite pools 50 51 52
Net Reactions 90 90 90
Xch Reactions 90 90 90
Free net reactions 17 16 16
Free xch reactions 13 17 16
Measured fluxes 3 3 3
GCMS metabolites 13 13 13
Micro-aerobic
Metabolite pools 55 54 53
Net Reactions 98 96 94
Xch Reactions 98 96 94
Free net reactions 21 20 19
Free xch reactions 15 16 16
Measured fluxes 8 7 6
Continued on next page
122
Component DL33 (wt) DL44 (∆ldh) DL66 (∆ldh∆pfl↑pdh)
GCMS metabolites 13 13 13
Fermentative
Metabolite pools 55 54 53
Net Reactions 98 96 94
Xch Reactions 98 96 94
Free net reactions 21 20 19
Free xch reactions 15 16 16
Measured fluxes 8 7 6
GCMS metabolites 13 13 13
The syntax of models was checked using the fmllint program in the Linux command line. Initial
simulation of fluxes was carried out using the fwdsim program to verify the validity of the chosen
free fluxes and metabolite stoichiometry and with the ’-s’ option to obtain the sensitivities of the
fluxes.
5.2.5 Iterative flux fitting procedure
Two approaches exist for the iterative flux fitting procedure. The first is a linear approach in which
a single starting set of fluxes is chosen and the fluxes are iteratively refined from this point to
create the flux distribution which most closely recreates the observed measured data. This ap-
proach has limitations as it may find a local rather than global best-fit flux distribution; it does
however provide a relatively swift and simple means of obtaining statistically valid flux distribu-
tions. The second is a non-linear approach in which multiple flux starting points are used and the
flux distribution iteratively refined from each. This is a more robust approach to flux calculation
but is far more computationally demanding.
The purpose of this study with a labelled feed of 20 % [U-13C] glucose was to establish a
metabolic network that was suitable for 13C-MFA of G. thermoglucosidasius and provide pre-
liminary flux data. As such the linear method fulfilled the requirements of the current study, the
more robust non-linear approach is detailed in the next chapter with a feed mixture chosen for it’s
ability to produce higher resolution flux maps.
Following optimisation of the free fluxes with the sscanner program, the iterative flux fitting proce-
dure was initiated using the fitfluxes program. The appropriateness of a simulated flux distribution
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is determined by a sum of squares function that represents the difference between the measured
and the simulated input data (isotopomer distributions and measured fluxes) - the residuum [144].
Where a residuum fell below a χ2 test at a probability of 0.95 it was considered to be a valid flux
distribution.
The fitfluxes program was allowed to perform 1000 iterations of flux distributions or less if the
residuum fell below the χ2 value within the 1000 iterations and the rate of decrease of the
residuum fell to a point where each iteration produced only a marginal decrease in the value
of the residuum.
5.3 Refining the network model with isotopomer data
5.3.1 Amino acid synthesis routes
Cellular metabolism uses two means of transferring an amine group in the synthesis of amino
acids. The first transfers the amine group from ammonia, in a dehydrogease reaction that also re-
quires a cofactor, normally NADH, which is oxidised to NAD+. The second is via a transaminase
reaction, in which the amine group is transferred from an existing amino acid and is independent
of cofactors. Some amino acids specifically use one or the other, whilst some amino acids, such
as valine, (Fig. 5.1) have parallel enzymes in their biosynthesis reactions, enabling the use of
either reaction type.
Figure 5.1: Routes for valine amination. An amine group can be transferred to 3-Methyl-2-
oxobutanoic acid from ammonia using (a.) a dehydrogenase reaction or (b.) a transaminase
reaction where the amine group is transferred from glutamic acid. The former requires oxidation
of a cofactor whilst the latter does not.
The transaminase reaction requires two exchanges between metabolite pools within a normal
13C-MFA model. One from the oxoacid that is being converted to an amino acid and the second
from the degradation of the amino acid that is providing the amine group, often this is glutamic
acid which is converted to oxoglutatarate. The second pool exchange is often not included in
metabolic models as these pools are directly adjacent to each other in the metabolic network
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with no rearrangement of carbon atoms from one metabolite to the other, so they can be consid-
ered a single pool, as any reaction which causes the conversion of one compound to another can
be quickly converted back without any effect on the overall flux distribution within the metabolic
network.
There is currently no consensus on whether both pool exchanges should be included in the amino
acids synthesis reactions of a 13C-MFA model however, with many metabolic models taking no
account of the second change in metabolite pools for the transaminase reactions, such as those
published by Beste et al. [85], Masakapalli et al. [106] and Bartek et al. [110]. The reaction
network published by van Ooyen et al. on the other hand includes all reaction steps [202].
In this study, the feeding of unlabelled amino acids presented a complication in the network.
Here, the metabolite pools of glutamic acid and oxoglutarate were not necessarily equivalent as
the former could principally be composed of carbon from extracellular unlabelled glutamic acid,
whereas the latter could be composed principally of 20 % carbon-13 from central metabolism.
An exchange between these two metabolite pools therefore would result in a disturbance be-
tween their isotopomer distributions. In this case therefore, it may be necessary to detail all
concomitant exchanges between the pools with amino acid synthesis, so that the stoichiometries
of isotopomers could be determined in the flux fitting.
In G. thermoglucosidasius, five amino acids can be synthesised using either a transaminase or
a dehydrogenase reaction: valine, leucine, isoleucine, tyrosine and phenylalanine, (Table 5.2).
With the exception of tyrosine and phenylalanine production, the dehydrogenase route is carried
out by tryptophan dehydrogenase (EC 1.4.1.19) and the transaminase route is carried out by
branched-chain-amino-acid transaminase (EC 2.6.1.42). Additionally, three further amino acids,
serine, aspartic acid and histidine are made solely via a transaminase reaction.
5.3.2 Affect of amino acid synthesis routes on residuum
In order to determine whether it is preferable to include the transaminase step in the metabolic
models or not, models were created for both options. For those with the transaminase step, each
reaction in Table 5.2 was included in the network, thus there were two reactions for the synthesis
of each of valine, leucine, isoleucine and tyrosine / phenylalanine. For the models without the
transaminase step, the transaminase reactions were removed (those carried out by glycerone-
phosphate O-acyltransferase (EC 2.3.1.42) and aromatic-amino-acid transaminase (EC 2.6.1.57)
/ arogenate dehydrogenase (EC 1.3.1.43)) and the reactions that had only a transaminase syn-
thesis route had glutamate and oxoglutarate removed from their substrate and product sides
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Table 5.3: Dual dehydrogenase / transaminase and single transaminase reactions in the amino
acid synthesis pathways of G. thermoglucosidasius metabolism
Dual dehydrogenase / transaminase reactions
Oxoisovalerate + NH3 + NADH + H+ → Valine + H2O + NAD+ (EC 1.4.1.19)
Oxoisovalerate + glutamate→ oxoglutarate + valine (EC 2.6.1.42)
Oxoisovalerate + NH3 + NADH + H+ → leucine + H2O + NAD+ + CO2 (EC
1.4.1.19)
Oxoisovalerate + glutamate→ oxoglutarate + leucine + CO2 (EC 2.6.1.42)
Threonine + pyruvate + NH3 + NADH + H+ → Isoleucine + CO2 + H2O + NAD+
(EC 1.4.1.19)
Threonine + pyruvate + glutamate → oxoglutarate + isoleucine + CO2 (EC
2.6.1.42)
Chorsimate + NH3 + NAD(P)H + H+→ phenylalanine / tyrosine + H2O + NAD(P)+
+ CO2 (EC 1.4.1.20)
Chorismate + glutamate → phenylalanine / tyrosine + oxoglutarate + CO2 (EC
2.6.1.57 / 1.3.1.43)
Single transaminase reactions
Phosphophglycerate + glutamate→ serine + oxoglurate
Oxaloacetate + glutamate→ oxoglutarate + aspartate
Ribose-5-phosphate + CX + glutamate→ histidine + oxoglutarate
respectively. Each of the two model types had 26 data sets in total; models were assessed for
their ability to produce statistically valid flux distributions.
Carrying out of the fitting procedure revealed that certain fluxes needed to be further constrained
to within physiological bounds in order to produce flux distributions which were biologically rel-
evant. This is partly because the isotopic labelling used in these experiments was unable to
resolve all pathways in the network, most notably the pentose phosphate pathway. Flux through
the oxidative branch of the pentose phosphate pathway was constrained to within reasonable
physiological bounds of 10 - 40 % of the flux from glucose-6-phosphate, guided by the demon-
strated pentose phosphate pathway flux in G. thermoglucosidasius by Tang et al. [190]. Likewise
in several models, particularly those under reduced oxygen conditions where flux through the
TCA is already limited, the TCA cycle had to be constrained to make flux through reactions less
than or equal to 0. Without this, models could become stuck in a local best-fit flux solution in
which the TCA cycle reactions went backwards but this frequently would not result in a residuum
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that was able to pass a χ2 test.
For two of the datasets one mass fragment had to be removed from the mass isotopomer data
in order to enable fitting - one of isoleucine and one of alanine as these two data sets consis-
tently had high residuals for the mass fragment in question. Removal of the isoleucine fragment
from one aerobic dataset of DL33 (wt) made the exchange flux from oxaloacetate to aspartate
indeterminable, which was identified using the flux sensitivities option with the fwdsim program;
loss of alanine from one micro-aerobic DL33 (wt) dataset did not affect the fluxes which could be
determined.
Of the 26 models which included the transaminase reactions, 18 were able to produce statistically
verifiable flux distributions. In contrast, of the 26 models which did not contain the transaminase
reactions, 22 were able to produce statistically verifiable flux distributions, (Table 5.2). The micro-
aerobic condition in all strains had the fewest fitting models with only 4 of the models with the
complete transaminase reactions and 6 without passing a χ2 test. This cannot be attributed to a
single cause however, as high residuals were found on different areas of the network. As might
be expected, the dual reactions where both a transaminase and dehydrogenase are present cre-
ated futile cycling with one reaction creating the amino acid in the forwards direction and the
other degrading it with the reverse reaction. In order to prevent this, dual reactions had to be
constrained to be less than or equal to 0.
Table 5.4: Proportion of 20 % [U-13C] isotope data resulting in flux distribution which passes χ2
test once dual /dehydrogenase transaminase reactions were removed.
Aeration DL33 (wt) DL44 (∆ldh) DL66 (∆ldh∆pfl↑pdh)
Aerobic 3 / 3 - One with
removal of alanine
fragment
3 / 3 2 / 3
micro-
aerobic
1 / 2 - With removal
of alanine fragment
3 / 3 2 / 3
Fermentative 3 / 3 3 / 3 3 / 3
5.4 Calculated flux distributions
The calculated flux distributions from the previous section without the glutamic acid - oxoglu-
tarate exchange in transaminase reactions are shown in Figures 5.2, 5.3 and 5.4 for aerobic,
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micro-aerobic and fermentative conditions respectively. Only the flux values for the data sets and
models which passed a χ2 test are shown, where multiple data sets passed a χ2 test the flux
distribution represents the average.
Whilst individual fluxes have not been calculated for the pentose phosphate pathway due to the
inability of the isotopic substrate feed to resolve this pathway, for all strains, particularly under
micro-aerobic conditions, the proportion of flux through glycolysis rather than the pentose phos-
phate pathway is high.
Aerobically, there was little difference between the strains except the engineered strains showed
a lower flux through oxoglutarate to succinate than the wild type. Aerobically DL33 (wt) and DL44
(∆ldh) should exhibit the same phenotype as genetic alterations have only been made in DL44
(∆ldh) to the ldh gene which is not induced aerobically. DL66 (∆ldh∆pfl↑pdh) conversely may
be affected aerobically by the presence of an anaerobic promoter regulating the pdh gene. In
this instance, the literature derived biomass constraints seem inadequate and excess carbon was
lost to biomass in the engineered strains. DL66 (∆ldh∆pfl↑pdh) also had a greater flux through
aconitase and isocitrate dehydrogenase due to uptake of citrate from the medium. DL33 (wt)
and DL44 (∆ldh) conversely secreted a small amount of citrate to the medium whilst undergoing
aerobic growth. Finally, the engineered strains make greater use of anaplerotic reactions than
the wild type.
It is worth noting that in strains DL33 (wt) and DL44 (∆ldh) under fermentative and micro-aerobic
conditions, where parallel reactions exist for conversion of pyruvate to acetyl-CoA, namely PDH
and pyruvate formate lyase (PFL), flux through PFL can only be accounted for by the presence of
formate in the medium. As G. thermoglucosidasius has a formate dehydrogenase for the conver-
sion of formate to CO2, very little formate would be detectable in the medium if this was active.
Therefore any flux through PFL in which the formate is subsequently converted to CO2 is indis-
tinguishable from flux through PDH and the fluxes have been combined accordingly, resulting in
a comparatively low flux through PFL.
micro-aerobically, flux to the TCA cycle was reduced as carbon was diverted to fermentation
products and acetate. TCA cycle flux was lowest in DL44 (∆ldh) and alanine was being pro-
duced as a fermentation product to the greatest extent in this strain, as well as a large amount of
acetate. Interestingly, even though levels of alanine production in DL44 (∆ldh) exceeded levels of
lactate production in DL33 (wt), ethanol was being produced as well, whilst in the wild type it was
not, indicating a higher requirement to re-oxidise NADH to NAD+ in this strain. Micro-aerobic
flux through the TCA cycle in DL66 (∆ldh∆pfl↑pdh) was higher than that of both DL33 (wt) and
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DL44 (∆ldh), presumably because of the higher Pdh activity under these conditions, suggesting
there may be potential to increase the flux to ethanol, possibly by up regulation of the alcohol de-
hydrogenase gene, without impacting growth of the strain. It is noteworthy however that part of
the increase was due to a greater uptake of citrate from the medium. The anaplerotic reactions
showed little difference between the strains with flux through phosphoenolpyruvate carboxyki-
nase flowing from phosphoenolpyruvate to oxaloacetate and flux through the other anaplerotic
reactions flowing from oxaloacetate and pyruvate to malate in all strains.
Under fermentative growth DL44 (∆ldh) changed from having the lowest TCA cycle flux to the
highest. The additional carbon originated from acetyl-CoA, external citrate and phosphoenolpyru-
vate via phosphoenolpyruvate carboxykinase which had a net flux in the reverse reaction in this
strain whereas in the wild type and DL66 (∆ldh∆pfl↑pdh) this reaction was working in the for-
wards direction.
DL66 (∆ldh∆pfl↑pdh) also had a greater TCA cycle flux than DL33 (wt) although less so than
DL44 (∆ldh). Likewise the anaplerotic reactions in this strain exhibited a greater flux relative to
DL33 (wt) with carbon being diverted from the TCA cycle to the lower half of glycolysis.
It is noteworthy that fluxes shown are averages of duplicate or triplicate samples and exhibit a
relatively high degree of variation. This is likely to be representative of two factors, firstly the diffi-
culty in accurately reproducing conditions within the small scale bioreactor and secondly, the fact
that these fluxes have been determined using a linear flux optimisation program, means there is
scope for the given flux distributions to represent local rather than global best fit flux solutions.
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5.5 Discussion
Global isotopomer fitting for 13C metabolic flux analysis is a powerful tool for the quantification
of intracellular fluxes. It has however remained a specialised tool of expert groups in the field of
metabolic research. The creation of tools to assist in the technique is enabling non experts to
apply the technique to a greater number of scientific questions and its application in this study
has extended metabolic studies of G. thermoglucosidasius.
Carrying out 13C-MFA in a non-model organism has added complexity as the metabolism of
such organisms is less well characterised than model organisms. The universal framework for
13C-MFA created by Wiechert et al. [87, 127] presents a means of applying the tool to any organ-
ism whereby a network model can be built directly from information within the genome sequence
using an alphabetical notation for the transitions of carbon atoms between metabolites and there-
fore is suitable for application to non-model organisms.
Here 13C-MFA was carried out within this framework on three strains of G. thermoglucosidasius
DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) under three levels of aeration using a la-
belled feed ratio of 20 % [U-13C] glucose : 80 % [U-12C] glucose and literature derived biomass
constraints. To date two previous isotopic metabolic flux studies have been carried out on G.
thermoglucosidasius strains - one using flux ratio analysis to study strain DL44 (∆ldh) [189] and
one in strain M10EXG [190]. This work has extended these studies by carrying out global iso-
topomer balancing and comparing the fluxes of wild type and engineered strains.
The inclusion of the transaminase reactions did not appear to help the flux fitting procedure
and ultimately resulted in a smaller number of the models finding a final flux distribution with a
residuum below the χ2 value. It may be that the additional reactions in the network add complex-
ity making it harder to find the best fit flux solution without helping to determine the interchange
between the oxoglutarate and glutamic acid metabolite pools.
The fluxes determined by Tang et al. [190] in strain M10EXG show a lower flux through glycolysis
than is shown here, with the remaining carbon diverted through the pentose phosphate pathway
which is likely to be due to lack of resolution of the pentose phosphate pathway in these flux
maps. It may be found that with a labelled feed that can resolve the pentose phosphate path-
way that a higher flux throughout the pentose phosphate pathway is also statistically valid, which
would consequently reduce flux through glycolysis.
There was a slight reduction in flux through the anaplerotic reactions under fermentative growth
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compared to aerobic growth in strains DL33 (wt) and DL44 (∆ldh). In contrast, DL66 (∆ldh∆pfl
↑pdh) shows an increase in flux through the anaplerotic reactions under fermentative growth.
The proportion of flux through these reactions under aerobic and anaerobic conditions been vari-
able across studies. Tang et al. [190] found a reduction in flux through the anaplerotic reactions
in the wild type strain under low oxygen conditions relative to aerobic growth as well, however the
standard deviation of flux in the study was too high for this difference to be definitive. Studies by
Bartosiak-Jentys [189] in strain DL44 (∆ldh) showed no change or an increase in the anaplerotic
reactions under micro-aerobic growth relative to aerobic growth [189]. There are notable differ-
ences between the modelling techniques used in this study and the present study however, such
as the accounting for unlabelled sources of carbon available to the cell, which may well explain
this observed difference. Studies in E. coli by Chen et al. [223] found that anaplerotic flux as a
proportion of glucose uptake also fell anaerobically by approximately a third. In the present study,
like that of Tang et al., the analysis is hampered by a high standard deviation of flux, for example
in the present study fermentative flux through the three anaplerotic reactions in DL66 (∆ldh∆pfl
↑pdh) were 23.7 ± 18.6, 11.3 ± 6.6 and 9.3 ± 22.7 and thus were not well resolved. This prob-
lems was addressed in subsequent flux modelling and described in the following chapter.
The metabolic network constructed from the DL33 (wt) genome information was found to be
capable of producing statistically reliable flux distributions based on the mass isotopomer dis-
tributions of proteinogenic amino acids and measured fluxes. These distributions have demon-
strated that there are observable differences in flux in relation to both i) levels of aeration and
ii) strain. Reducing levels of oxygen generally reduced flux through the TCA cycle across the
strains. Under micro-aerobic (strain DL66 (∆ldh∆pfl↑pdh)) and fermentative conditions (strain
DL44 (∆ldh) and DL66 (∆ldh∆pfl ↑pdh)) the engineered strains show greater TCA cycle flux
than the wild type strain. An important consideration however, is the loss of ethanol as vapour
during cultivation, as all cultivations were carried out at a relatively higher temperature of 66 °C.
As the engineered strains produce a greater amount of ethanol as a proportion of their total fer-
mentation products, carbon that has not been accounted for because of the volatility of ethanol
will be increased in these strains, potentially causing an increase in intracellular carbon. This
would not reflect physiological conditions and may explain the increase in TCA flux in the engi-
neered strains. In the present flux modelling, efflux to ethanol was used as measured efflux, in
subsequent modelling in Chapter 6, this has been changed to a free flux so that any ethanol that
had been lost during cultivation was incorporated.
It should be noted that flux maps have not been generated for all flux distributions. It has been
noted that it is rare for biological systems to fit metabolic networks straight away due to the
complexity and variation that exist in these systems [127, 144]. The analysis here may have
been particularly hindered however, by three factors: the use of a feed which cannot resolve all
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pathways within the network, the use of literature derived biomass constraints which may differ
slightly from actual biomass output due to differences in strains and growth conditions and finally
the use of a linear flux optimisation method which may allow flux optimisation to become stuck
in local best-fit solutions. These limitations therefore have been addressed in the next chapter to
study the anaerobic metabolism of the organism.
135
613C metabolic flux analysis of Geobacillus
thermoglucosidasius using positionally labelled
glucose
The use of a labelled feed ratio of 20:80 [U-13C] to [U-12C] glucose has enabled construction
of working 13C metabolic flux models of Geobacillus thermoglucosidasius, this feed ratio how-
ever does not provide high flux resolution of the entire metabolic network, with resolution of the
pentose phosphate pathway and glyoxylate cycle being particularly poor. Isotope labelling sim-
ulations (S. Masakapalli, unpublished data) demonstrate a high standard deviation of flux within
the pentose phosphate pathway and glyoxylate cycle using the 20 : 80 [U-13C] glucose to [U-12C]
glucose ratio. This can be greatly improved, however, by changing to a feed ratio of 60:40 [1-13C]
glucose to [U-13C] glucose. A similar feed ratio to this has been applied in 13C-MFA studies
of other species, such as Corynebacterium glutamicum [110], Bacillus subtilis [132] and Pichia
pastoris [224].
6.1 Isotope labelling experiments
Isotope feeding experiments were carried out in a small scale bioreactor, as described for uni-
formly labelled glucose feeding experiments (Chapter 4). Medium composition (including total
glucose input) was the same as described in Chapter 3, however glucose feed contained a 60 :
40 ratio of [1-13C] glucose to [U-13C] glucose.
This chapter will focus on the metabolic flux of the three strains DL33 (wt), DL44 (∆ldh) and
DL66 (∆ldh∆pfl↑pdh) under fermentative growth as this is the condition most suited to under-
standing the metabolism of the stains for the purpose of improving ethanol production. Aeration
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was delivered to each culture at a rate of 0.5 vvm.
The strains were cultivated on the labelled feed mixture to isotopic and metabolic steady state as
described previously (Section 4.2). Measured fluxes into and out of the cell were measured by
HPLC analysis, as described in Section 2.7.1. Intracellular isotopomer distributions were mea-
sured by GC-MS as described in Section 2.7.3 and isotopomer distributions of external metabo-
lites were also analysed by GC-MS as described in Section 2.7.4.
Culture OD 600 nm at steady state was measured spectrophotometrically to be 0.83, 0.71 and
0.95 AU for strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) respectively and converted
to g DCW as described in Chapter 4.
6.2 Measured fluxes
An underlying assumption of 13C metabolic flux analysis is that the action of enzymes on sub-
strates is not affected by the isotopic state of the carbon atoms in the substrate [116]. The
repetition of the fermentative condition with a different isotope feed therefore, whilst changing
the isotopomers of intracellular metabolites, should not influence overall flux distribution. Never-
theless, due to the inherent variability seen between replicate experiments with [U-13C] glucose
carried out in the small scale chemostat (Chapter 3, Fig. 3.8 and Fig. 3.9) measurements for the
uptake of glucose and efflux of acetate, lactate, succinate, ethanol and pyruvate were repeated
for the positionally labelled glucose cultivations, so that the absolute values of these could be
applied in the flux fitting procedure (Fig. 6.1). Measurements for external amino acid and citrate
concentrations were taken from the [U-13C] glucose cultivations, with the standard deviation be-
tween replicates forming upper and lower bounds for the flux of their respective reactions.
As found previously, there was a step wise increase in specific ethanol production from wild type
strain, DL33 (wt), in which there was no detectable ethanol in the extracellular medium to DL44
(∆ldh) and then DL66 (∆ldh∆pfl↑pdh), which exhibited the greatest ethanol output (Fig. 6.1
E.). The lack of ethanol produced by the wild type strain was consistent with the high lactate
production at almost 33 mM per OD unit of culture (Fig. 6.1 B).
Strain DL44 (∆ldh) had the highest specific production rates of acetate, succinate and pyruvate
(Fig. 6.1 A D F), indicating a degree of metabolic stress on this strain, which was consistent
with the strain failing to utilise all the available glucose (Fig. 6.1 C). Whilst acetate, pyruvate and
succinate production decreased in strain DL66 (∆ldh∆pfl↑pdh) in comparison to strain DL44
(∆ldh), the strain still had a higher specific production rate of acetate and succinate relative to
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the wild type.
The culture medium was also checked for the presence of formate; only very minimal amounts
were detected in the medium of both DL33 (wt) and DL44 (∆ldh) and as the reactions through
PDH and PFL are parallel to one another the flux of the two pathways was combined in the flux
calculation. Lactate was not detected in the medium of either of the engineered strains (Fig. 6.1
B)
The measured concentrations of metabolites and glucose were converted to measured fluxes for
the flux calculation based on the chemostat dilution rate of 0.1 hr-1 as described in Chapter 5.
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Figure 6.1: The concentrations of A) acetate B) lactate C) residual glucose D) succinate E)
ethanol and F) pyruvate in the external medium of cultivations of DL33 (wt), DL44 (∆ldh) and
DL66 (∆ldh∆pfl↑pdh) grown fermentatively on a 60 : 40 ratio of [1-13C] glucose to [U-13C] glu-
cose in chemostat at a dilution rate of 0.1 hr-1. Concentrations are in mM per OD 600 nm AU
of the cell culture with the exception of glucose which is in absolute concentration. All mea-
surements were by HPLC analysis; error bars represent standard errors of analytical triplicate
samples.
6.3 Mass isotopomer distributions of proteinogenic amino acids
The mass fragments of the supplemented amino acids glutamate, serine and threonine, and their
direct metabolic descendants proline, glycine and isoleucine respectively, showed variable mass
isotopomer distributions (Fig. 6.2) between the different strains. Serine, glutamate and proline
showed a stepwise increase in the proportion of the M+0 weight within their mass isotopomer
distributions, with DL33 (wt) having the smallest M+0 weight, DL66 (∆ldh∆pfl↑pdh) having the
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largest, and that of DL44 (∆ldh) being between the two. In contrast, in the mass isotopomer
distributions of glycine and threonine, DL44 (∆ldh) had the largest M+0 weight followed by DL66
(∆ldh∆pfl↑pdh) and then DL33 (wt), which had the smallest. Isoleucine showed little variation,
although there were noticeable differences in the M+2 and M+3 weights of DL44 (∆ldh) com-
pared to the other strains. Differences between these mass fragments between the strains was
expected as the culture OD 600 nm differed between the cultures, whilst the supplemented amino
acid concentration stayed constant and thus there will be varying amounts of amino acid avail-
able per gram of biomass. This however cannot account for the alternative patterns of isotopic
distribution observed here and thus suggests potential differences in fluxes between the strains.
As observed in [U-13C] glucose labelling experiments, there was greater variation in the mass
isotopomer distribution of histidine between the strains compared to that of phenylalanine (Fig.
6.3), indicating variations in the oxidative branch of the pentose phosphate pathway between the
strains, which did not extend to the non-oxidative branch of the pentose phosphate pathway.
Aspartate and, to a lesser extent, lysine (Fig. 6.4) showed a stepwise increase in the M+0
weights with the mutations to the strains, with DL33 (wt) having the smallest M+0 weight and
DL66 (∆ldh∆pfl↑pdh) having the greatest. The relatively large unlabelled fraction of aspartate
appears to have resulted from unlabelled carbon entering metabolism from glutamate or per-
haps citrate as the mass isotopomer distribution of aspartate closely resembled that of glutamic
acid. Whilst aspartate is converted directly to threonine in vivo, this reaction is irreversible under
cellular conditions and the mass isotopomers of threonine and aspartate show a considerably
different pattern, therefore unlabelled aspartate was not being derived from unlabelled threonine
added to the culture. As described for flux modelling in Chapter 5, the effect of unlabelled sub-
strates was taken into consideration whilst carrying out isotopomer fitting.
The amino acids produced from the end of glycolysis - alanine, valine and leucine (Fig. 6.5)
showed very little variation between the strains, indicating that glycolytic flux had been largely
unaffected by metabolic engineering of the strains.
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Figure 6.2: Mass isotopomer distributions of MTBSTFA derivatized intracellular supplemented
amino acids and their direct metabolic descendants after fermentative cultivation on a 60 : 40
ratio of [1-13C] glucose to [U-13C] glucose at a dilution rate of 0.1 hr -1. A) serine M-57 fragment.
B) glycine M-57 fragment. C) glutamate M-57 fragment. D) proline M-85 fragment. E) threonine
M-57 fragment, F) isoleucine M-57 fragment. Values are averages of technical triplicate samples.
Error bars show standard error. Where no error is visible it was below 0.01 %.
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Figure 6.3: Mass isotopomer distributions of MTBSTFA derivatized intracellular (A) histidine and
(B) phenylalanine M-57 fragments after fermentative cultivation on a 60 : 40 ratio of [1-13C]
glucose to [U-13C] glucose at a dilution rate of 0.1 hr -1. Values are averages of technical triplicate
samples. Error bars show standard error. Where no error is visible it was below 0.01 %.
Figure 6.4: Mass isotopomer distributions of MTBSTFA derivatized intracellular (A) aspartate
M-57 fragment and (B) lysine M-57 fragments after fermentative cultivation on a 60 : 40 ratio of
[1-13C] glucose to [U-13C] glucose at a dilution rate of 0.1 hr -1. Values are averages of technical
triplicate samples. Error bars show standard error. Where no error is visible it was below 0.01 %.
142
Figure 6.5: Mass isotopomer distributions of MTBSTFA derivatized intracellular (A) valine M-57
fragment, (B) alanine M-57 fragment and (C) leucine M-85 fragment after fermentative cultivation
on a 60 : 40 ratio of [1-13C] glucose to [U-13C] glucose at a dilution rate of 0.1 hr -1. Values
are averages of technical triplicate samples. Error bars show standard error. Where no error is
visible it was below 0.01 %.
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6.4 Mass isotopomer distribution of extracellular metabolites
In order to acquire further information for modelling of flux distributions, external metabolites of
the cell were analysed for their mass isotopomer distributions using GC-MS.
Pyruvate was detected in the medium of all strains but overlapped with an unknown compound
so the mass isotopomer distribution could not be reliably obtained. Malate had mass isotopomer
distributions which are similar in both DL33 (wt) and DL66(∆ldh∆pfl↑pdh), whilst slightly differ-
ent in DL44 (∆ldh) (Fig. 6.6 A). The mass isotopomer distributions of lactate and alanine were
similar in the wild type strain DL33 (wt) (Fig. 6.6 B). Interestingly, some of the extracellular serine
was labelled, indicating this has been synthesised de novo in the strains and has either been
excreted or appeared in the extracellular medium as a result of cell lysis. In the wild type strain,
approximately 20 % of the extracellular serine had at least one labelled carbon atom. This was
reduced in DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) in which only about 4 % and 12 % respec-
tively of the extracellular serine was labelled to some degree (Fig. 6.6 C). The external and
internal serine mass isotopomer distributions differed due to the mixture of supplemented amino
acid with de novo synthesised amino acid.
Figure 6.6: Mass isotopomer distributions of external MTBSTFA derivatized metabolites from
positionally labelled glucose experiments. A) malate M-57 fragment B) lactate M-57 fragment
(DL33 (wt)) and alanine M-57 fragment (DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh))
C) serine M-57 fragment. Values are averages of 6 analytical replicate data sets. Error bars
represent standard error between replicate datasets.
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All citrate in the external medium was unlabelled in each strain indicating that there was no ex-
change flux between the internal and external citrate pools under fermentative conditions (Fig.
6.7 A.). The mass isotopomer distributions of succinate (Fig. 6.7 B.) more closely reflected that
of intracellular glutamate (Fig. 6.2 C.) than malate (Fig. 6.6 B.), suggesting there may be differ-
ing flux in the anaplerotic reactions between the strains. As with serine, the mass isotopomer
distribution of external glutamate (Fig. 6.7 C.) did not reflect that of the intracellular amino acid.
Figure 6.7: Mass isotopomer distributions of external MTBSTFA derivatized metabolites from
positionally labelled glucose experiments. A) citrate B) succinate C) glutamate. Values are av-
erages of 6 analytical replicate data sets. Error bars represent standard error between technical
triplicate datasets.
External threonine was not present in any of the strains indicating that all of the supplemented
threonine was being utilised by the cells.
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6.5 Model construction
The initial model used for simulation of positionally labelled glucose experiments was the same
as that used for the uniformly labelled glucose experiments except the pathway for conversion of
fructose-6-phosphate to ribulose-5-phosphate via arabino-hex-3-ulose-6-phosphate in the pen-
tose phosphate pathway was included, (Appendix B, Table B.3). This reaction is distinct from the
otherwise parallel pathway which converts glucose-6-phosphate to ribulose-5-phosphate in that
it is reversible. As all strains were undergoing fermentative growth, all reactions for fermentation
product synthesis and efflux relevant for each strain (Appendix B, Table B.2) were also included
in the metabolic models.
Input pools were changed so that there was no unlabelled glucose source but, [1-13C] glucose
was included, with a natural abundance of carbon-13 of 1.13 % as described in Chapter 5.
Uptake of [1-13C] glucose and [U-13C] glucose were included as separate reactions, the stoi-
chiometries of which were set to a 60:40 uptake ratio using net constraints.
Mass isotopomers of lactate, malate and succinate were extracted from GC-MS *.cdf files using
Matlab and corrected for naturally occurring isotopes using the MS Correction Tool [200] so that
the unlabelled biomass proportion from chemostat experiments could be included in the mass
isotopomers. To enable this, a list detailing the structures of the TBDMS derivatives / fragments
of lactate, malate and succinate was generated (Appendix A, Table A.4) and the metabolites
were corrected for the natural abundance of isotopomers. Metabolites were identified in GC-MS
chromatograms based on their details in the Fiehn Lib GC-MS metabolite library (Appendix A,
Table A.3.) [197].
6.6 Biomass composition and efflux rates
New biomass constraints were included in the models, which had been determined based on
biomass analysis carried out on each of the strains undergoing fermentative growth (S. Masaka-
palli, unpublished. Appendix E, Table E.2). For each strain biomass requirements were deter-
mined based on individual glucose uptake rates and the biomass produced during each cultiva-
tion (Table 6.1)
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Table 6.1: Biomass output for strains undergoing fermentative growth.
All units in µmoles per gram DCW per hour
Metabolite DL33 (wt) DL44 (∆ldh) DL66 (∆ldh∆pfl↑pdh)
Acetate1 2.827 2.745 3.606
Fructose-6-phosphate2 0.128 0.124 0.163
Glucose-6-phosphate3 0.230 0.223 0.293
Glyceraldehyde-3-phosphate 4 0.143 0.139 0.182
Ribose-5-phosphate 5 0.403 0.339 0.458
Ribulose-5-phosphate 0.047 0.046 0.060
Xylose-5-phosphate 0.211 0.205 0.269
Aspartate 0.466 0.389 0.539
Threonine 0.282 0.235 0.327
Isoleucine 0.286 0.239 0.331
Lysine 0.333 0.278 0.385
Glutamate 0.676 0.564 0.782
Proline 0.175 0.146 0.202
Arginine 0.192 0.160 0.223
Tyrosine + phenylalanine 0.261 0.218 0.302
Tryptophan 0.108 0.090 0.125
Serine 0.190 0.159 0.220
Glycine 0.428 0.357 0.495
Cysteine 0.113 0.094 0.131
Methionine 0.089 0.074 0.103
Alanine 0.540 0.450 0.625
Valine 0.395 0.329 0.457
Leucine 0.365 0.304 0.422
Histidine 0.082 0.068 0.095
1Includes efflux to fatty acids
2Includes efflux to mannose
3Includes efflux to galactose
4Includes efflux to glycerol
5Includes efflux to ribose to ribonucleic acids and deoxyribonucleic acids
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6.7 Isotopomer based metabolic flux analysis
Models were constructed and checked for syntax as detailed previously (Chapter 5). As also
stated previously, flux analysis was carried out using the inbuilt commands of 13CFLUX2 [148]
for simulations and statistical analysis. Monte Carlo simulations of the models constrained by the
biomass effluxes and mass isotopomer measurements were run to obtain the overall flux distri-
bution. The procedure involved varying the starting free flux values randomly using the ssampler
program followed by running multiple simulations from each set of starting free fluxes using the
multifit command. This ensured many simulations converged to low residuals that were able to
pass a χ2 test. Such simulations were considered to be the global best-fit flux solution. In any
simulations where the residual did not pass the χ2 cut off, the flux distribution was rejected as it
could have represented a local best-fit flux solution.
The mass isotopomer distribution of lactate was not included for isotopomer fitting due to over-
lap on the GC-MS chromatogram; lactate efflux detected by HPLC analysis was included as a
measured flux as part of the flux calculation. Ethanol efflux was set to be a free flux to enable
the inclusion of ethanol that had been lost through vaporisation and so not detected by the HPLC
analysis of the culture supernatant.
Following the initial calculation, some of the metabolite pools were pooled together to improve
the fitting and reliability of the calculated fluxes. High variability in the fluxes was seen between
the anaplerotic reactions, as was also found with the 20:80 [U-13C] glucose to [U-12C] glucose
feed ratio, and the two major pathways leading from glycolysis to the pentose phosphate via
gluconate-6-phosphate and arabino-hex-3-ulose, indicating the inability of the models to distin-
guish between these pathways (Appendix C, Fig. C.1). Consequently both the oxaloacetate
and malate, and phosphoenolpyruvate and pyruvate pools were combined and the three existing
anaplerotic reactions combined to a single reversible reaction between phosphoenol pyruvate /
pyruvate and oxaloacetate / malate. In addition the two pathways from glycolysis were combined
to a single reversible reaction. This resulted in greater confidence of the fluxes and additionally a
greater proportion of least square residuums of the observed and simulated values passed a χ2
test at a probability of 0.95 (Table 6.2).
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Table 6.2: Proportion of least square residuals of the observed and
simulated values passing χ2 test at a probability of 0.95
Strain Metabolite pools not
combined
Metabolite pools com-
bined
DL33 (wt) 78 / 100 98 /100
DL44 (∆ldh) 68 / 100 99 / 100
DL66 (∆ldh∆pfl↑pdh) 56 / 100 98 / 100
The final network model of reactions is shown in Appendix B, Table B.1 and components forming
the models for each strain are shown in Table 6.3
Table 6.3: Components of each model for strains under fermentative
growth on positionally labelled glucose
Component DL33 (wt) DL44 (∆ldh) DL66 (∆ldh∆pfl↑pdh)
Metabolite pools 53 51 51
Net Reactions 90 86 86
Xch Reactions 90 86 86
Free net reactions 16 15 15
Free xch reactions 18 18 18
Measured fluxes 7 5 5
GCMS metabolites 15 15 15
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6.8 Flux maps of G. thermoglucosidasius strains DL33 (wt),
DL44(∆ldh) and DL66 (∆ldh∆pfl↑pdh)
The in vivo flux distributions of G. thermoglucosidasius strains (DL33 (wt) Fig. 6.9; DL44 (∆ldh)
Fig 6.10; DL66 (∆ldh∆pfl↑pdh) Fig. 6.11) measured under fermentative conditions, were scaled
to a glucose uptake rate set at 100 and compared. Some notable differences in fluxes were
observed between the strains, particularly in the anaplerotic reactions and the TCA cycle. Gly-
colysis is largely unchanged between the three strains. Similarly the oxidative pentose phosphate
pathway was largely the same between the strains; however a greater standard deviation of flux
was observed in the engineered strains. Overall, the diversion of flux from glycolysis to the oxida-
tive pentose phosphate pathway was between 15 - 16 % for all strains. The non-oxidative branch
of the pentose phosphate pathway was more consistent between strains at around 5 % of flux
going through transketolase and transaldolase. Exchange flux through the oxidative branch of
the pentose phosphate pathway, from glucose-6-phosphate to ribulose-5-phosphate, for each
strain was low in both DL33 (wt) and DL66 (∆ldh∆pfl↑pdh) at a flux of 0.56 % ± 0.70 and 0.85
% ± 1.07 respectively indicating very little exchange from ribulose-5-phosphate via arabino-hex-
3-ulose-6-phosphate to glycolysis. In strain DL44 (∆ldh), the exchange flux through this reaction
was higher however at 9.42 % ± 3.03.
One of the most prominent differences between the strains was in the direction of anaplerotic
flux (Fig. 6.8). In DL33 (wt) net flux through the anaplerotic reactions was from malate / ox-
alacetate to pyruvate / phosphenolpyruvate, with a net flux of 8.42 % ± 1.52. In the engineered
strains however, the direction of net flux was reversed from phosphenolpyruvate / pyruvate to
malate / oxaloacetate, with a flux of 3.34 % ± 0.95 in DL44 (∆ldh) and 7.19 % ± 0.73 in DL66
(∆ldh∆pfl↑pdh). Due to the pooling of metabolites, it was not possible to distinguish which re-
action was responsible for the net flux calculated in each strain. For DL33 (wt) three reactions
carried out by two enzymes were able to work in the direction of the net flux calculated in this
strain, whilst for the engineered strains there were four possible reactions by three enzymes
which could be used (Table 6.4)
DL33 (wt) could be using phosphoenolpyruvate carboxykinase (PEPCK) in the direction of phos-
phoenolpyruvate, although this is unlikely as this reaction consumes ATP, or it could alternatively
be using the NADP-dependent malic enzyme (MEP) from either malate or oxaloacetate, which
is not ATP dependent but does reduce NADP+ to NADPH (from malate only). The engineered
strains could also be using either of these two enzymes as both carry out reversible reactions in
vivo. Additionally, G. thermoglucosidasius has a pyruvate carboxylase (PC), which operates in
the direction seen in the engineered strains: this reaction however requires the consumption of
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Figure 6.8: in vivo metabolic flux around the pyruvate node of G. thermoglucosidasius strains
A) DL33 (wt) B) DL44 (∆ldh) and C) (∆ldh∆pfl↑pdh) during fermentative growth. Abbreviations:
PEP, phosphoenolpyruvate; PYR, pyruvate; EtOH, ethanol; AcCoa, Acetyl CoA; MAL, malate;
OAA, oxaloacetate; CIT, citrate; ICT, isocitrate; n/d, flux not determined. Fluxes show averages
of multiple flux solutions passing χ2 at a 95 % confidence interval; ± indicates the standard
deviation of flux.
ATP and so would be an unlikely route for anaerobic flux when alternative routes are available.
There were substantial differences between the strains in flux through the TCA cycle. DL33 (wt)
had the highest flux of all the strains with an overall flux of 35 - 40 %. DL44 (∆ldh) TCA cycle
flux however was almost half that of the wild type strain, at approximately 18 - 22 % flux through
all TCA cycle reactions, with a corresponding loss of a large amount of carbon to the fermenta-
tion products ethanol and alanine as well as to acetate. In DL66 (∆ldh∆pfl↑pdh) TCA cycle flux
increased relative to DL44 (∆ldh) but is still lower than the wild type strain. Additional carbon to
the TCA cycle in DL66 (∆ldh∆pfl↑pdh) originated from increased flux through PDH, greater net
flux from the anaplerotic reactions to the TCA cycle and also an increased uptake of citrate from
the medium. Overall flux through TCA cycle reactions in DL66 (∆ldh∆pfl↑pdh) was between
approximately 22 - 31 %.
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Table 6.4: Anaplerotic reactions which function in the direction of observed net anaplerotic flux
in each strain
Strain Enzyme Reaction
DL33 (wt) Phopshoenolpyruvate car-
boxykinase (PEPCK) (EC
4.1.1.49)
OAA + ATP→ PEP + CO2 + ADP
Malic enzyme (MEP) (EC
1.1.1.40)
MAL + NADP+ → PYR + CO2 +
NADPH
OAA→ PYR + CO2
DL44 (∆ldh),
DL66 (∆ldh
Pyruvate carboxylase (PC)
(EC 6.4.1.1)
PYR + HCO3 + ATP→ OAA + ADP
∆pfl ↑pdh)
PEPCK PEP + CO2 + ADP→ OAA + ATP
MEP PYR + CO2 + NADPH → MAL +
NADP+
PYR + CO2 → OAA
Finally, flux through the glyoxylate cycle was low in each strain, although it was slightly lower
in strain DL66 (∆ldh∆pfl↑pdh) than strain DL33 (wt). Flux was calculated at 2.20 % ± 1.64,
1.90 % ± 0.85 and 0.30 % ± 0.41 for strains DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh)
respectively.
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Figure 6.9: In vivo fluxes of G. thermoglucosidasius strain DL33 (wt) during fermentative growth.
Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-bis-
phosphate; GAP, glyceraldehyde 3-phosphate; PGA, 2-phosphoglycerate; PEP/PYR, phospho-
enolpyruvate and pyruvate; EtOH, ethanol; AcCoA, Acetyl CoA; CIT, citrate; ICT, isocitrate; OGA,
oxoglutarate; SUC, succinate; FUM, fumarate; MAL / OAA, malate and oxaloacetate; Ru5P,
ribulose 5-phosophate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate; X5P, xylose 5-
phosphate; S7P, sedoheptulose 7-phosphate; n/d, flux not determined. Pyruvate / phosphe-
nolpyruvate and malate / oxaloacetate pools and the fluxes between them were indistinguish-
able. Flux from glucose-6-phosphate to ribulose-5-phosphate includes net flux from fructose-6-
phosphate to ribulose-5-phosphate via arabino-hex-3-ulose-6-phosphate. Main values are the
average of 96 simulations for which the least squares residual of simulated and measured values
is below χ2 at a 95 % confidence interval ± indicates standard deviation of flux.
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Figure 6.10: In vivo fluxes of G. thermoglucosidasius strain DL44 (∆ldh) during fermentative
growth. Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-
bis-phosphate; GAP, glyceraldehyde 3-phosphate; PGA, 2-phosphoglycerate; PEP/PYR, phos-
phoenolpyruvate and pyruvate; EtOH, ethanol; AcCoA, Acetyl CoA; CIT, citrate; ICT, isocitrate;
OGA, oxoglutarate; SUC, succinate; FUM, fumarate; MAL / OAA, malate and oxaloacetate;
Ru5P, ribulose 5-phosophate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate; X5P, xylose
5-phosphate; S7P, sedoheptulose 7-phosphate; n/d, flux not determined. Pyruvate / phosphe-
nolpyruvate and malate / oxaloacetate pools and the fluxes between them were indistinguish-
able. Flux from glucose-6-phosphate to ribulose-5-phosphate includes net flux from fructose-6-
phosphate to ribulose-5-phosphate via arabino-hex-3-ulose-6-phosphate. Main values are the
average of 100 simulations for which the least squares residual of simulated and measured val-
ues is below χ2 at a 95 % confidence interval ± indicates standard deviation of flux.
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Figure 6.11: In vivo fluxes of G. thermoglucosidasius strain DL66 (∆ldh∆pfl↑pdh) during
fermentative growth. Abbreviations: G6P, glucose 6-phosphate; F6P, fructose 6-phosphate;
FBP, fructose 1,6-bis-phosphate; GAP, glyceraldehyde 3-phosphate; PGA, 2-phosphoglycerate;
PEP/PYR, phosphoenolpyruvate and pyruvate; EtOH, ethanol; AcCoA, Acetyl CoA; CIT, citrate;
ICT, isocitrate; OGA, oxoglutarate; SUC, succinate; FUM, fumarate; MAL / OAA, malate and ox-
aloacetate; Ru5P, ribulose 5-phosophate; R5P, ribose 5-phosphate; E4P, erythrose 4-phosphate;
X5P, xylose 5-phosphate; S7P, sedoheptulose 7-phosphate; n/d, flux not determined. Pyruvate
/ phosphenolpyruvate and malate / oxaloacetate pools and the fluxes between them were in-
distinguishable. Flux from glucose-6-phosphate to ribulose-5-phosphate includes net flux from
fructose-6-phosphate to ribulose-5-phosphate via arabino-hex-3-ulose-6-phosphate. Main val-
ues are the average of 83 simulations for which the least squares residual of simulated and
measured values is below χ2 at a 95 % confidence interval ± indicates standard deviation of
flux.
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6.9 Discussion
As discovered with the [U-13C] glucose experiments, the supplemented amino acids and their
direct metabolic descendants, whilst having large M+0 weights in their mass isotopomer distribu-
tions, still contained a substantial proportion of carbon-13 labelling, indicating that these amino
acids were still being synthesised de novo from central carbon metabolism. Histidine showed
the greatest variation of all the amino acids between triplicate samples, which may be due to the
relatively low intensity of this metabolite on GC-MS chromatograms. Recent developments in the
protocol used in this study have been carried out to improve histidine resolution which would aid
any future studies [225]. Mass isotopomer distributions of external citrate indicate that during
fermentative growth this metabolite is taken up from the medium and is not exported from the
cell. Interestingly, the mass isotopomer distributions of external serine and glutamate contained
labelled carbon indicating that these amino acids were not only being synthesised but also se-
creted from the cell. The amount that was secreted was probably very small however, as total
serine and glutamate concentration in the medium was very low, as measured in Chapter 4.
The calculated flux distributions here using 60 % [1-13C] glucose with 40 % [U-13C] glucose dif-
fered considerably from those obtained using a labelled feed mix of 20 % [U-13C] glucose with
80 % [U-12C] glucose, shown in Chapter 5, highlighting the importance of using a labelled feed
mixture that is able to accurately resolve the pathways in the metabolic network. Additionally,
carrying out multiple simulations from different starting fluxes in the current analysis resulted in
a robust analysis. It is possible that the previous lack of multiple simulations and uncertainties
in many fluxes prevented identification of the need to combine the pyruvate / phosphoenolpyru-
vate and malate / oxaloacetate metabolite pools and combine parallel reactions in the pentose
phosphate pathway. In light of this, calculated fluxes obtained by simulations of single starting
fluxes were insufficient to accurately determine the physiological state of the cell. Furthermore,
the application of biomass measurements in this chapter which were taken from the same strains
and growth conditions as the isotopomer data will have further aided the analysis. Finally, in the
analysis described in this chapter, the efflux of ethanol from the cell was set as a free flux, so that
flux through this pathway would represent both the measured ethanol in the external cell culture
medium and any ethanol that had been lost through vaporisation. In contrast, in the previous
chapter, ethanol efflux was included as a measured flux. A result of this is that the total ethanol
efflux and also the flux through the TCA cycle were substantially different in this analysis than
in the previous one. Using 20 % [U-13C] glucose with 80 % [U-12C] glucose, the TCA cycle flux
was higher in the engineered strains; when accounting for the evaporation of ethanol however,
the flux through the TCA is actually lower in the engineered strains.
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The combining of the phosphoenol pyruvate / pyruvate and malate / oxaloacetate pools carried
out in this study has prevented the resolution of individual anaplerotic reactions, pyruvate kinase
and malate dehydrogenase but has enabled the determination of an overall flux solution for the
cell and removed the problem found using the 20:80 [U-13C] glucose to [U-12C] glucose feed
ratio, in which the anaplerotic reactions were not suitably resolved. This combined approach has
been reported previously in 13C-MFA studies of microbial cells [85, 107, 115]. Feeding with other
positionally labelled isotopes may enable the resolution of these reactions.
The final flux solutions indicated that all strains had a similar flux through glycolysis, the pentose
phosphate pathway and the glyoxylate cycle. The most pronounced differences were in the direc-
tion of net anaplerotic flux and TCA cycle fux. In the wild type strain the anaplerotic reactions had
a net flux to phosphoenolpyruvate and pyruvate, whilst in the engineered strains they exhibited a
net flux to oxaloacetate and malate. In the TCA cycle, flux was greatest in DL33 (wt), lowest in
DL44 (∆ldh), and between the other two strains in DL66 (∆ldh∆pfl↑pdh).
Differences in anaplerotic flux as a result of alterations to fermentation pathways have been pre-
viously reported [115]. Becker et al. demonstrated an increase in flux through PEPCK to malate /
oxaloacetate in a Basfia succiniciproducens (∆ldh∆pfl) double mutant relative to a (∆ldh) single
mutant. In the same study, the wild type strain was found to address an NADH imbalance by flux
through MEP to pyruvate, which was not seen in the engineered strains. This could account for
the apparent difference in the net direction of flux between the wild type and engineered strains
seen in this study. Furthermore, the higher flux through PEPCK in this study could be the basis
for the increased efflux of acetate and succinate in the engineered strains.
There are two potential mechanisms which could have caused flux in the engineered strains to
divert through PEPCK or MEP rather than using PDH / PFL. Disruption of the ldh gene was likely
to have increased the metabolite pools of pyruvate and phosphenolpyruvate, which is evident in
DL44 (∆ldh) from the greater efflux of pyrvuate to the external medium (Fig. 6.1 F): this would
provide an increased substrate pool for PEPCK / MEP to function in the direction of oxaloac-
etate / malate. However, if this was the case, flux through the anaplerotic reactions should have
decreased with up regulation of expression of the pdh gene, as this should increase flux from
pyruvate (Fig. 6.10) but this was not seen here, with flux through the anaplerotic reactions in-
creasing in DL66 (∆ldh∆pfl↑pdh) relative to DL44 (∆ldh). Therefore it may be that flux through
either of these enzymes was regulated by a balancing of cofactors, as PEPCK regenerates ATP
and MEP regenerates NADP+ in the direction of oxaloacetate / malate.
The flux through the TCA cycle was reduced in the engineered strains compared to the wild type.
157
Strain DL44 (∆ldh) had the lowest TCA cycle flux; in strain (∆ldh∆pfl↑pdh) this had recovered
to some extent but is still below that of the wild type. This suggests that in the engineered strains,
NAD+ availability may be hindering TCA cycle flux. A low flux through the TCA cycle may also
limit the availability of metabolic precursors and be a source of metabolic stress for the strains.
The fluxes calculated here with the use of positionally labelled glucose in the wild type strain DL33
(wt) were comparable to those calculated for G. thermoglucosidasius wild type strain M10EXG
grown under micro-aerobic conditions carried out by Tang et al. [190] in terms of flux through
the pentose phosphate pathway, glycolysis and the net direction of flux through the anaplerotic
reactions. There was a difference however in flux through the TCA cycle, as the flux observed
in the current study was almost two fold greater through some reactions than the previous study.
This however is likely to be a direct consequence of differences in the amount of carbon that
were diverted to fermentation products in each strain, which in turn depends on specific aeration
conditions. In addition, Tang et al. found that flux through the glyoxylate cycle was comparatively
high and, as a result, flux through isocitrate dehygrogenase and OGDC was reduced, whilst
in the current study the opposite was found to be true. There is no immediate explanation for
this difference and whilst it may reflect slightly different growth conditions between the strains
and differences in the isotopic substrates (60 % [1-13C] glucose 40 % [U-13C] glucose in the
present study compared to 100 % [1-13C] glucose by Tang et al.). It would be advantageous
to determine the validity of this discrepancy which could be through the application of transcrip-
tomic, proteomic and metabolomic studies. RNA-seq analysis carried out at the University of
Bath (unpublished) revealed that in G. thermoglucosidasius strain NCIMB 11955 (wt) growing
anaerobically, expression of the isocitrate lyase gene was 16.7 RPKM, whilst expression of the
oxoglutarate dehydrogenase E1 component was 102.1 RPKM, suggesting that the flux calcu-
lated in the present study may be closer to physiological conditions. However, other factors may
influence flux, in addition to the transcript level of the enzymes, such as the influence of post-
translational modifications and enzyme kinetics.
In this chapter the use of positionally labelled isomers of glucose has enabled the calculation
of flux distribution across the network of central metabolism of G. thermoglucosidasius using
global isotopomer balancing, whilst accounting for the affects of unlabelled amino acids on mass
isotopomer distributions. The calculated fluxes have been obtained through use of a multiple
simulation approach, which has enabled the comparative analysis of wild type with engineered
strains.
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7Transcriptomic analysis of Geobacillus
thermoglucosidasius
7.1 Introduction
A frequent approach in systems biology studies is to combine investigations on multiple levels
of biological hierarchy [16, 21, 27, 45, 74, 226, 227]. This combined approach can be used
to verify and provide further insight into targets for metabolic engineering. For example Shi et
al. identified down regulated genes in a riboflavin producing strain of B. subtilis as targets for
engineering, which was confirmed by metabolomic data showing a low concentration of the ac-
tivator of the operon of the associated genes [21]. Additionally, different approaches can also
be complementary to one another by revealing different aspects of metabolism. For example in
a study by Hanke et al., 13C-metabolic flux analysis and transcriptomic data were both able to
identify an increase in the pentose phosphate pathway activity of Gluconobacter oxydans during
its second growth phase but transcriptomic studies also highlighted the expression of possible
stress response genes during the same phase [226]. Thus multiple systems biology approaches
can have an additive effect on the understanding of metabolism. This chapter therefore aimed
to extend the study of metabolism of Geobacillus thermoglucosidasius to include transcriptomic
analysis using high-throughput sequencing (RNA-seq).
As RNA-seq seeks to quantify cell wide gene expression, it is important to maintain the integrity
of the RNA transcripts. RNA is continually degraded in the cells by RNase enzymes as a means
of controlling protein expression; in bacterial cells, the typical half-life of mRNA ranges from less
than a minute to an hour [228]. Consequently, RNA that is being extracted for analysis from the
cell can have its integrity compromised by both exogenous and endogenous RNases. A study by
Gallego-Romero et al. on the effects of RNA sample degradation on gene expression profiling
by RNA-seq found that whilst all transcripts could still be detected in degraded samples, the rate
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of degradation was not universal across the transcripts and thus the measured differential gene
expression levels can be altered from their physiologically relevant levels by RNA degradation
[229]. It is therefore paramount in RNA-seq that the integrity of RNA samples is maintained in
order for the measured transcript expression levels to accurately reflect those in the cell.
It has been noted that extraction of RNA from thermophiles can be complicated due to the
RNases in these species having higher catalytic rates and being more resistant to denaturation
compared to mesophilic RNases [192, 230, 231]. A study conducted by Brown et al. [231] found
the maximum catalytic rates for RNases from Thermus aquaticus and Thermotoga maritima to
be 3.1 x 108 M-1 min-1 and 2.2 x 108 M-1 min-1 respectively, whilst for E. coli it was calculated at
0.75 x 108 M-1 min-1; furthermore, in the same study, perhaps unsurprisingly, it was found that
the thermophilic RNases were more far more resistant to heat denaturation that their mesophilic
counterparts.
Whilst high throughput transcriptome profiling (RNA-seq) has been carried out in the thermophilic
fungi Myceliophthora thermophila and Thielavia terrestris [232], to date there have been no re-
ports of the technique being applied to thermophilic bacteria. It has been found that extraction
and analysis of RNA from G. thermoglucosidasius is hindered by problems of degradation as
noted in other thermophilic bacteria [192]. Sharkey et al. published a protocol to address the
problem of RNA extraction in G. thermoglucosidasius; whilst this protocol has been applied to
transcriptome analysis using qRT-PCR, to date it has not been used for either microarray or RNA-
seq studies.
7.2 Extraction of RNA from G. thermoglucosidasius
In a previous study, RNA has been extracted from G. thermoglucosidasius strains using the
RNeasy Bacteria Mini Kit, (Qiagen, Crawley, UK) which provided RNA of sufficient yield and
quality for qRT-PCR [189]. This method excludes all RNA molecules less than 200 nucleotides
long [233], so the sample will be enriched for mRNA but will exclude many small RNA (sRNA)
molecules from the analysis, the expression of which can be related to control of transcription
and can provide information in addition to coding sequence expression.
Several other commercial kits have been developed for the extraction of bacterial RNA for tran-
scriptomic analysis. Thus, in order to avoid the exclusion of sRNA, the ability of the RNeasy
Bacteria Mini Kit (Qiagen, Crawley, UK) to extract intact RNA from G. thermoglucosidasius was
compared with two further commercial kits, the Ribopure Bacteria kit (Ambion, Paisley, UK) and
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the mirVana miRNA Isolation kit (Ambion, Paisley, UK), which enriches the extracted RNA for
sRNA molecules.
Extraction with each kit was carried out using a day culture of G. thermoglucosidasius strain
NCIMB 11955 (wt), as the DL33 (wt) genome sequence was not available for the alignment of
sequenced reads at the commencement of these experiments. Extraction was carried out as
described in Section 2.4.7 and the RNA analysed as described in Section 2.4.9 using a Biorad
Experion System. For each kit the RNA was stabilised in the culture prior to extraction using
RNAprotect Bacteria Reagent (Qiagen, Crawley, UK) according to the manufacturer’s instruc-
tions. Initial use of mirVana miRNA Isolation kit (Ambion, Paisley, UK) according to the manufac-
turer’s instructions did not produce any RNA from G. thermoglucosidasius but a tenfold increase
in miRNA homogenate (reagent supplied with the kit) and the addition of excess acid-chloroform-
phenol solution successfully extracted some RNA.
Each kit gave RNA which produced discernible bands on the Experion analyser, for the 23S
and 16S bacterial ribosomal RNA subunits, the Ambion mirVana miRNA Isolation kit also pro-
duced a visible 5S rRNA fraction (Fig. 7.1). Analysis of the 23S to 16S ratios (a measure of
the degradation of the RNA, with a ratio of 2.0 being optimal) of the RNA produced by the kits
(Table 7.1) shows that whilst integrity of the RNA was highest using the Qiagen RNeasy Bac-
teria Mini Kit (Qiagen, Crawley, UK), with the Ribopure Bacteria kit (Ambion, Paisley, UK) this
remained reasonably high at 1.52, and the mirVana miRNA Isolation kit (Ambion, Paisley, UK)
had a comparatively low ratio of 1.12. Both the Ribopure Bacteria kit (Ambion, Paisley, UK)
and mirVana miRNA Isolation kit (Ambion, Paisley, UK) gave lower RNA yields than the Qiagen
RNeasy Bacteria Mini Kit (Qiagen, Crawley, UK); however, yield with the Ribopure Bacteria kit
(Ambion, Paisley, UK) could be increased by extending the lysis time. In light of these results,
the Ribopure Bacteria kit (Ambion, Paisley, UK) was chosen for further RNA extraction due to its
ability to co-purify sRNA without impacting markedly on the integrity of the RNA.
Table 7.1: Comparison of kits for extraction of RNA from G. thermoglucosidasius strain NCIMB
11955 (wt)
Kit Ratio
[23S/16S]
Yield [ng /
µl]
Compatibility with RNA-
seq
Ambion RiboPure - Bacte-
ria kit
1.52 91.82 Compatible.
Ambion mirVana miRNA
Isolation kit
1.12 181.35 Compatible.
Qiagen RNeasy Bacteria
Mini Kit
1.77 716.74 Compatible for sequencing
of transcripts greater than
200 nts only.
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Figure 7.1: Comparison of commercial kits for extraction of RNA from G. thermoglucosidasius
NCIMB 11955 (wt) for RNA-seq analysis. Lane L: ladder. Extractions of RNA carried out using
Ambion RiboPure kit (Lane 1); Ambion mirVana miRNA Isolation kit (Lane 2); Qiagen RNeasy
Bacteria Mini Kit (Lane 3). Bands at 3000 and 1500 bases represent the 23S and 16S ribosomal
subunits respectively. RNA visualised using Biorad Experion System.
In order to optimise the time of extraction of RNA from the culture using the Ribopure Bacteria
kit (Ambion, Paisley, UK), batch cultures of NCIMB 11955 (wt) were grown in shake flasks and
RNA extracted in triplicate samples at 3, 4 and 5 hours post inoculation (Fig. 7.2 and Table 7.2).
The 23S / 16S ratios of the samples varied noticeably between triplicate samples, particularly at
3 and 5 hours post inoculation. Four hours post inoculation showed, on average, the least degra-
dation of the samples and the least variability between triplicate samples and thus was used as
the optimal sample time.
Table 7.2: Time course of RNA extractions from G. thermoglucosidasius NCIMB 11955 (wt) in
batch culture using the Ambion RiboPure Bacteria kit. Hours indicating time past inoculation of
culture.
Hours OD 600 nm (AU) Ratio [23S/16S] (triplicate samples)
3 0.765 1.70 1.38 1.97
4 2.397 2.09 2.03 1.77
5 3.097 1.40 1.39 0.96
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Figure 7.2: Time course of RNA extractions from G. thermoglucosidasius NCIMB 11955 (wt) in
batch culture using Ambion RiboPure Bacteria kit. Lane L: Ladder. Extractions carried out at
3 hours (lanes 1-3), 4 hours (lanes 4-6) and 5 hours (lanes 7-9) after inoculation of the culture.
Bands at 3000 and 1500 bases represent the 23S and 16S ribosomal subunits respectively. RNA
visualised using Biorad Experion System.
In order to a) verify that the chosen RNA extraction method was able to produce a cDNA library
which in turn, could be sequenced and mapped against the genome sequence and to b) provide
an overview of the expressed transcripts a composite sample of RNA was made consisting of
RNA extracted from cultures grown under different growth conditions and on different media. The
conditions were chosen to give an overview of transcripts within the cell prior to the investigation
of RNA samples which relate to the condition used in 13C-MFA.
Strain NCIMB 11955 (wt) was cultured under four different conditions for four hours and extracted
using Ribopure Bacteria kit (Ambion, Paisley, UK) (Fig 7.3 and Table 7.3). The four conditions
were as follows: 1) rich medium (TGP), aerobic growth 2) minimal medium (ASM with 0.5 %
glucose, 12µM thiamine, 953 µl glutamate, 428 µl serine, 336 µl threonine), aerobic growth 3)
rich medium (TGP), micro-aerobic growth, 4) minimal medium (ASM with 0.5 % glucose, 12 µM
thiamine, 953 µl glutamate, 428 µl serine, 336 µl threonine, 0.1 % yeast extract, 0.1 % tryptone),
micro-aerobic growth. The external medium of all strains was analysed by HPLC to check for
the presence of fermentation products. Only cells grown in the minimal medium-micro-aerobic
condition produced detectable levels of lactate, indicating that the culture was undergoing fer-
mentative metabolism. Notably, degradation of the RNA was more pronounced in cells grown
under the micro-aerobic conditions with both media types, as indicated by the 23S/16S ratios
falling from 1.60 and 1.50 to 1.26 and 1.29 from aerobic to micro-aerobic conditions respec-
tively. Likewise, the 23S/16S ratio was slightly reduced using minimal medium compared to rich
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medium. Both of these suggest that degradation of the RNA was more pronounced when the
strain was growing under conditions which increase metabolic stress.
Figure 7.3: RNA extracted from G. thermoglucosidasius strain NCIMB 11955 (wt) in batch cul-
ture under four different conditions for composite sample for RNA-seq analysis. Lane L: ladder.
Strain NCIMB 11955 (wt) cultured in 1) rich medium, aerobic growth (lane 1) 2) minimal medium,
aerobic growth (lane 2) 3) rich medium, micro-aerobic growth (lane 3), 4) minimal medium, micro-
aerobic growth (lane 4). Bands at 3000 and 1500 bases represent the 23S and 16S ribosomal
subunits respectively. RNA visualised using Biorad Experion System.
Table 7.3: Preliminary RNA extracted for sequencing as a composite sample from G. thermoglu-
cosidasius strain NCIMB 11955 (wt) in batch culture using Ambion RiboPure bacteria kit
Culture condition OD 600 nm
(AU)
RNA yield
(ng µl-1)
Ratio
[23S/16S]
HPLC analysis
Rich, aerobic 1.943 530.19 1.60 No detectable fer-
mentation products
Minimal, aerobic 0.733 587.98 1.50 < 1 mM acetate
Rich, micro-aerobic 0.542 302.08 1.26 No detectable fer-
mentation products
Minimal, micro-
aerobic
0.533 321.47 1.29 < 1 mM acetate, 3
mM lactate
The RNA extracted from the four conditions was combined to make a composite sample for
sequencing, the total RNA taken from each condition was normalised so that the relative con-
centration of each of the four conditions in the composite sample was equal. The samples were
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converted to cDNA, ribodepleted and sequenced on a SOLiD platform at the Deep Seq facility at
the University of Nottingham. The cDNA libraries were size-selected for RNA molecules of 110
bp and over so mRNA and most sRNA were included in the sequencing. Sequencing was car-
ried out to a depth of approximately 0.3 gigabases. QC of the composite sample carried out by
DeepSeq (Fig. 7.4) on an Agilent Bioanalyzer assessed the integrity of the RNA by RNA integrity
number (RIN) at 7.7.
Figure 7.4: QC of composite RNA sample carried out by DeepSeq at the University of Nottingham
on an Agilent Bioanalyzer.
Sequencing of the composite sample produced 26,231,160 raw reads, of which only 5.06 %
could be mapped to the reference genome of the strain. It was not found possible to establish
unequivocal the reason such a low number of reads mapping to the genome. A de novo assembly
of the sequenced reads, when aligned against genome sequences in the NCBI database using
BLAST produced Geobacillus species as the species with the greatest alignment, reducing the
likelihood of the lack of alignment to the G. thermoglucosidasius genome being due to a contam-
ination event. It is possible that the lack of alignment therefore could have been caused by degra-
dation of the sample which has resulted in transcripts not being reliable reassembled from the
sequenced reads. Attempts were made to reproduce the composite sample for re-sequencing,
however RNA integrity was highly variable and it did not prove possible to consistently extract
RNA in the volume required for sequencing (20 µg), using the Ambion RiboPure Bacteria kit,
which was not substantially degraded in any growth condition. A more reliable means of extract-
ing RNA from Geobacillus spp. was therefore sought that would be compatible with RNA-seq
analyses, particularly where experimental conditions may dictate that the cell was already under
metabolic stress and thus RNA integrity could inherently be compromised.
The strain investigated was changed to G. thermoglucosidasius strain DL33 (wt) due to newly
availably genome sequence information for this strain and a greater applicability of this strain to
13C-MFA experiments.
In a search for alternative methods, it was not possible to extract any RNA, degraded or otherwise
from cultures of G. thermoglucosidasius grown at 55 °C using the protocol published by Sharkey
et al. [192]. Even if this had been successful, it would not have been applicable to studies of G.
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thermoglucosidasius as the authors found it to be only useful for cultures grown at temperatures
of up to 55 °C. A great deal of work with Geobacillus spp. is carried out at 60 - 70 °C, including
the 13C metabolic flux analysis carried out in the present study, and accordingly, a technique
was required that could enable transcriptional data to also be gained from studies carried out at
higher temperatures.
The triisopropylnapthalene (TNS) - p-4-aminosalicyclic acid (PAS) buffer used in the protocol
published by Sharkey et al. is reported to be more effective at denaturing thermophilic RNAses
[192]. To test this, the denaturation buffer was included at a range of concentrations in the lysis
step of extraction using the Ambion Ribopure Bacteria Kit (Fig. 7.5. Table 7.4). Strain DL33 (wt)
was grown in shake flasks aerobically in TGP medium, TNS-PAS buffer was included at the lysis
step at volumes of 0 µl, 10 µl, 20 µl, 40 µl, 100 µl, 300 µl, 500 µl, 700 µl and 1 ml. However,
all RNA extracted was of poor quality and high quantities of TNS-Buffer (40 µl and above) had a
detrimental effect on the RNA. At 10 µl and 20 µl there was a slightly higher 23S/16S ratio than
without the inclusion of TNS-PAS buffer, however, as the difference was minimal and the RNA
was still somewhat degraded, this was inconclusive.
Figure 7.5: Extraction of RNA from G. thermoglucosidasius strain DL33 (wt) using TNS-PAS
buffer in the Ambion RiboPure Bacteria kit lysis step. L: ladder. volume of TNS-PAS buffer
included 1: 0 µl, 2: 10 µl, 3: 20 µl, 4: 40 µl, 5: 100 µl, 6: 300 µl, 7: 500 µl, 8: 700 µl, 9: 1
ml. Bands at 3000 and 1500 bases represent the 23S and 16S ribosomal subunits respectively.
RNA visualised using Biorad Experion System.
As the inclusion of TNS-PAS as an RNase denaturant did not noticeably aid the extraction of
intact RNA, a hot phenol method was attempted for RNA extraction. The method published by
Atshan et al. [193] uses an initial denaturation and extraction of RNA in hot phenol followed by
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Table 7.4: Extraction of RNA from G. thermoglucosidasius strain DL33 (wt) using TNS-PAS
buffer in the lysis step of Ambion RiboPure bacteria kit.
Volume of TNS-PAS
buffer (µl)
[RNA] (ng/µl) Ratio
[23S/16S]
0 173.73 0.35
10 134.45 0.37
20 35.88 0.43
40 82.67 0.34
100 116.27 0.28
300 115.04 0.17
500 116.23 0.26
700 84.77 0.21
1000 63.00 0.13
purification using the RNeasy Bacteria Mini Kit (Qiagen, Crawley, UK).
An extraction carried out on aerobically grown strain DL33 (wt) in rich medium (TGP) showed two
distinct bands on an agarose gel representing 23S and 16S rRNA subunits (Fig. 7.6). In light of
this, the method was extended to cultures grown on different carbon sources and under different
levels of aeration and analysed using a Biorad Experion System (Fig. 7.7 and Table 7.5). All
cultures were grown in batch in centrifuge tubes at 55 °C, with the exception of one culture which
was grown in a small chemostat set up as described in Section 2.3.2.2 at an aeration level of
0.5 vvm of compressed air. Substantial variability can be seen in the level of degradation of the
RNA, with the micro-aerobic samples being more degraded than the aerobic, suggesting again
that the rate of degradation of the RNA is related to the level of metabolic stress exerted on the
cell. Overall the amount of degradation of the RNA extracted using this technique was higher
than found with commercial RNA extraction kits. Additionally, the yield of RNA using this method
was highly variable, ranging between 9 ng µl-1 and 335 ng µl-1.
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Figure 7.6: Extraction of RNA from aerobically grown G. thermoglucosidasius strain DL33 (wt)
using the hot phenol method [193]. Lane 1 and 2 show duplicate extractions with the exception
that the yield in sample 1 was increased by incubating the elution buffer on the sample column
at room temperature for 1 minute prior to elution. RNA analysed on 0.8 % agarose gel.
Figure 7.7: Extraction of RNA from G. thermoglucosidasius strain DL33 (wt) using the hot phenol
method [193]. Lane L: ladder. Lanes 1-8 conditions as described in Table 7.5. Bands at 3000
and 1500 bases represent the 23S and 16S ribosomal subunits respectively. RNA visualised
using Biorad Experion System.
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Table 7.5: Extraction of RNA from G. thermoglucosidasius strain DL33 (wt) grown on different
carbon sources and under aerobic and micro-aerobic aeration using the hot phenol method [193].
Lane Carbon
source
medium com-
position
aeration [RNA] (ng/µl) Ratio [23S/16S]
1 Glycerol rich aerobic 56.50 0.89
2 Glucose minimal micro-
aerobic
(chemostat)
18.81 0.36
3 Xylose minimal aerobic 353.44 0.51
4 Succinate minimal aerobic 178.76 0.68
5 Glucose minimal aerobic 143.17 0.66
6 Xylose minimal aerobic 37.89 0.67
7 Glucose minimal aerobic 27.46 1.01
8 Glycerol rich aerobic 41.90 0.79
9 Succinate minimal aerobic 9.03 0.77
10 Glycerol rich micro-
aerobic
(centrifuge
tube)
83.55 1.25
7.3 RNA-seq of wild type G. thermoglucosidasius
In light of the difficulty in extracting consistently high quality RNA from G. thermoglucosidasius a
sample was taken from strain DL33 (wt) growing aerobically in rich medium (TGP) and extracted
using the Qiagen RNeasy Bacteria Mini Kit, as this kit has previously been used in qRT-PCR
studies of G. thermoglucosidasius [189]. These conditions were the least metabolically demand-
ing for the cell and thus likely to produce the least degraded RNA and the most reliable results.
The data obtained from this sample was nevertheless limited both in terms of the loss of sRNA
and the diversity of the transcripts due to the use of a rich medium and high aeration condition.
Table 7.6: RNA extracted from aerobically grown G. thermoglucosidasius strain DL33 (wt) using
the Qiagen RNeasy Bacteria Mini Kit for RNA-seq. Lane L: ladder, lanes 1 and 2: duplicate
samples of DL33 (wt) RNA.
Lane [RNA] (ng/µl) Ratio
[23S/16S]
1 99.92 1.16
2 344.35 1.23
Duplicate samples were extracted from DL33 (wt) and 23S/16S ratios for the duplicate samples
were measured at 1.16 and 1.23 (Fig. 7.8 and Table 7.6). Whole transcriptome sequencing of
the RNA was carried out using a SOLiD sequencer at the DeepSeq facility at the University of
Nottingham as stated previously. QC of the RNA sample carried out by DeepSeq, measured the
RIN at 9.9 (Fig. 7.9).
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Figure 7.8: RNA extracted from aerobically grown G. thermoglucosidasius strain DL33 (wt) using
the Qiagen RNeasy Bacteria Mini Kit for RNA-seq. Lane L: ladder, lanes 1 and 2: duplicate
samples of DL33 (wt) RNA. Bands at 3000 and 1500 bases represent the 23S and 16S ribosomal
subunits respectively. RNA visualised using Biorad Experion System.
Figure 7.9: QC of RNA extracted from aerobically grown G. thermoglucosidasius strain DL33
(wt) carried out by DeepSeq at the University of Nottingham on an Agilent Bioanalyzer.
Of 25,472,657 sequenced reads, 68.33 % were mapped to the the DL33 (wt) genome post fil-
tering, of which 93.48 % were uniquely mapped. The DL33 (wt) annotated genome sequence
described in Chapter 3 contained 4,213 genes, whilst the sequenced transcriptome showed that
549 of these had no expressed transcripts in the sequenced sample. A proportion of these genes
that were not being expressed could be accounted for by the growth conditions of the cell at the
time of sampling. For example, as the carbon source was glycerol, 6-phosphofructokinase had
no expressed transcripts; this would not have been the case if the carbon source was glucose.
It is also possible that some non-expressed transcripts represent mis-annotations in the genome
sequence.
Expression is measured in reads per kilo base per million reads (RPKM) [234]. The RPKM mea-
sure of expression is a standardised term in RNA sequencing analysis which normalises the
number of reads aligned against the genome for the length of the transcript and sample concen-
tration [234]. This prevents longer transcripts being calculated as having higher expression levels
simply due to a greater length of genome coverage and the RNA concentration in the sample un-
duly affecting the total expression counts. Thus gene expression levels can be compared both
170
within and between data sets.
Table 7.7: Transcripts exhibiting the highest expression levels in G. thermoglucosidasius strain
DL33 (wt) under aerobic growth. The table shows all genes where transcripts accounted for over
1 % of total RPKM.
Rank Description RPKM % of RPKM
1 Hypothetical protein 45956 9.75
2 Transcriptional regulator, DeoR
family
23292 4.94
3 Acetaldehyde dehydrogenase,
ethanolamine utilization cluster
21590 4.58
4 Hypothetical protein 9537 2.02
5 Hypothetical protein 9294 1.97
6 DNA-binding protein HBsu 6771 1.44
7 Phosphoesterase 5694 1.21
8 Alkyl hydroperoxide reductase
subunit C-like protein
4745 1.01
Eight transcripts had expression levels that were greater than 1 % of total expression (Table 7.7);
together these eight transcripts accounted for over a quarter of all RNA expressed within the cell.
The most expressed transcript, at 9.75 % of all expression, was a nucleotide sequence of 153
bases in length, annotated as a hypothetical protein in the DL33 (wt) genome sequence. Neither
the nucleotide sequence nor the translated protein sequence had homology to any known gene
or protein sequence when aligned to sequences in the NCBI databases using the blast or blastp
algorithms. Likewise, the fourth and fifth most expressed transcripts also encoded hypothetical
proteins with no homology to a known protein. A notable feature of these three highly expressed
and unidentified transcripts was their length, being just 153, 141 and 153 each. This suggests
that they were likely to represent sRNA sequences which have a regulatory function within the
cell.
The remaining five highly expressed transcripts were identifiable by their nucleotide sequences
as encoding: a DeOR family transcriptional regulator; acetaldehyde dehydrogenase; a DNA bind-
ing protein, HBsu, which has previously been identified as essential for growth in Bacillus subtilis
[235]; a phosphatase; and an alkyl hydroperoxide reductase subunit, which is used in the cell
for protection against reactive nitrogen intermediates [236]. Having high expression levels, these
represent a possible source of strong promoters which could be useful when added to the tools
available for metabolic engineering of G. thermoglucosidasius.
Due to their applicability to the 13C-MFA investigations carried out in this study, the expression
levels of enzymes carrying out the major reactions of central carbon metabolism were looked
at in detail. The enzymes of glycolysis (Fig. 7.10), showed varying gene expression levels as
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glycerol constituted the major carbon source: glucokinase (gk ), glucose-6-phosphate isomerase
(pgi), 6-phosphofructokinase (pfk ), enolase (eno) and pyruvate kinase (pyk ) all had relatively low
expression. It is notable that the NAD+ dependent glyceraldehyde-3-phosphate dehydrogenase
(gap) gene was predominantly expressed over its NADP+ dependent counterpart.
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Figure 7.10: Gene expression levels in glycolysis and gluconeogenesis. Metabolites are shown
in capitals, gene transcripts are shown in boxed, italicised script. Gene abbreviations: glk,
glucokinase; pgi, glucose-6-phosphate isomerase; fbp1, fructose-1,6-bisphosphatase;pfk, 6-
phosphofructokinase; fba, fructosebisphosphate aldolase; gap, glyceraldehyde-3-phosphate de-
hydrogenase; pgk, phosphoglycerate kinase; pgm, phosphoglycerate mutase; eno, enolase; pyk,
pyruvate kinase. Graph shows RPKM values for each gene to the nearest integer.
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Figure 7.11: Gene expression levels in the TCA cycle, glyoxylate cycle and anaplerotic reac-
tions. Metabolites are shown in capitals, gene transcripts are shown in boxed, italicised script.
Gene abbreviations: pyk, pyruvate kinase; pdhA/B, pyruvate dehydrogenase E1 component;
pde, dihydrolipoamide dehydrogenase; pde2, dihydrolipoamide acetyltransferase; can, aconite;
icd, isocitrate dehydrogenase; sucA, 2-oxoglutarate dehydrogenase E1 component; sucB2, dihy-
drolipoamide succinyltransferase; ogsA/B, oxoglutarate succinyl transferase alpha / beta chain;
sucD/C, succinyl CoA ligase alpha / beta chain; sdhA, succinate dehydrogenase iron-sulphur
protein; sdhB, succinate dehydrogenase flavoprotein subunit; fumA, fumarase; mdh, malate de-
hydrogenase; meP, NADP+ dependent malic enzyme; pc, pyruvate carboxylase; pepck ATP,
phosphoenolpyruvate carboxykinase ATP dependent; icl1, isocitrate lyase; malSG, malate syn-
thase G. Graph shows RPKM values for each gene to the nearest integer.
In the TCA cycle (Fig. 7.11) expression was generally high, except in the genes of succinate de-
hydrogenase (sdhA, sdhB), fumarase (fumA) and malate dehydrogenase (mdh). This suggests
that malate and oxaloacetate were being produced via the anaplerotic reactions. The NADP+
dependent isocitrate dehydrogenase (icd NADP), exhibited no expression, suggesting that the
cells were using the glyoxylate cycle and flux to oxoglutarate may be supplied by reverse flux
from succinate.
174
Figure 7.12: Gene expression levels in the pentose phosphate pathway. Metabolites are
shown in capitals, gene transcripts are shown in boxed, italicised script. Gene abbrevia-
tions: gdph, glucose-6-phosphate 1-dehydrogenase; pglDH, 6-phosphogluconate dehydroge-
nase; repi, ribulose-phosphate 3-epimerase; risB, ribose 5-phosphate isomerase B; tk, transke-
tolase; ta, transaldolase; pgi, glucose-6-phosphate isomerase; pfk, 6-phosphofructokinase; fba,
fructosebisphosphate aldolase. Graph shows RPKM values for each gene to the nearest integer.
In the pentose phosphate pathway (Fig. 7.12) all enzymes of the non oxidative branch had high
expression levels, suggesting that these are being used for the production of pentose sugars.
6-Phosphogluconate dehydrogenase also had relatively high expression; glucose-6-phosphate
1-dehydrogenase however had a low level of expression, which may be due to the major carbon
source of the culture being glycerol.
7.4 Discussion
Difficulties in the extraction of intact RNA from G. thermoglucosidasius, which have been re-
ported previously [192], have also been found in this study. In spite of this, it has been possible
to extract RNA suitable for RNA-seq using the Qiagen RNeasy bacteria mini kit. This method
for RNA extraction is not ideal as it has been reported to exclude transcripts which are less than
200 nucleotides in length [233]. However, several of the most expressed transcripts sequenced
in this study were between 141-153 nucleotides in length, indicating that at least a proportion of
sRNA transcripts are preserved. It is not clear therefore whether the measured expression levels
of the short transcripts identified in this study are true to in vivo gene expression, or whether they
may have been underestimated as a result of transcript loss.
Initial sequencing of a composite RNA sample prepared in this study using the Ambion RiboP-
175
ure bacteria kit resulted in the majority of transcripts (95 %) not being mapped to the reference
genome. A de novo assembly of the unmapped reads (carried out by DeepSeq Nottingham)
was aligned against genome sequences in the NCBI database using the blastn algorithm and
returned species of G. thermoglucosidasius as the most similar alignment, followed by related
species of Anoxybacillus and Bacillus, suggesting that contamination of the sample was not the
reason for the lack of aligned reads. It may be that degradation of the sample using this method
of extraction was too great for accurate alignment of transcripts post sequencing; this however
could not be confirmed as sequencing of RNA extracted using this method could not be repeated
due to the general degradation of samples, indicating that this method is generally not accept-
able as a means of extracting RNA from G. thermoglucosidasius for high throughput sequencing.
It is unfortunate that this study has not seen the refinement of a method that can be used to
consistently extract RNA from G. thermoglucosidasius and it is clear that this warrants further
substantial investigation. Of particular interest is the use of TNS-PAS buffer to denature ther-
mophilic RNase enzymes as this has previously been found to be effective [192] but has not
been observed to make a substantial impact on the level of RNA degradation in this study. There
was general degradation of RNA when this buffer was combined with the Ambion RiboPure bac-
teria RNA kit but it is possible that this denaturant may be used effectively with another protocol.
RNA sample degradation, signified by a drop in the measured RIN of the sample, affects the
relative proportion of expressed transcripts measured [229], therefore the integrity of the RNA
is paramount to studies using RNA-seq to analyse transcriptomics. The apparent propensity for
rapid degradation of RNA in G. thermoglucosidasius should therefore be considered in all tran-
scriptomic studies of the species. It is noteworthy that these problems have not been reported
in the mesophilic related genus Bacillus, and several studies have been carried out which apply
RNA-seq to species of this genus [237–239].
For transcriptomic studies in G. thermoglucosidasius to be extended, particularly using anaerobic
growth conditions which place the cell under greater metabolic stress and appear to expedite the
rate of RNA degradation, problems of extraction of intact RNA need to be addressed. The factors
directly affecting RIN, which has become the de facto measure of quantifying RNA integrity, need
to be comprehensively established. Investigations in this study have been hampered by a lack
of in-house means to measure RIN and the non-linear relationship between 23S/16S ratio, the
method that has been used in this study to quantify RNA degradation, and RIN. RIN has been
found to be a more comprehensive means of assessment of RNA samples [240] and given the
problems of RNA degradation in G. thermoglucosidasius should be used in any future studies.
An accurate means of quantifying RNA degradation is important but likewise, so is preventing
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degradation in the first place, or developing a means to account for the impact RNA degradation
may have had on the final measured expression levels.
The reasons proposed for the observed difficulties in maintaining the integrity of RNA in ther-
mophilic organisms have been that thermophilic RNases are more resistant to denaturation and
additionally have greater catalytic activity [192, 230, 231]. Two types of transcript discovered to
be very highly expressed in the current study, a phosphatase and sRNA molecules, have been
previously implicated in mRNA degradation in bacteria. sRNA molecules can carry out many
regulatory functions within the cell such as preventing translation of mRNA through base pairing
with the RNA molecule but can also facilitate degradation of mRNA [241–243]. Phosphatases
can also be involved in mRNA degradation in bacterial cells by cleavage of 5’ pyrophosphate
[244]. Further investigation will be required to determine whether the highly expressed tran-
scripts discovered here mediate RNA decay and thus contribute to the observed rapid decay
RNA in G. thermoglucosidasius.
Despite problems with extracting intact RNA from G. thermoglucosidasius this study has been
successful in extraction of RNA with a high level of integrity from strain DL33 (wt) under the con-
ditions which exerted a relatively low amount of metabolic stress on the cells. A major advantage
of carrying out RNA-seq over microarray analysis is that it enables the analysis of genes without
the prior specification of which should be investigated. In this study, of the most highly expressed
transcripts that were discovered, many were for unknown genes and thus would not have been
identified prior to sequencing. These genes however hold potential as sources of strong promot-
ers for application in further metabolic engineering of the organism. Further work will be required
to determine the conditions under which these promoters are active or whether expression from
them is constitutive.
Finally, the application of RNA-seq here has added to knowledge that has been gained about the
organism from genome sequencing. Expression of transcripts in the pentose phosphate path-
way showed high expression of the transcripts of the non-oxidative pentose phosphate pathway.
Expression of glucose-6-phosphate dehydrogenase was very low, suggesting that, if flux through
this pathway is possible based on the thermolability of glucono-1,5-lactone-6-phosphate, it is very
low here, as would be expected during growth on glycerol. Expression of 6-phosphogluconate
dehydrogenase was however much higher; this enzyme is not associated with any other reac-
tions other than its role in the pentose phosphate pathway converting gluconate-6-phosphate
to ribulose-5-phosphate but it is not clear what could be supplying gluconate-6-phosphate as
a substrate in this reaction. DL33 (wt) encodes for a gluconokinase (EC 2.7.1.12) which can
produce gluconate-6-phosphate from gluconate, which was also found to be expressed in the
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analysis here, albeit at a low level with an RPKM of 6 but there are no enzymes encoded in
the genome sequence that catalyse to production of gluconate. This suggests that the pentose
phosphate pathway of G. thermoglucosidasius may need further investigation to establish why
6-phosphogluconate dehydrogenase is highly expressed under the conditions studied here and
whether this enzyme has an alternative function in metabolism of the organism.
The RNA-seq analysis here found that in the growth conditions studied, NAD+ dependent gap
was more highly expressed than the NADP+ dependent gap. It was also shown that the NADP+
dependent icd in the TCA cycle was not expressed, suggesting that under these conditions,
carbon flux was channelled via the glyoxylate cycle. It should be borne in mind however that
the ability to reliably extract RNA under only condition in the current study has prevented the the
ability to carryout analysis of differential expression, thus limiting the knowledge gained and high-
lighting the need to determine a robust means of analysis of the RNA of G. thermoglucosidasius.
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8General discussion and further work
Increasingly, systems biology approaches are being applied to metabolic engineering, driven by
advances in functional genomics studies, fluxomic and metabolomic studies. Taking a systems
biology approach to metabolic engineering enables the identification of targets for genetic engi-
neering that take into consideration the metabolism of the whole cell. This study has built upon
previous work to enhance bioethanol production in G. thermoglucosidasius by taking a systems
biology approach to understanding its physiology. This has been through the use of genomic,
transcriptomic and fluxomic analysis of the wild type strain and comparative fluxomic analysis of
the engineered strains.
Physiological studies of strain DL66 (∆ldh∆pfl↑pdh) (Chapter 3) revealed that ethanol produc-
tion by this strain was aided by the presence of thiamine, which is likely to be a result of the
requirement of the pyruvate dehydrogenase complex for thiamine pyrophosphate as a cofac-
tor. Furthermore, where thiamine was included in culture medium, the culture growth rate was
increased in the presence of undefined medium components from tryptone and yeast extract,
indicating that the strain has un-met nutritional requirements under fermentative growth; this is in
keeping with previous studies on this strain [189]. The specific requirements of the strain were
not elucidated here; it may be that the strain has complex nutritional requirements for fermenta-
tive growth as tryptone and yeast extract combined had the most marked effect in increasing the
growth rate of the culture. As found in a previous study [189], the organism could not achieve
steady state growth in chemostats under strict anaerobic conditions even when grown in a rich
medium, suggesting that at least a small amount of oxygen may be essential for growth of the
organism.
Three amino acids, L-glutamate, L-serine and L-threonine, were used to supplement the growth
of the three strains, DL33 (wt), DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) during isotope feeding
experiments used for 13C-MFA in this study. The three amino acids were used to support the in-
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dustrial ethanol production process using strain TM242 (∆ldh↑pdh∆pfl), which is the equivalent
of DL66 (∆ldh∆pfl↑pdh) (R. Cripps, personal communication); however, only serine was found to
be essential for growth and ethanologenesis of strain DL66 (∆ldh∆pfl↑pdh) in this study. A pre-
vious study into the growth of DL44 (∆ldh) found that five amino acids, L-glutamate, L-isoleucine,
L-methionine, L-serine and L-valine [189] were necessary for fermentative growth. Methionine
and isoleucine both derive from oxaloacetate, so provision of threonine probably allows sufficient
flux to both these end products, while the requirement for valine was believed to result from the
effects of isoleucine supplementation on the regulation of common steps in isoleucine and valine
biosynthesis [189, 245]. It is probable that L-glutamate and L-threonine are required by DL44
(∆ldh) due to the decreased flux to the TCA cycle in this strain, demonstrated in this study, and
possible redox stress that the strain may undergo during fermentative growth but this requirement
has been removed in DL66 (∆ldh∆pfl↑pdh) by up regulation of the pdh gene. Decreasing the
number of supplemented amino acids from five to three was useful in this study as it reduces the
number of carbon sources available to the culture, simplifying 13C-MFA calculations. Removal of
threonine from the medium of a steady state culture of strain DL66 (∆ldh∆pfl↑pdh) was actually
found to enhance the growth; this may well be due to the co-regulation of the threonine and ly-
sine biosynthesis pathways and the supplementation of threonine inhibiting lysine biosynthesis
[211]. Nevertheless, the three amino acids were included for all strains for ease of comparison,
enabling each strain to reach steady state growth at a dilution rate of 0.1 hr-1 under fermentative,
micro-aerobic and aerobic conditions, facilitating the study of the strains by 13C-MFA.
Genome sequencing of wild-type strain DL33 (wt) (Chapter 3) has been applied in this study in
order to provide a reference genome for the mapping of sequenced reads of the transcriptome
and to provide information for the construction of metabolic models for 13C-MFA. Analysis of this
genome sequence has provided further insight into the metabolic network of the strain. Notably,
G. thermoglucosidasius strain DL33 (wt), like other species within the Geobacillus genus, en-
codes some but not all of the enzymes within the oxidative branch of the pentose phosphate
pathway. The strain lacks a 6-phosphogluconolactonase for conversion of glucono-1,5-lactone
6-phosphate to gluconate-6-phosphate. It is not unknown for some prokaryotic organisms to
lack an oxidative pentose phosphate pathway, for example, annotated genome sequences within
the KEGG Database show that archea such as members of the genera Sulfolobus and Ther-
mococcus, and some bacteria such as members of the Thermus and Mycoplasma genera do
not encode any enzymes of the oxidative pentose phosphate pathway. In contrast to these
other organisms, Geobacillus spp encode both a glucose-6-phosphate 1-dehydrogenase and
6-phosphogluconate dehydrogenase, suggesting that carbon flux may still be able to proceed
via this pathway but it is dependent on the thermolability of glucono-1,5-lactone 6-phosphate for
spontaneous conversion to gluconate-6-phosphate.
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The lack of a 6-phosphogluconolactonase may interfere with the ability of the strains to regener-
ate NADPH. The genome sequence encodes for several enzymes in central carbon metabolism
which could provide additional regeneration of NADPH, specifically an NADP+-dependent malic
enzyme, an NADP+-dependent isocitrate lyase and an NADP+ dependent glyceraldehyde 3-
phosphate dehydrogenase. Furthermore, in this study it was found that serine was necessary
to maintain steady state growth of DL66 (∆ldh∆pfl↑pdh). A recent study has revealed that ser-
ine is important for NADP+ reduction in mammalian cells by driving conversion of methylenete-
trahydrofolate to 10-formyl-tetrahydrofolate, which involves concomitant NADPH regeneration;
this pathway was found to account for approximately the same amount of NADPH regeneration
in mammalian cells as the oxidative pentose phosphate pathway [246]. The mass isotopomer
distributions of amino acids determined in the present study indicate that a portion of the unla-
belled serine supplemented to cultures is channelled into glycine synthesis. As glycine synthe-
sis involves concomitant production of methylenetetrahydrofolate, it is possible that the strains
requirement for serine is driven by a requirement to reduce NADP+. Further work would be
required, however, to determine whether this is the case, such as by the use of isotopically la-
belled serine or glycine, as described by Fan et al [246]. It is also possible however that the
requirement for serine is driven by the relative proportions of NADH / NAD+ under fermentative
conditions. NADH may inhibit the forwards reaction of phosphoglycerate dehydrogenase in the
serine biosynthesis pathway, as NAD+ is required as a cofactor for this reaction.
In order to further understanding of the fundamental metabolism of the organism, it would be
useful to confirm whether metabolic flux is taking place through the oxidative branch of the pen-
tose phosphate pathway based on the thermolability of glucono-1,5-lactone 6-phosphate. Due
to the presence of the pathway for conversion of fructose-6-phosphate to ribulose-6-phosphate
via arabino-hex-3-ulose-6-phosphate in G. thermoglucosidasius, it is not possible to resolve
metabolic flux between these two pathways in this study, as the transition of carbon atoms is
the same between the two pathways. By use of one of the aerobic strains of Geobacillus how-
ever, such as G. kaustophilus or G. thermoleovorans, neither of which encodes for the pathway
via arabino-hex-3-ulose-6-phosphate, it would be possible to measure metabolic flux which is
taking place through the oxidative pentose phosphate pathway.
Analysis of mass isotopomer distributions found that the supplemented amino acids serine, glu-
tamate and threonine are not absolute requirements for the strains, even under fermentative
conditions. Each strain was capable of de novo synthesis of the amino acids, indicated by the
presence of labelled carbon in all three amino acids under all aeration conditions of each strain
(Chapters 4 and 6). Also, for each amino acid, the amount that was supplemented to the cul-
tures in this study was not sufficient to shut off biosynthesis through feedback-inhibition. The
proportion of labelling of the amino acids differed from one amino acid to another. When the
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cultures were fed on 20 % [U-13C] glucose (Chapter 4), the proportion of labelling in the amino
acids produced from pyruvate - alanine, valine and leucine, remained largely at 20 %, indicating
metabolic steady state. The three supplemented amino acids, along with the amino acids that
are produced from them, namely glycine, proline and isoleucine, all contained a lower proportion
of carbon-13, which decreased with decreasing aeration level. The same effect was also seen
in aspartate; in this case the additional unlabelled carbon is likely to have originated from citrate
and glutamate in the medium.
In this study two approaches were taken to the modelling of isotopomer data to produce overall
flux maps for the cell. Initially biological replicates of each condition and strain were grown in the
small scale bioreactor and each data set modelled separately using a linear isotopomer fitting
method. This approach enabled the production of working models of G. thermoglucosidasius
metabolism and preliminary flux data which revealed differences between the strains and aera-
tion conditions in anaplerotic flux and the TCA cycle. Importantly, it was found that inclusion in
the models of all transaminase steps in amino acid biosynthesis pathways lead to less models
being able to find global flux solutions. Additionally, under lower aeration conditions, some flux
distributions produced showed the TCA cycle operating in reverse but the residuums would not
pass a χ2 test at a 95 % confidence interval, indicating a local best-fit flux distribution. Constrain-
ing the TCA cycle in the forward direction resulted in a greater number of global best fit solutions
which did pass the χ2 cut off point. The flux data generated using this first approach exhibited
substantial variability, which can be attributed to problems with accurately reproducing conditions
in a small bioreactor and also the linear modelling approach finding only one flux solution for the
isotopomer data, as well as the isotopic labelling used not being able to resolve the entirety of
the metabolic network.
The second approach modelled single isotopomer datasets from chemostat cultivations using a
multi-simulation approach, which avoids local best-fit flux solutions by providing multiple flux so-
lutions for each model. In this study, 100 different flux solutions were produced from each model
using the multi-simulation approach, from which, all those passing a χ2 cut off were used to cal-
culate the average flux and the standard deviation of flux. This latter approach produced high
resolution of the fluxes across the metabolic network. There were two exceptions however in the
case of the anaplerotic reactions and parallel reactions through the pentose phosphate pathway.
The pooling of these two sets of pathways was found to enable the production of overall high
resolution flux distributions for each of the strains and removed the high level of variability seen
in the anaplerotic reactions in the initial flux modelling approach. Furthermore, in the second
approach, ethanol efflux was set as a free flux so that the amount of ethanol flux was determined
during the isotopomer fitting procedure and incorporated the amount ethanol that was lost during
cultivation due to evaporation. As a result TCA cycle flux in the second approach to flux mod-
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elling was found to be different to that of the first approach, with the wild type strain having a
higher TCA cycle flux than the engineered strains.
The multiple simulation flux modelling approach revealed that the strains differed in their anaplerotic
reactions under fermentative growth, with the wild type strain, DL33 (wt) exhibiting a net flux in
the direction of pyruvate / phosphoenolpyruvate. In contrast the engineered strains exhibited a
net flux in the direction of malate / oxaloacetate. The alteration of the overall net flux in the engi-
neered stains may be due to the strain using flux through phosphoenolpyruvate carboxykinase to
generate ATP. It may also be that flux through the PDH (strain DL66 (∆ldh∆pfl↑pdh) and strain
DL44 (∆ldh)) or PFL (strain DL44 (∆ldh) only) needs to be increased by upregulation of the
respective enzymes, in order to cope with the increased flux through these pathways which has
been generated by carbon no longer being lost to lactate under fermentative conditions in these
strains. Flux in the direction of oxaloacetate / malate was higher in DL66 (∆ldh∆pfl↑pdh) than
DL44 (∆ldh); this has been reported previously in B. succiniciproducens, where a higher flux was
seen through the same route in a ∆ldh∆pfl double knockout strain compared to a ∆ldh single
knock out strain [115]. In addition, flux through the TCA cycle was reduced in the engineered
strains, it was lowest in strain DL44 (∆ldh); DL66 (∆ldh∆pfl↑pdh), whilst having a higher TCA
cycle flux than DL44 (∆ldh), was still below that of DL33 (wt). This suggests that enzymes requir-
ing NAD+ as a cofactor, such as the oxoglutarate dehydrogenase complex and malate deydro-
genase, may be inhibited in the engineered strains under fermentative conditions due to higher
levels of NADH. A lower flux through the TCA cycle may contribute the requirement for additional
amino acids described in the previous study of DL44 (∆ldh) [189], as a lack of flux to oxaloac-
etate and oxoglutarate could inhibit the production of amino acids for which these compounds
are precursors. Furthermore excess pyruvate in the engineered strains, due to decreased flux to
the TCA cycle, could increase flux to valine which could inhibit isoleucine biosynthesis, as valine
inhibits acetohydroxyacid synthetase, which is common to both the biosynthetic pathways of va-
line and isoleucine [247]. Overall, the second approach to 13C-MFA was able to provide a more
reliable flux analysis of the strains, due mostly to using a labelled isotope feed that was able to
resolve all the major pathways of the network and also the use of multiple simulations, so that
many flux distributions could be created that converged on an optimal global best-fit flux solution
for the isotopomer data.
The work carried out in this study has revealed potential targets which could be applied in
metabolic engineering of G. thermoglucosidasius strain DL66 (∆ldh∆pfl↑pdh) to enhance ethanol
production. Notably, it was found (Chapter 4) that alanine was being produced as a fermentation
product in the strains and this increased in the engineered strains. Metabolic engineering of the
alanine biosynthesis pathway to change the alanine dehydrogenase gene for a transaminase
counterpart could prevent loss of carbon through this pathway as it would no longer regener-
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ate NAD+. Both biofuel products for which G. thermoglucosidasius has been identified as a
potential producer, bioethanol [12] and isobutanol [176], have final reduction steps by alcohol
dehydrogenase in their production pathways, plus an additional reduction step by ketol-acid re-
ductoisomerase in the case isobutanol. The way in which the cell maintains its redox balance is
therefore critical for biofuel production. In the present study, flux to ethanol could be increased
if alanine biosynthesis was altered so it no longer provided a means of NAD+ regeneration,
this would increase the capacity of the organism as a biofuel producer. Additionally, changes to
the anaplerotic reactions caused by genetic engineering of the organism, shown by 13C-MFA,
could be addressed potentially by further upregulation of pdh in strain DL66 (∆ldh∆pfl↑pdh),
which could also increase carbon flux to ethanol production by reducing the flux through the
anaplerotic reactions to malate and oxaloacetate. This could however, negatively impact upon
the phenotype of the strain by further reducing TCA cycle flux.
As Geobacillus spp have been identified as organisms that could be applied in the production of
other compounds [172, 176], the analysis of the genomic sequence of the organism in this study
can aid the development of G. thermoglucosidasius for production of novel chemicals by enabling
identification of relevant pathways. Furthermore, the flux models, which have been constructed
here can be applied in other metabolic studies of Geobacillus spp., also potentially aiding devel-
opment of Geobacillus spp for production of novel compounds.
In the application of RNA-seq to G. thermoglucosidasius in this study, it was found that RNA from
G. thermoglucosidasius is prone to rapid degradation which compromises the ability to accu-
rately carry out high throughput transcriptomic analysis of the organism. Nevertheless, RNA-seq
was carried out and has been used to identify the transcripts for enzymes in central carbon
metabolism. This transcript data could also help to guide the development of the molecular bi-
ology tools available for the continued development of G. thermoglucosidasius by helping to de-
termine the relative strength of different promoters that can be applied in metabolic engineering.
A benefit to carrying out analysis at a systems level is it can reveal unexpected outcomes. This
study has identified several highly expressed transcripts under the condition studied; these se-
quences have the potential to be sources of strong promoters which can be applied in metabolic
engineering of G. thermoglucosidasius but are unlikely to have been identified without taking a
systems approach. For transcriptomic studies of G. thermoglucosidasius to be extended how-
ever, it will be necessary to continue refinement of RNA handling and analysis techniques in
order to ensure that degradation of RNA does not influence the measured expression levels. Re-
cent work by collaborators at the University of Bath (unpublished) has seen the analysis of RNA
from G. thermoglucosidasius strain NCIMB 11955 (wt), which had been extracted from cells un-
der both aerobic and anaerobic growth conditions using the same method as was applied in the
present study. This was achieved by sequencing a smaller volume of RNA and using samples
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which had degraded further than would generally be used in RNA-seq analysis. Whilst work
may be required to account for the effect of degradation on the measured expression levels, this
is a very promising step towards more complete transcriptomic analysis of G. thermoglucosida-
sius. A notable limitation of the current work is the need for further biological replicates in flux
analysis and RNA-seq for comparison of data and better statistical determination of results. It
has recently been noted that a lack of biological replicates in RNA-seq data, in order to increase
the sequencing depth of individual samples, has a negative effect on the ultimate analyses for
differential gene expression [248]. Furthermore, as discrepancy was found between the present
study and that of Tang et al. [190] on the flux distribution between the glyoxylate cycle and the
TCA cycle, further biological replicates of flux analysis using the isotopically labelled feed which
can resolve the glyoxylate cycle (60 % [1-13C] glucose with 40 % [U-13C glucose), would enable
greater comparison of the two studies.
A full systems biology understanding of an organism encompasses several aspects, specifically
understanding the structure, dynamics and control of the system and being able to design de-
sired properties of the system [2], extension of this study using metabolomic and proteomic
techniques could help complete a full picture of G. thermoglucosidasius metabolism. Both pro-
teomics and metabolomics could help to further understand the structure of the system, such as
the unresolved structure of the oxidative branch of the pentose phosphate pathway, by reveal-
ing to what extent the enzymes and metabolites of this pathway are produced. Likewise, both
could provide further understanding on the split of flux between isocitrate dehydrogenase and
the glyoxylate cycle as, in the present study flux was determined to be predominantly through
isocitrate dehydrogenase, whilst in the previous study by Tang et al. [190], a greater proportion
of flux was found to be going through the glyoxylate cycle under fermentative conditions. Fur-
thermore, metabolomic and proteomic analysis combined with further transcriptomic analysis of
G. thermoglucosidasius, when used in combination could help to determine at which level of the
biological hierarchy control is exerted over metabolic processes, for example whether control of
certain routes of flux is exerted at the level of transcription or translation. Knowledge of such
processes is useful for the targeting metabolic engineering approaches. To date there are no re-
ports of metabolomic analyses carried out in species of Geobacillus; however proteomic analysis
has been carried out in three species, namely G. thermodenitrificans [160], G. thermoleovorans
[249, 250] and Geobacillus sp. E263 with a bacteriophage [251]. This has led to the character-
isation of novel pathways [160] and the annotation of gene function [249, 250], indicating how
further application of systems biology techniques in G. thermoglucosidasius may help to further
understand this organism.
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8.1 Conclusions
Taking a systems biology approach to understanding the physiology of wild type and engineered
G. thermoglucosidasius has revealed new aspects of metabolism in the organism not previously
studied. This has provided potential new targets for the continued engineering of this host for
development as a bioethanol producer. Additionally, it lays the foundations for further metabolic
engineering employing systems biology techniques in G. thermoglucosidasius, which could be
applied in the production of other useful compounds.
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AIdentification of MTBSTFA derivatized amino acids
Table A.1: Approximate retention time and m/z ratio of MTBSTFA
derivatized amino acid fragments used for identification of proteino-
genic amino acids on mass spectra. *NB the M-159 fragment of ala-
nine is not detectable with the acquisition parameters used in this
study.
Amino acid Approx. reten-
tion time (min)
Mass fragment M+0 m/z
Alanine 2 TBDMS 3.51 M-15 302
M-57 260
M-85 232
M-159 158*
Glycine 2 TBDMS 3.61 M-15 288
M-57 246
M-85 218
Valine 2 TBDMS 4.06 M-15 330
M-57 288
M-85 260
M-159 186
Leucine 2 TBDMS 4.25 M-15 344
M-57 302
M-85 274
M-159 200
Continued on next page
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Amino acid Approx. reten-
tion time (min)
Mass fragment M+0 m/z
Isoleucine 2 TBDMS 4.40 M-15 344
M-57 302
M-85 274
M-159 200
Proline 2 TBDMS 4.64 M-15 328
M-57 286
M-85 258
M-159 184
Methionine 2 TBDMS 5.66 M-15 362
M-57 320
M-85 292
M-159 218
Serine 3 TBDMS 5.73 M-15 432
M-57 390
M-85 362
M-159 288
Threonine 3 TBDMS 5.83 M-15 446
M-57 404
M-85 376
M-159 302
Phenylalanine 2 TBDMS 6.21 M-15 378
M-57 336
M-85 308
M-159 234
Aspartate 3 TBDMS 6.53 M-15 460
M-57 418
M-85 390
M-159 316
Continued on next page
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Amino acid Approx. reten-
tion time (min)
Mass fragment M+0 m/z
Glutamic acid 3 TBDMS 7.07 M-15 460
M-57 418
M-85 390
M-159 316
Lysine 3 TBDMS 7.57 M-15 473
M-57 431
M-85 403
M-159 329
Histidine 3 TBDMS 8.48 M-15 482
M-57 440
M-85 412
M-159 338
Tyrosine 3 TBDMS 8.70 M-15 508
M-57 466
M-85 438
M-159 364
Table A.2: Metabolites and their corresponding TBDMS derivatives
for mass correction using IsoCor software
Metabolites Metabolite Formula
Ala M-57 CH3NHCHCOO
Gly M-57 CH2NHCOO
Val M-57 C2H6CHCHNHCOO
Leu M-85 C2H6CHCH2CHNHO
Ile M-159 CH3CH2CH3CHCHNH
Pro M-85 NC3H6CHO
Ser M-57 OCH2CHNHCOO
Continued on next page
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Metabolites Metabolite Formula
Thr M-57 CH3CHOCHNHCOO
Phe M-57 C6H5CH2CHNHCOO
Asp M-57 COOCH2NHCHCOO
Glu M-57 COOCH2CH2NHCHCOO
Lys M-57 NHC4H8NHCHCOO
His M-57 NCHNCCHCH2NHCHCOO
Metabolite Derivative Formula
Ala M-57 C2H6SiC6H15Si
Gly M-57 C2H6SiC6H15Si
Val M-57 C2H6SiC6H15Si
Leu M-85 C2H6SiC6H15Si
Ile M-159 C6H15Si
Pro M-85 C2H6SiC6H15Si
Ser M-57 C2H6SiC6H15SiC6H15Si
Thr M-57 C2H6SiC6H15SiC6H15Si
Phe M-57 C2H6SiC6H15Si
Asp M-57 C2H6SiC6H15SiC6H15Si
Glu M-57 C2H6SiC6H15SiC6H15Si
Lys M-57 C6H15SiC6H15SiC6H15Si
His M-57 C2H6SiC6H15SiC6H15Si
Table A.3: Approximate retention time and m/z of M=0 weights of
MTBSTFA derivatized external metabolites fragments identified in this
study based on their details in the Fiehn Lib GC-MS metabolite library
[197].
Metabolite Approx. reten-
tion time (min)
Mass fragment M+0 m/z ratio
Lactate 2 TBDMS 12.68 M-57 261
Succinate 2 TBDMS 15.75 M-57 289
Malate 3 TBDMS 19.21 M-57 419
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Table A.4: External metabolites and their corresponding TBDMS
derivatives used for mass correction with the Matlab MS Correction
tool in this study [200].
Metabolites Metabolite Formula
Lac M-57 CH3CHOCOO
Suc M-57 COOCH2CH2COO
Mal M-57 COOCH2CHOCOO
Metabolite Derivative Formula
Lac M-57 C2H6SiC6H15Si
Suc M-57 C2H6SiC6H15Si
Mal M-57 C2H6SiC6H15SiC6H15Si
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BGeobacillus thermoglucosidasius reaction
networks for 13C metabolic flux analysis using
13CFLUX2
B.1 Reaction network for aerobic metabolism of G. thermoglu-
cosidasius
Table B.1: Final metabolic network of aerobic reactions used in 13C-
MFA calculation with positionally labelled glucose isomers.
Reaction Stoichiometry and carbon atom transitions
uptS SER (#ABC)→ Ser (#ABC)
uptT THR (#ABCD)→ The (#ABCD)
uptE GLU (#ABC)→ Glu (#ABCD)
uptU GLCU (#ABCDEF)→ GLC (#ABCDEF)
upt0 GLC0 (#ABCDEF)→ Glu (#ABCDEF)
upt GLC (#ABCDEF)→ G6P (#ABCDEF)
uptco2 co2 (#A)→ CO2 (#A)
uptcx cx (#A)→ CX (#A)
uptC Cit (#ABCDEF)→ CitICit (#ABCDEF)
emp1 G6P (#ABCDEF)→ F6P (#ABCDEF)
emp2 F6P (#ABCDEF)→ FBP (#ABCDEF)
emp3 FBP (#ABCDEF) → GAP (#ABC) + GAP
(#ABC)
emp4 GAP (#ABC)→ PGA (#ABC)
emp5 PGA (#ABC)→ PEP/PYR (#ABC)
ppp1 G6P (#ABCDEF) → Ru5P (#BCDEF) + CO2
(#A)
Continued on next page
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Reaction Stoichiometry and carbon atom transitions
ppp2 Ru5P (#ABCDE)→ X5P (#ABCDE)
ppp3 Ru5P (#ABCDE)→ R5P (#ABCDE)
ppp4 X5P (#ABCDE) + E4P (#abcd)→ GAP (#CDE)
+ F6P (#ABabcd)
ppp5 X5P (#ABCDE) + R5P (#abcde) → S7P
(#ABabcde) + GAP (#CDE)
ppp6 GAP (#ABC) + S7P (#abcdefg) → E4P (#defg)
+ F6P (#abcABC)
tca1 PEP/PYR (#ABC)→ AcCoA (#BC) + CO2 (#A)
tca2 MAL/OAA (#ABCD) + AcCoA (#ab) → CitICit
(#DCBbaA)
tca3 CitICit (#ABCDEF) → OGA (#ABCDE) + CO2
(#F)
tca4 OGA (#ABCDE)→ SUC (#BCDE) + CO2 (#A)
tca4a SUC (#ABCD)→ FUM (#ABCD)
tca5a FUM (#ABCD)→ MAL/OAA (#ABCD)
tca5b FUM (#ABCD)→ MAL/OAA (#DCBA)
gs1 CitICit (#ABCDEF) → Glx (#AB) + SUC
(#DCEF)
gs2 Glx (#AB) + AcCoA (#ab)→MAL/OAA (#ABba)
ana1 MAL/OAA (#ABCD)→ PEP/PYR (#ABC) + CO2
(#D)
BM_pga1 PGA (#ABC)→ Ser (#ABC)
BM_pga2 Ser (#ABC)→ Gly (#AB) + CX (#C)
BM_pga3 Ser (#ABC)→ Cys (#ABC)
BM_pga4 Cys (#ABC) + Thr (#abcd) + CX (#e) → Met
(#abcde) + PEP/PYR (#ABC)
BM_pyr1 PEP/PYR (#ABC)→ ALA (#ABC)
BM_pyr3 PEP/PYR (#ABC) + PYR (#abc) → AKV (#AB-
bcC) + CO2 (#a)
BM_pyr2 AKV (#ABCDE)→ VAL (#ABCDE)
BM_pyr4 AKV (#ABCDE) + AcCoA (#ab) → LEU (#ab-
BCDE) + CO2 (#A)
BM_pep1 PEP/PYR (#ABC) + E4P (#abcd) → DHAP
(#ABCabcd)
Continued on next page
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Reaction Stoichiometry and carbon atom transitions
BM_pep2 PEP/PYR (#ABC) + DHAP (#abcdefg) →
CHOR (#ABCabcdefg)
BM_pep3a CHOR (#ABCDEFGHIJ) → TyrPhe (#ABCE-
FGHIJ) + CO2 (#D)
BM_pep3b CHOR (#ABCDEFGHIJ) → TyrPhe (#ABCEJI-
HGF) + CO2 (#D)
BM_pep4 CHOR (#ABCDEFGHIJ) + R5P (#abcde) + Ser
(#jkl)→ GAP (#cde) + PEP/PYR (#ABC) + D (#
CO2 + Trp (#jklEFGHIJab)
BM_oga1 OGA (#ABCDE)→ Gly (#ABCDE)
BM_oga2 Glu (#ABCDE)→ Pro (#ABCDE)
BM_oga3 Glu (#ABCDE) + CO2 (#a)→ Arg (#ABCDEa)
BM_oaa1 MAL/OAA (#ABCD)→ Asp (#ABCD)
BM_oaa2 Asp (#ABCD) + CX (#a) + Cys (#fgh) → Met
(#ABCDa) + PEP/PYR (#fgh)
BM_oaa3 ASP (#ABCD)→ THR (#ABCD)
BM_oaa4 Thr (#ABCD) + PEP/PYR (#abc) → Ile (#AB-
bCDc) + CO2 (#a)
BM_oaa7 ILE (#ABCDEF) + CX (#a)→ SUC (#ABCDa) +
CO2 (#A) + AcCoA (#EF)
BM_oaa6a Asp (#ABCD) + PEP/PYR (#abc) → Lys
(#ABCDcb) + CO2 (#a)
BM_oaa6a Asp (#ABCD) + PEP/PYR (#abc) → Lys
(#abcDCB) + CO2 (#A)
BM_r5p1 R5P (#ABCDE) + CX (#a)→ His (#ABCDEa)
Reactions for efflux of metabolites to medium and biomass
BM_pga1_aux Ser (#ABC)
BM_pga2_aux Gly (#AB)
BM_pga3_aux Cys (#ABC)
BM_pga4_aux Met (#ABCDE)
BM_pyr1_aux Ala (#ABC)
BM_pyr2_aux Val (#ABCDE)
BM_pyr4_aux Leu (#ABCDEF)
BM_pep3_aux TyrPhe (#ABCDEFGHI)
BM_pep4_aux Trp (#ABCDEFGHIJK)
Continued on next page
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Reaction Stoichiometry and carbon atom transitions
BM_oga1_aux Glu (#ABCDE)
BM_oga2_aux Pro (#ABCDE)
BM_oga3_aux Arg (#ABCDEF)
BM_oaa1_aux Asp (#ABCD)
BM_oaa3_aux Thr (#ABCD)
BM_oaa4_aux Ile (#ABCDEF)
BM_oaa6_aux Lys (#ABCDEF)
BM_r5p1_aux HIS (#ABCDEF)
BM_G6P G6P (#ABCDEF)
BM_F6P F6P (#ABCDEF)
BM_GAP GAP (#ABC)
BM_R5P R5P (#ABCDE)
BM_Ru5P Ru5P (#ABCDE)
BM_X5P X5P (#ABCDE)
BM_Ac AcCoA (#AB)
CoOut CO2 (#A)
1Citrate out reaction was replaced with citrate uptake reaction where applicable
B.2 Reaction network for anaerobic metabolism of G. ther-
moglucosidasius
All flux calculations carried out for fermentative and micr-aerobic growth included the reactions for
aerobic growth, (Table B.1), with additional reactions for the production and efflux of fermentation
products and pyruvate and acetate shown below.
Table B.2: Reactions added to network for calculation of flux under
fermentative and micro-aerobic conditions.
Reaction Stoichiometry and carbon atom transitions
Ferm_1 PEP/PYR (#ABC)→ Lac (#ABC)
Ferm_2 PEP/PYR (#ABC)→ AcCoA (#BC) + For (#A)
Ferm_3 AcCoA (#AB)→ Eth (#AB)
LacOut Lac (#ABC)
Continued on next page
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Reaction Stoichiometry and carbon atom transitions
ForOut For (#A)
EthOut Eth (#AB)
SucOut Suc (#ABCD)
PyrOut PEP/PYR (#ABC)
AlaOut Ala (#ABC)
Ferm4 AcCoA (#AB)→ Ace (#AB)
AceOut Ace (#AB)
Reaction networks for DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) were constructed so that they
reflected the metabolic engineering of these strains. The "Ferm 1" and "LacOut" reactions were
removed from the DL44 (∆ldh) and DL66 (∆ldh∆pfl↑pdh) models and additionally the "Ferm 2"
and "ForOut" reactions were removed from the DL66 (∆ldh∆pfl↑pdh) model.
B.3 Reaction for conversion of fructose-6-phosphate to ribulose-
6-phosphate
Reaction included for the reversible conversion of fructose-6-phosphate to ribulose-5-phosphate
via arabino-hex-3-ulose-6-phosphate in the simulation of positionally labelled isotope experi-
ments.
Table B.3: Arabino-hex-3-ulose-6-phosphate pathway found in the
pentose phosphate pathway of G. thermoglucosidasius.
Reaction Stoichiometry and carbon atom transitions
ppp7 F6P (#ABCDEF) → Ru5P (#BCDEF) + A (#
CO2
219
CCombining of metabolite pools in metabolic flux
calculation
220
Figure C.1: Combining of metabolite pools in metabolic flux calculation. Multiple simulations
of metabolic flux models of A) DL33 (wt), B) DL44 (∆ldh) and C) DL66 (∆ldh∆pfl↑pdh). Grey
bars show average flux for each reaction of simulations passing a χ2 test without any pooling
of metabolites or combining of reactions. Red bars show average flux with the pooling of ox-
aloacetate and malate into a single metabolite, phosphoenolpyruvate and pyruvate into a single
metabolite and the combining of reactions ppp1 and ppp7 into a single reversible reaction. Error
bars show the standard deviation of the flux between simulations passing χ2 test.
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DCultivation of G. thermoglucosidasius
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Figure D.1: Cultivation of G. thermoglucosidasius] A-C 60 % [1-13C] glucose 40 % [U-13C] glu-
cose, A: DL33 fermentative, B: DL44 (∆ldh fermentative, C: DL66 (∆ldh∆pfl↑pdh) fermentative.
D-L 20 % [1-13C] glucose 80 % [U-13C] glucose, D: DL33 fermentative, E: DL44 (∆ldh fermen-
tative, F: DL66 (∆ldh∆pfl↑pdh) fermentative. G: DL33 micro-aerobic, H: DL44 (∆ldh microaer-
obic, I: DL66 (∆ldh∆pfl↑pdh) micro-aerobic. J: DL33 aerobic, K: DL44 (∆ldh) aerobic, L: DL66
(∆ldh∆pfl↑pdh) aerobic.
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EBiomass requirements of strains G.
thermoglucosidasius
Table E.1: Biomass requirements used for modelling of 20 [U-13C]-
glucose:80 [U-12C]-glucose isotopomer data
Metabolite Organism Requirement
(mmol g
DCW)
Reference
Asp/Asn G. thermoglucosidasius TM242 447.24 S. Masakapalli, University
of Bath (Unpublished)
Thr G. thermoglucosidasius TM242 270.80 S. Masakapalli, University
of Bath (Unpublished)
Ser G. thermoglucosidasius TM242 182.51 S. Masakapalli, University
of Bath (Unpublished)
Glu/Gln G. thermoglucosidasius TM242 648.88 S. Masakapalli, University
of Bath (Unpublished)
Gly G. thermoglucosidasius TM242 410.79 S. Masakapalli, University
of Bath (Unpublished)
Ala G. thermoglucosidasius TM242 518.08 S. Masakapalli, University
of Bath (Unpublished)
Val G. thermoglucosidasius TM242 378.99 S. Masakapalli, University
of Bath (Unpublished)
Met G. thermoglucosidasius TM242 85.62 S. Masakapalli, University
of Bath (Unpublished)
Ile G. thermoglucosidasius TM242 274.86 S. Masakapalli, University
of Bath (Unpublished)
Continued on next page
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Metabolite Organism Requirement
(mmol g
DCW
Reference
Leu G. thermoglucosidasius TM242 350.10 S. Masakapalli, University
of Bath (Unpublished)
Tyr G. thermoglucosidasius TM242 104.38 S. Masakapalli, University
of Bath (Unpublished)
Phe G. thermoglucosidasius TM242 146.21 S. Masakapalli, University
of Bath (Unpublished)
His G. thermoglucosidasius TM242 78.41 S. Masakapalli, University
of Bath (Unpublished)
Lys G. thermoglucosidasius TM242 319.56 S. Masakapalli, University
of Bath (Unpublished)
Arg G. thermoglucosidasius TM242 184.47 S. Masakapalli, University
of Bath (Unpublished)
Pro G. thermoglucosidasius TM242 167.80 S. Masakapalli, University
of Bath (Unpublished)
Trp* G. thermoglucosidasius TM242 103.40 S. Masakapalli, University
of Bath (Unpublished)
Cys* G. thermoglucosidasius TM242 108.68 S. Masakapalli, University
of Bath (Unpublished)
Acetyl CoA G. thermoglucosidasius M10EXG 513 [190]
Glucose-6-
phosphate
B. Subtilis 712 [222]
Glyceraldehyde
3-phosphate
B. Subtilis 428 [222]
Ribose-5-
phosphate
B. Subtilis 445 [222]
Phosphenol-
pyruvate
B. Subtilis 642 [222]
Pyruvate B. Subtilis 2994 [222]
Oxaloacetate B. Subtilis 1785 [222]
Oxoglutarate B. Subtilis 1236 [222]
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Table E.2: Biomass requirements of strains DL33 (wt) DL44 (∆ldh)
and DL66 (∆ldh∆pfl↑pdh) undergoing fermentative growth. Study
was undertaken at University of Bath in collaboration with S. Masaka-
palli.
Requirement (mmol g DCW)
Metabolite DL33 (wt) DL44 (∆ldh) DL66
(∆ldh∆pfl↑pdh)
Asp/Asn 0.499 0.486 0.505
Thr 0.302 0.295 0.306
Ser 0.204 0.199 0.206
Glu/Gln 0.724 0.706 0.732
Gly 0.458 0.447 0.464
Ala 0.578 0.564 0.585
Val 0.423 0.412 0.428
Met 0.096 0.093 0.097
Ile 0.307 0.299 0.310
Leu 0.391 0.381 0.395
Tyr 0.116 0.114 0.118
Phe 0.163 0.159 0.165
His 0.087 0.085 0.088
Lys 0.357 0.348 0.361
Arg 0.206 0.201 0.208
Pro 0.187 0.183 0.189
Trp 0.115 0.112 0.117
Cys 0.121 0.118 0.123
dAMP 0.016 0.015 0.017
dCMP 0.012 0.012 0.013
dTMP 0.016 0.015 0.017
dGMP 0.012 0.012 0.013
AMP 0.100 0.099 0.098
GMP 0.128 0.127 0.127
CMP 0.070 0.070 0.069
UMP 0.076 0.076 0.075
Arabinose 0.050 0.057 0.056
Galactose 0.234 0.266 0.261
Continued on next page
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Requirement (mmol g DCW)
Metabolite DL33 (wt) DL44 (∆ldh) DL66
(∆ldh∆pfl↑pdh)
Glucose 0.012 0.013 0.013
Xylose 0.226 0.256 0.251
Mannose 0.007 0.008 0.008
Fructose 0.130 0.147 0.144
Glycerol (3C) 0.153 0.174 0.170
Fatty acid (2C) 3.027 3.436 3.374
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FCommands used for isotopomer metabolic flux
calculation using 13CFLUX2
Table F.1: Commands used for isotopomer metabolic flux calculation
in this study using 13CFLUX2 software programs. All commands are
detailed in the 13CFLUX2 reference manual [201]
Command Function
fmllint Carries out semantic and syntactic check of flux models
sscanner Choses a set of free fluxes based on the analytical centre
of the model constraints
fwdsim Carries out single simulation of isotopomer model. Use
with ’-s’ option provides the sensitivities of the fluxes
fitfluxes Carries out simulations of up to 1000 iterations to repro-
duce a set of measured isotopomers in an isotopomer
model
ssampler Creates a set of random flux distributions from the stoi-
chiometries of the metabolic model
multifit As fitfluxes but can be used to run simulations from mul-
tiple free flux starting points using values generated from
ssampler
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